id sid tid token lemma pos iajs-1880 1 1 microsoft microsoft PROPN iajs-1880 1 2 word word NOUN iajs-1880 1 3 539 539 NUM iajs-1880 1 4 - - SYM iajs-1880 1 5 551 551 NUM iajs-1880 1 6 ihsciconf ihsciconf NOUN iajs-1880 1 7 2017 2017 NUM iajs-1880 1 8 special special ADJ iajs-1880 1 9 issue issue NOUN iajs-1880 1 10 ibn ibn PROPN iajs-1880 1 11 al al PROPN iajs-1880 1 12 - - PUNCT iajs-1880 1 13 haitham haitham PROPN iajs-1880 1 14 journal journal PROPN iajs-1880 1 15 for for ADP iajs-1880 1 16 pure pure ADJ iajs-1880 1 17 and and CCONJ iajs-1880 1 18 applied apply VERB iajs-1880 1 19 science science NOUN iajs-1880 1 20 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 1 21 for for ADP iajs-1880 1 22 more more ADJ iajs-1880 1 23 information information NOUN iajs-1880 1 24 about about ADP iajs-1880 1 25 the the DET iajs-1880 1 26 conference conference NOUN iajs-1880 1 27 please please INTJ iajs-1880 1 28 visit visit VERB iajs-1880 1 29 the the DET iajs-1880 1 30 websites website NOUN iajs-1880 1 31 : : PUNCT iajs-1880 1 32 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 1 33           SPACE iajs-1880 1 34 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 1 35     SPACE iajs-1880 1 36 biology|539 biology|539 NOUN iajs-1880 1 37         SPACE iajs-1880 1 38 seroprevalence seroprevalence NOUN iajs-1880 1 39 of of ADP iajs-1880 1 40 toxoplasmosis toxoplasmosis NOUN iajs-1880 1 41 antibodies antibodie VERB iajs-1880 1 42 among among ADP iajs-1880 1 43 diabetes diabetes NOUN iajs-1880 1 44 mellitus mellitus NOUN iajs-1880 1 45 patients patient NOUN iajs-1880 1 46 and and CCONJ iajs-1880 1 47 assessment assessment VERB iajs-1880 1 48 some some DET iajs-1880 1 49 biochemical biochemical ADJ iajs-1880 1 50 markers marker NOUN iajs-1880 1 51 sarah sarah PROPN iajs-1880 1 52 ali ali PROPN iajs-1880 1 53 saeed saeed PROPN iajs-1880 1 54 israa israa PROPN iajs-1880 1 55 kasim kasim PROPN iajs-1880 1 56 al al PROPN iajs-1880 1 57 - - PUNCT iajs-1880 1 58 aubaidi aubaidi PROPN iajs-1880 2 1 israakasem@gmail.com israakasem@gmail.com PROPN iajs-1880 2 2 department department PROPN iajs-1880 2 3 of of ADP iajs-1880 2 4 biology biology NOUN iajs-1880 2 5 , , PUNCT iajs-1880 2 6 college college NOUN iajs-1880 2 7 of of ADP iajs-1880 2 8 education education NOUN iajs-1880 2 9 for for ADP iajs-1880 2 10 pure pure ADJ iajs-1880 2 11 science science NOUN iajs-1880 2 12 ( ( PUNCT iajs-1880 2 13 ibn ibn PROPN iajs-1880 2 14 alhaitham alhaitham NOUN iajs-1880 2 15 ) ) PUNCT iajs-1880 2 16 , , PUNCT iajs-1880 2 17 university university NOUN iajs-1880 2 18 of of ADP iajs-1880 2 19 baghdad baghdad PROPN iajs-1880 2 20 abstract abstract ADJ iajs-1880 2 21 toxoplasma toxoplasma NOUN iajs-1880 2 22 gondii gondii NOUN iajs-1880 2 23 is be AUX iajs-1880 2 24 a a DET iajs-1880 2 25 protozoan protozoan NOUN iajs-1880 2 26 intracellular intracellular ADJ iajs-1880 2 27 coccidian coccidian ADJ iajs-1880 2 28 protozoan protozoan NOUN iajs-1880 2 29 parasite parasite NOUN iajs-1880 2 30 . . PUNCT iajs-1880 3 1 latent latent ADJ iajs-1880 3 2 toxoplasmosis toxoplasmosis NOUN iajs-1880 3 3 threat threat NOUN iajs-1880 3 4 to to ADP iajs-1880 3 5 immunocompetent immunocompetent ADJ iajs-1880 3 6 individuals individual NOUN iajs-1880 3 7 . . PUNCT iajs-1880 4 1 diabetic diabetic ADJ iajs-1880 4 2 patients patient NOUN iajs-1880 4 3 are be AUX iajs-1880 4 4 more more ADV iajs-1880 4 5 susceptible susceptible ADJ iajs-1880 4 6 to to PART iajs-1880 4 7 infect infect VERB iajs-1880 4 8 with with ADP iajs-1880 4 9 toxoplasmosis toxoplasmosis NOUN iajs-1880 4 10 due due ADP iajs-1880 4 11 to to ADP iajs-1880 4 12 their their PRON iajs-1880 4 13 low low ADJ iajs-1880 4 14 level level NOUN iajs-1880 4 15 of of ADP iajs-1880 4 16 immunity immunity NOUN iajs-1880 4 17 response response NOUN iajs-1880 4 18 . . PUNCT iajs-1880 5 1 the the DET iajs-1880 5 2 purpose purpose NOUN iajs-1880 5 3 of of ADP iajs-1880 5 4 this this DET iajs-1880 5 5 research research NOUN iajs-1880 5 6 is be AUX iajs-1880 5 7 to to PART iajs-1880 5 8 define define VERB iajs-1880 5 9 the the DET iajs-1880 5 10 association association NOUN iajs-1880 5 11 between between ADP iajs-1880 5 12 toxoplasmosis toxoplasmosis NOUN iajs-1880 5 13 and and CCONJ iajs-1880 5 14 diabetes diabetes NOUN iajs-1880 5 15 mellitus mellitus NOUN iajs-1880 5 16 and and CCONJ iajs-1880 5 17 detection detection NOUN iajs-1880 5 18 serum serum NOUN iajs-1880 5 19 levels level NOUN iajs-1880 5 20 of of ADP iajs-1880 5 21 chemokines chemokine NOUN iajs-1880 5 22 ( ( PUNCT iajs-1880 5 23 monocyte monocyte NOUN iajs-1880 5 24 chemoattractant chemoattractant NOUN iajs-1880 5 25 protien-1 protien-1 NUM iajs-1880 5 26 and and CCONJ iajs-1880 5 27 transforming transform VERB iajs-1880 5 28 growth growth NOUN iajs-1880 5 29 factor factor NOUN iajs-1880 5 30 - - PUNCT iajs-1880 5 31 β β NOUN iajs-1880 5 32 ) ) PUNCT iajs-1880 5 33 in in ADP iajs-1880 5 34 diabetic diabetic ADJ iajs-1880 5 35 patients patient NOUN iajs-1880 5 36 infected infect VERB iajs-1880 5 37 with with ADP iajs-1880 5 38 toxoplasmosis toxoplasmosis PROPN iajs-1880 5 39 . . PUNCT iajs-1880 6 1 serum serum NOUN iajs-1880 6 2 samples sample NOUN iajs-1880 6 3 were be AUX iajs-1880 6 4 collected collect VERB iajs-1880 6 5 from from ADP iajs-1880 6 6 120 120 NUM iajs-1880 6 7 diabetic diabetic ADJ iajs-1880 6 8 patients patient NOUN iajs-1880 6 9 and and CCONJ iajs-1880 6 10 50 50 NUM iajs-1880 6 11 healthy healthy ADJ iajs-1880 6 12 individuals individual NOUN iajs-1880 6 13 as as ADP iajs-1880 6 14 a a DET iajs-1880 6 15 control control NOUN iajs-1880 6 16 group group NOUN iajs-1880 6 17 from from ADP iajs-1880 6 18 the the DET iajs-1880 6 19 imamein imamein PROPN iajs-1880 6 20 kadhimein kadhimein PROPN iajs-1880 6 21 medical medical ADJ iajs-1880 6 22 city city NOUN iajs-1880 6 23 in in ADP iajs-1880 6 24 baghdad baghdad PROPN iajs-1880 6 25 . . PUNCT iajs-1880 7 1 in in ADP iajs-1880 7 2 order order NOUN iajs-1880 7 3 to to PART iajs-1880 7 4 diagnose diagnose VERB iajs-1880 7 5 diabetes diabetes NOUN iajs-1880 7 6 , , PUNCT iajs-1880 7 7 fasting fast VERB iajs-1880 7 8 and and CCONJ iajs-1880 7 9 random random ADJ iajs-1880 7 10 blood blood NOUN iajs-1880 7 11 glucose glucose NOUN iajs-1880 7 12 tests test NOUN iajs-1880 7 13 were be AUX iajs-1880 7 14 used use VERB iajs-1880 7 15 . . PUNCT iajs-1880 8 1 the the DET iajs-1880 8 2 diagnosis diagnosis NOUN iajs-1880 8 3 of of ADP iajs-1880 8 4 toxoplasmosis toxoplasmosis NOUN iajs-1880 8 5 was be AUX iajs-1880 8 6 done do VERB iajs-1880 8 7 by by ADP iajs-1880 8 8 using use VERB iajs-1880 8 9 toxo toxo ADJ iajs-1880 8 10 igm igm NOUN iajs-1880 8 11 and and CCONJ iajs-1880 8 12 igg igg PROPN iajs-1880 8 13 immulite immulite PROPN iajs-1880 8 14 torch torch PROPN iajs-1880 8 15 assay assay VERB iajs-1880 8 16 . . PUNCT iajs-1880 9 1 chemokines chemokine NOUN iajs-1880 9 2 levels level NOUN iajs-1880 9 3 were be AUX iajs-1880 9 4 measured measure VERB iajs-1880 9 5 by by ADP iajs-1880 9 6 elisa elisa NOUN iajs-1880 9 7 method method NOUN iajs-1880 9 8 . . PUNCT iajs-1880 10 1 the the DET iajs-1880 10 2 results result NOUN iajs-1880 10 3 clarified clarify VERB iajs-1880 10 4 that that SCONJ iajs-1880 10 5 all all DET iajs-1880 10 6 samples sample NOUN iajs-1880 10 7 were be AUX iajs-1880 10 8 seronegative seronegative ADJ iajs-1880 10 9 for for ADP iajs-1880 10 10 igm igm PROPN iajs-1880 10 11 antibodies antibody NOUN iajs-1880 10 12 while while SCONJ iajs-1880 10 13 50 50 NUM iajs-1880 10 14 ( ( PUNCT iajs-1880 10 15 41.67 41.67 NUM iajs-1880 10 16 % % NOUN iajs-1880 10 17 ) ) PUNCT iajs-1880 10 18 diabetic diabetic ADJ iajs-1880 10 19 patients patient NOUN iajs-1880 10 20 were be AUX iajs-1880 10 21 seropositive seropositive ADJ iajs-1880 10 22 for for ADP iajs-1880 10 23 igg igg PROPN iajs-1880 10 24 antibodies antibody NOUN iajs-1880 10 25 and and CCONJ iajs-1880 10 26 70 70 NUM iajs-1880 10 27 ( ( PUNCT iajs-1880 10 28 58.33 58.33 NUM iajs-1880 10 29 % % NOUN iajs-1880 10 30 ) ) PUNCT iajs-1880 10 31 diabetic diabetic ADJ iajs-1880 10 32 patients patient NOUN iajs-1880 10 33 and and CCONJ iajs-1880 10 34 50 50 NUM iajs-1880 10 35 healthy healthy ADJ iajs-1880 10 36 controls control NOUN iajs-1880 10 37 were be AUX iajs-1880 10 38 seronegative seronegative ADJ iajs-1880 10 39 for for ADP iajs-1880 10 40 igg igg PROPN iajs-1880 10 41 antibodies antibodie VERB iajs-1880 10 42 . . PUNCT iajs-1880 11 1 serum serum NOUN iajs-1880 11 2 level level NOUN iajs-1880 11 3 of of ADP iajs-1880 11 4 mcp-1 mcp-1 NOUN iajs-1880 11 5 was be AUX iajs-1880 11 6 recorded record VERB iajs-1880 11 7 an an DET iajs-1880 11 8 increase increase NOUN iajs-1880 11 9 in in ADP iajs-1880 11 10 a a DET iajs-1880 11 11 group group NOUN iajs-1880 11 12 of of ADP iajs-1880 11 13 diabetic diabetic ADJ iajs-1880 11 14 patients patient NOUN iajs-1880 11 15 infected infect VERB iajs-1880 11 16 with with ADP iajs-1880 11 17 toxoplasmosis toxoplasmosis PROPN iajs-1880 11 18 169.66 169.66 NUM iajs-1880 11 19 ± ± NUM iajs-1880 11 20 131.35 131.35 NUM iajs-1880 11 21 pg pg NOUN iajs-1880 11 22 / / SYM iajs-1880 11 23 ml ml NOUN iajs-1880 11 24 with with ADP iajs-1880 11 25 highly highly ADV iajs-1880 11 26 significant significant ADJ iajs-1880 11 27 differences difference NOUN iajs-1880 11 28 ( ( PUNCT iajs-1880 11 29 p p X iajs-1880 11 30 < < X iajs-1880 11 31 0.001 0.001 NUM iajs-1880 11 32 ) ) PUNCT iajs-1880 11 33 also also ADV iajs-1880 11 34 tgf tgf PROPN iajs-1880 11 35 - - PUNCT iajs-1880 11 36 β β NOUN iajs-1880 11 37 level level NOUN iajs-1880 11 38 was be AUX iajs-1880 11 39 increased increase VERB iajs-1880 11 40 in in ADP iajs-1880 11 41 a a DET iajs-1880 11 42 group group NOUN iajs-1880 11 43 of of ADP iajs-1880 11 44 diabetic diabetic ADJ iajs-1880 11 45 patients patient NOUN iajs-1880 11 46 infected infect VERB iajs-1880 11 47 with with ADP iajs-1880 11 48 toxoplasmosis toxoplasmosis PROPN iajs-1880 11 49 0.53 0.53 NUM iajs-1880 11 50 ± ± NUM iajs-1880 11 51 0.242 0.242 NUM iajs-1880 11 52 pg pg NOUN iajs-1880 11 53 / / SYM iajs-1880 11 54 ml ml NOUN iajs-1880 11 55 with with ADP iajs-1880 11 56 highly highly ADV iajs-1880 11 57 significant significant ADJ iajs-1880 11 58 differences difference NOUN iajs-1880 11 59 ( ( PUNCT iajs-1880 11 60 p p NOUN iajs-1880 11 61 ≤ ≤ NUM iajs-1880 11 62 0.0001 0.0001 NUM iajs-1880 11 63 ) ) PUNCT iajs-1880 11 64 when when SCONJ iajs-1880 11 65 compare compare VERB iajs-1880 11 66 with with ADP iajs-1880 11 67 the the DET iajs-1880 11 68 studied study VERB iajs-1880 11 69 groups group NOUN iajs-1880 11 70 . . PUNCT iajs-1880 12 1 keywords keyword NOUN iajs-1880 12 2 : : PUNCT iajs-1880 12 3 toxoplasmosis toxoplasmosis NOUN iajs-1880 12 4 , , PUNCT iajs-1880 12 5 diabetes diabetes NOUN iajs-1880 12 6 mellitus mellitus NOUN iajs-1880 12 7 ( ( PUNCT iajs-1880 12 8 type type NOUN iajs-1880 12 9 2 2 NUM iajs-1880 12 10 ) ) PUNCT iajs-1880 12 11 , , PUNCT iajs-1880 12 12 mcp-1 mcp-1 NOUN iajs-1880 12 13 , , PUNCT iajs-1880 12 14 tgf tgf PROPN iajs-1880 12 15 - - PUNCT iajs-1880 12 16 β β NOUN iajs-1880 12 17 . . PUNCT iajs-1880 13 1 ihsciconf ihsciconf PROPN iajs-1880 13 2 2017 2017 NUM iajs-1880 13 3 special special ADJ iajs-1880 13 4 issue issue NOUN iajs-1880 13 5 ibn ibn PROPN iajs-1880 13 6 al al PROPN iajs-1880 13 7 - - PUNCT iajs-1880 13 8 haitham haitham PROPN iajs-1880 13 9 journal journal PROPN iajs-1880 13 10 for for ADP iajs-1880 13 11 pure pure ADJ iajs-1880 13 12 and and CCONJ iajs-1880 13 13 applied apply VERB iajs-1880 13 14 science science NOUN iajs-1880 13 15 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 13 16 for for ADP iajs-1880 13 17 more more ADJ iajs-1880 13 18 information information NOUN iajs-1880 13 19 about about ADP iajs-1880 13 20 the the DET iajs-1880 13 21 conference conference NOUN iajs-1880 13 22 please please INTJ iajs-1880 13 23 visit visit VERB iajs-1880 13 24 the the DET iajs-1880 13 25 websites website NOUN iajs-1880 13 26 : : PUNCT iajs-1880 13 27 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 13 28           SPACE iajs-1880 13 29 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 13 30     SPACE iajs-1880 13 31 biology|540 biology|540 NOUN iajs-1880 13 32         SPACE iajs-1880 13 33 1 1 NUM iajs-1880 13 34 . . PUNCT iajs-1880 14 1 introduction introduction NOUN iajs-1880 14 2 toxoplasmosis toxoplasmosis NOUN iajs-1880 14 3 is be AUX iajs-1880 14 4 an an DET iajs-1880 14 5 important important ADJ iajs-1880 14 6 zoonotic zoonotic ADJ iajs-1880 14 7 disease disease NOUN iajs-1880 14 8 caused cause VERB iajs-1880 14 9 by by ADP iajs-1880 14 10 intracellular intracellular ADJ iajs-1880 14 11 obligate obligate NOUN iajs-1880 14 12 protozoan protozoan NOUN iajs-1880 14 13 called call VERB iajs-1880 14 14 toxoplasma toxoplasma NOUN iajs-1880 14 15 gondii gondii NOUN iajs-1880 14 16 . . PUNCT iajs-1880 15 1 this this DET iajs-1880 15 2 parasite parasite NOUN iajs-1880 15 3 has have VERB iajs-1880 15 4 two two NUM iajs-1880 15 5 stages stage NOUN iajs-1880 15 6 in in ADP iajs-1880 15 7 the the DET iajs-1880 15 8 life life NOUN iajs-1880 15 9 cycle cycle NOUN iajs-1880 15 10 , , PUNCT iajs-1880 15 11 asexual asexual ADJ iajs-1880 15 12 stage stage NOUN iajs-1880 15 13 occurs occur VERB iajs-1880 15 14 in in ADP iajs-1880 15 15 any any DET iajs-1880 15 16 warm warm ADJ iajs-1880 15 17 - - PUNCT iajs-1880 15 18 blooded blooded ADJ iajs-1880 15 19 animal animal NOUN iajs-1880 15 20 ( ( PUNCT iajs-1880 15 21 intermediate intermediate ADJ iajs-1880 15 22 host host NOUN iajs-1880 15 23 ) ) PUNCT iajs-1880 15 24 and and CCONJ iajs-1880 15 25 sexual sexual ADJ iajs-1880 15 26 stage stage NOUN iajs-1880 15 27 occurs occur VERB iajs-1880 15 28 in in ADP iajs-1880 15 29 felines feline NOUN iajs-1880 15 30 ( ( PUNCT iajs-1880 15 31 definitive definitive ADJ iajs-1880 15 32 host host NOUN iajs-1880 15 33 ) ) PUNCT iajs-1880 16 1 [ [ X iajs-1880 16 2 1 1 NUM iajs-1880 16 3 ] ] PUNCT iajs-1880 16 4 . . PUNCT iajs-1880 17 1 t.gondii t.gondii PROPN iajs-1880 17 2 has have VERB iajs-1880 17 3 three three NUM iajs-1880 17 4 morphological morphological ADJ iajs-1880 17 5 stages stage NOUN iajs-1880 17 6 : : PUNCT iajs-1880 17 7 tachyzoites tachyzoite VERB iajs-1880 17 8 that that PRON iajs-1880 17 9 multiplied multiply VERB iajs-1880 17 10 rapidly rapidly ADV iajs-1880 17 11 in in ADP iajs-1880 17 12 any any DET iajs-1880 17 13 intermediate intermediate ADJ iajs-1880 17 14 host host NOUN iajs-1880 17 15 cell cell NOUN iajs-1880 17 16 and and CCONJ iajs-1880 17 17 in in ADP iajs-1880 17 18 non non ADJ iajs-1880 17 19 - - ADJ iajs-1880 17 20 intestinal intestinal ADJ iajs-1880 17 21 epithelial epithelial ADJ iajs-1880 17 22 cells cell NOUN iajs-1880 17 23 of of ADP iajs-1880 17 24 the the DET iajs-1880 17 25 felines feline NOUN iajs-1880 17 26 , , PUNCT iajs-1880 17 27 bradyzoites bradyzoite VERB iajs-1880 17 28 that that PRON iajs-1880 17 29 multiplied multiply VERB iajs-1880 17 30 slowly slowly ADV iajs-1880 17 31 within within ADP iajs-1880 17 32 a a DET iajs-1880 17 33 tissue tissue NOUN iajs-1880 17 34 cyst cyst NOUN iajs-1880 17 35 and and CCONJ iajs-1880 17 36 oocysts oocyst NOUN iajs-1880 17 37 develops develop VERB iajs-1880 17 38 in in ADP iajs-1880 17 39 the the DET iajs-1880 17 40 intestine intestine NOUN iajs-1880 17 41 of of ADP iajs-1880 17 42 felines feline NOUN iajs-1880 17 43 . . PUNCT iajs-1880 18 1 humans human NOUN iajs-1880 18 2 are be AUX iajs-1880 18 3 infected infect VERB iajs-1880 18 4 by by ADP iajs-1880 18 5 contaminated contaminate VERB iajs-1880 18 6 water water NOUN iajs-1880 18 7 , , PUNCT iajs-1880 18 8 half half ADV iajs-1880 18 9 - - PUNCT iajs-1880 18 10 cooked cook VERB iajs-1880 18 11 meat meat NOUN iajs-1880 18 12 and and CCONJ iajs-1880 18 13 vegetables vegetable NOUN iajs-1880 18 14 that that PRON iajs-1880 18 15 are be AUX iajs-1880 18 16 not not PART iajs-1880 18 17 disinfected disinfect VERB iajs-1880 18 18 [ [ PUNCT iajs-1880 18 19 2 2 NUM iajs-1880 18 20 ] ] PUNCT iajs-1880 18 21 . . PUNCT iajs-1880 19 1 its its PRON iajs-1880 19 2 distribution distribution NOUN iajs-1880 19 3 in in ADP iajs-1880 19 4 worldwide worldwide ADJ iajs-1880 19 5 and and CCONJ iajs-1880 19 6 about about ADV iajs-1880 19 7 20 20 NUM iajs-1880 19 8 - - SYM iajs-1880 19 9 90 90 NUM iajs-1880 19 10 % % NOUN iajs-1880 19 11 of of ADP iajs-1880 19 12 world world NOUN iajs-1880 19 13 adult adult NOUN iajs-1880 19 14 population population NOUN iajs-1880 19 15 has have AUX iajs-1880 19 16 serum serum NOUN iajs-1880 19 17 toxoplasma toxoplasma PROPN iajs-1880 19 18 antibodies antibodie VERB iajs-1880 19 19 . . PUNCT iajs-1880 20 1 several several ADJ iajs-1880 20 2 factors factor NOUN iajs-1880 20 3 affected affect VERB iajs-1880 20 4 on on ADP iajs-1880 20 5 the the DET iajs-1880 20 6 distribution distribution NOUN iajs-1880 20 7 of of ADP iajs-1880 20 8 this this DET iajs-1880 20 9 parasite parasite NOUN iajs-1880 20 10 such such ADJ iajs-1880 20 11 as as ADP iajs-1880 20 12 cultural cultural ADJ iajs-1880 20 13 levels level NOUN iajs-1880 20 14 , , PUNCT iajs-1880 20 15 age age NOUN iajs-1880 20 16 , , PUNCT iajs-1880 20 17 residency residency NOUN iajs-1880 20 18 , , PUNCT iajs-1880 20 19 sanitation sanitation NOUN iajs-1880 20 20 , , PUNCT iajs-1880 20 21 nutritional nutritional ADJ iajs-1880 20 22 habits habit NOUN iajs-1880 20 23 , , PUNCT iajs-1880 20 24 gender gender NOUN iajs-1880 20 25 , , PUNCT iajs-1880 20 26 modes mode NOUN iajs-1880 20 27 and and CCONJ iajs-1880 20 28 cat cat NOUN iajs-1880 20 29 bearing bear VERB iajs-1880 20 30 houses house NOUN iajs-1880 20 31 [ [ X iajs-1880 20 32 3 3 NUM iajs-1880 20 33 ] ] PUNCT iajs-1880 20 34 . . PUNCT iajs-1880 21 1 parasites parasite NOUN iajs-1880 21 2 will will AUX iajs-1880 21 3 proliferate proliferate VERB iajs-1880 21 4 within within ADP iajs-1880 21 5 the the DET iajs-1880 21 6 host host NOUN iajs-1880 21 7 cells cell NOUN iajs-1880 21 8 lysing lyse VERB iajs-1880 21 9 them they PRON iajs-1880 21 10 , , PUNCT iajs-1880 21 11 which which PRON iajs-1880 21 12 they they PRON iajs-1880 21 13 can can AUX iajs-1880 21 14 disseminate disseminate VERB iajs-1880 21 15 through through ADP iajs-1880 21 16 the the DET iajs-1880 21 17 body body NOUN iajs-1880 21 18 by by ADP iajs-1880 21 19 blood blood NOUN iajs-1880 21 20 circulation circulation NOUN iajs-1880 21 21 and and CCONJ iajs-1880 21 22 infect infect VERB iajs-1880 21 23 any any DET iajs-1880 21 24 cells cell NOUN iajs-1880 21 25 . . PUNCT iajs-1880 22 1 fetus fetus NOUN iajs-1880 22 2 through through ADP iajs-1880 22 3 the the DET iajs-1880 22 4 placenta placenta NOUN iajs-1880 22 5 of of ADP iajs-1880 22 6 infected infected ADJ iajs-1880 22 7 mothers mother NOUN iajs-1880 22 8 can can AUX iajs-1880 22 9 acquire acquire VERB iajs-1880 22 10 infection infection NOUN iajs-1880 22 11 ; ; PUNCT iajs-1880 22 12 congenital congenital ADJ iajs-1880 22 13 toxoplasmosis toxoplasmosis NOUN iajs-1880 22 14 may may AUX iajs-1880 22 15 cause cause VERB iajs-1880 22 16 serious serious ADJ iajs-1880 22 17 damage damage NOUN iajs-1880 22 18 to to ADP iajs-1880 22 19 the the DET iajs-1880 22 20 fetus fetus NOUN iajs-1880 22 21 [ [ X iajs-1880 22 22 4 4 NUM iajs-1880 22 23 ] ] PUNCT iajs-1880 22 24 . . PUNCT iajs-1880 23 1 diabetes diabetes NOUN iajs-1880 23 2 like like ADP iajs-1880 23 3 human human ADJ iajs-1880 23 4 immunodeficiency immunodeficiency NOUN iajs-1880 23 5 virus virus NOUN iajs-1880 23 6 ( ( PUNCT iajs-1880 23 7 hiv hiv PROPN iajs-1880 23 8 ) ) PUNCT iajs-1880 23 9 or or CCONJ iajs-1880 23 10 other other ADJ iajs-1880 23 11 immunodeficiency immunodeficiency NOUN iajs-1880 23 12 disorders disorder NOUN iajs-1880 23 13 can can AUX iajs-1880 23 14 lead lead VERB iajs-1880 23 15 to to ADP iajs-1880 23 16 opportunistic opportunistic ADJ iajs-1880 23 17 infections infection NOUN iajs-1880 23 18 . . PUNCT iajs-1880 24 1 there there PRON iajs-1880 24 2 are be VERB iajs-1880 24 3 several several ADJ iajs-1880 24 4 reports report NOUN iajs-1880 24 5 demonstrating demonstrate VERB iajs-1880 24 6 that that SCONJ iajs-1880 24 7 diabetic diabetic ADJ iajs-1880 24 8 patients patient NOUN iajs-1880 24 9 have have VERB iajs-1880 24 10 an an DET iajs-1880 24 11 increased increase VERB iajs-1880 24 12 susceptibility susceptibility NOUN iajs-1880 24 13 to to ADP iajs-1880 24 14 many many ADJ iajs-1880 24 15 specific specific ADJ iajs-1880 24 16 infections infection NOUN iajs-1880 24 17 such such ADJ iajs-1880 24 18 as as ADP iajs-1880 24 19 toxoplasmosis toxoplasmosis NOUN iajs-1880 24 20 [ [ X iajs-1880 24 21 5 5 NUM iajs-1880 24 22 ] ] PUNCT iajs-1880 24 23 . . PUNCT iajs-1880 25 1 diabetes diabetes NOUN iajs-1880 25 2 mellitus mellitus NOUN iajs-1880 25 3 is be AUX iajs-1880 25 4 a a DET iajs-1880 25 5 chronic chronic ADJ iajs-1880 25 6 disorder disorder NOUN iajs-1880 25 7 characterized characterize VERB iajs-1880 25 8 by by ADP iajs-1880 25 9 persistent persistent ADJ iajs-1880 25 10 hyperglycemia hyperglycemia NOUN iajs-1880 25 11 with with ADP iajs-1880 25 12 disturbances disturbance NOUN iajs-1880 25 13 in in ADP iajs-1880 25 14 fat fat ADJ iajs-1880 25 15 , , PUNCT iajs-1880 25 16 carbohydrate carbohydrate NOUN iajs-1880 25 17 , , PUNCT iajs-1880 25 18 and and CCONJ iajs-1880 25 19 protein protein NOUN iajs-1880 25 20 metabolism metabolism NOUN iajs-1880 25 21 causing cause VERB iajs-1880 25 22 from from ADP iajs-1880 25 23 abnormalities abnormality NOUN iajs-1880 25 24 in in ADP iajs-1880 25 25 secretion secretion NOUN iajs-1880 25 26 or or CCONJ iajs-1880 25 27 action action NOUN iajs-1880 25 28 of of ADP iajs-1880 25 29 insulin insulin NOUN iajs-1880 25 30 [ [ X iajs-1880 25 31 6 6 NUM iajs-1880 25 32 ] ] PUNCT iajs-1880 25 33 . . PUNCT iajs-1880 26 1 it it PRON iajs-1880 26 2 classified classify VERB iajs-1880 26 3 according accord VERB iajs-1880 26 4 to to ADP iajs-1880 26 5 american american ADJ iajs-1880 26 6 diabetes diabetes NOUN iajs-1880 26 7 association association NOUN iajs-1880 26 8 in in ADP iajs-1880 26 9 to to ADP iajs-1880 26 10 four four NUM iajs-1880 26 11 clinical clinical ADJ iajs-1880 26 12 classes class NOUN iajs-1880 26 13 : : PUNCT iajs-1880 26 14 insulin insulin NOUN iajs-1880 26 15 dependent dependent ADJ iajs-1880 26 16 diabetes diabetes NOUN iajs-1880 26 17 mellitus mellitus NOUN iajs-1880 26 18 ( ( PUNCT iajs-1880 26 19 t1d t1d PROPN iajs-1880 26 20 ) ) PUNCT iajs-1880 26 21 , , PUNCT iajs-1880 26 22 non non ADJ iajs-1880 26 23 - - ADJ iajs-1880 26 24 insulin insulin ADJ iajs-1880 26 25 dependent dependent ADJ iajs-1880 26 26 diabetes diabetes NOUN iajs-1880 26 27 mellitus mellitus NOUN iajs-1880 26 28 ( ( PUNCT iajs-1880 26 29 t2d t2d NUM iajs-1880 26 30 ) ) PUNCT iajs-1880 26 31 , , PUNCT iajs-1880 26 32 gestational gestational ADJ iajs-1880 26 33 diabetes diabetes NOUN iajs-1880 26 34 mellitus mellitus NOUN iajs-1880 26 35 ( ( PUNCT iajs-1880 26 36 gdm gdm NOUN iajs-1880 26 37 ) ) PUNCT iajs-1880 26 38 and and CCONJ iajs-1880 26 39 other other ADJ iajs-1880 26 40 specific specific ADJ iajs-1880 26 41 types type NOUN iajs-1880 26 42 of of ADP iajs-1880 26 43 diabetes diabetes NOUN iajs-1880 26 44 [ [ X iajs-1880 26 45 7 7 NUM iajs-1880 26 46 ] ] PUNCT iajs-1880 26 47 . . PUNCT iajs-1880 27 1 about about ADV iajs-1880 27 2 10 10 NUM iajs-1880 27 3 % % NOUN iajs-1880 27 4 of of ADP iajs-1880 27 5 diabetes diabetes NOUN iajs-1880 27 6 distribution distribution NOUN iajs-1880 27 7 was be AUX iajs-1880 27 8 type type NOUN iajs-1880 27 9 1 1 NUM iajs-1880 27 10 and and CCONJ iajs-1880 27 11 gestational gestational ADJ iajs-1880 27 12 diabetes diabetes NOUN iajs-1880 27 13 while while SCONJ iajs-1880 27 14 90 90 NUM iajs-1880 27 15 % % NOUN iajs-1880 27 16 was be AUX iajs-1880 27 17 diabetes diabetes NOUN iajs-1880 27 18 type type NOUN iajs-1880 27 19 2 2 NUM iajs-1880 27 20 . . PUNCT iajs-1880 27 21 t2d t2d NOUN iajs-1880 27 22 characterized characterize VERB iajs-1880 27 23 by by ADP iajs-1880 27 24 abnormally abnormally ADV iajs-1880 27 25 high high ADJ iajs-1880 27 26 blood blood NOUN iajs-1880 27 27 glucose glucose NOUN iajs-1880 27 28 resulting result VERB iajs-1880 27 29 from from ADP iajs-1880 27 30 relative relative ADJ iajs-1880 27 31 insulin insulin NOUN iajs-1880 27 32 deficiency deficiency NOUN iajs-1880 27 33 . . PUNCT iajs-1880 28 1 general general ADJ iajs-1880 28 2 symptoms symptom NOUN iajs-1880 28 3 of of ADP iajs-1880 28 4 diabetes diabetes NOUN iajs-1880 28 5 include include VERB iajs-1880 28 6 frequent frequent ADJ iajs-1880 28 7 urination urination NOUN iajs-1880 28 8 , , PUNCT iajs-1880 28 9 increased increase VERB iajs-1880 28 10 , , PUNCT iajs-1880 28 11 unexplained unexplained ADJ iajs-1880 28 12 weight weight NOUN iajs-1880 28 13 loss loss NOUN iajs-1880 28 14 and and CCONJ iajs-1880 28 15 thirst thirst NOUN iajs-1880 28 16 , , PUNCT iajs-1880 28 17 also also ADV iajs-1880 28 18 may may AUX iajs-1880 28 19 include include VERB iajs-1880 28 20 feeling feel VERB iajs-1880 28 21 tired tired ADJ iajs-1880 28 22 and and CCONJ iajs-1880 28 23 increased increase VERB iajs-1880 28 24 hunger hunger NOUN iajs-1880 28 25 [ [ X iajs-1880 28 26 8 8 NUM iajs-1880 28 27 ] ] PUNCT iajs-1880 28 28 . . PUNCT iajs-1880 29 1 diabetic diabetic ADJ iajs-1880 29 2 patients patient NOUN iajs-1880 29 3 are be AUX iajs-1880 29 4 more more ADV iajs-1880 29 5 susceptible susceptible ADJ iajs-1880 29 6 to to PART iajs-1880 29 7 infect infect VERB iajs-1880 29 8 with with ADP iajs-1880 29 9 toxoplasmosis toxoplasmosis NOUN iajs-1880 29 10 due due ADP iajs-1880 29 11 to to ADP iajs-1880 29 12 low low ADJ iajs-1880 29 13 level level NOUN iajs-1880 29 14 immunity immunity NOUN iajs-1880 29 15 response response NOUN iajs-1880 29 16 [ [ X iajs-1880 29 17 9 9 NUM iajs-1880 29 18 ] ] PUNCT iajs-1880 29 19 . . PUNCT iajs-1880 30 1 in in ADP iajs-1880 30 2 immunocompetent immunocompetent ADJ iajs-1880 30 3 individuals individual NOUN iajs-1880 30 4 90 90 NUM iajs-1880 30 5 % % NOUN iajs-1880 30 6 of of ADP iajs-1880 30 7 toxoplasmosis toxoplasmosis NOUN iajs-1880 30 8 infection infection NOUN iajs-1880 30 9 is be AUX iajs-1880 30 10 asymptomatic asymptomatic ADJ iajs-1880 30 11 [ [ X iajs-1880 30 12 10 10 NUM iajs-1880 30 13 ] ] PUNCT iajs-1880 30 14 . . PUNCT iajs-1880 31 1 infection infection NOUN iajs-1880 31 2 with with ADP iajs-1880 31 3 t. t. NOUN iajs-1880 31 4 gondii gondii NOUN iajs-1880 31 5 causes cause VERB iajs-1880 31 6 humoral humoral ADJ iajs-1880 31 7 immunity immunity NOUN iajs-1880 31 8 ( ( PUNCT iajs-1880 31 9 h.i h.i PROPN iajs-1880 31 10 . . PUNCT iajs-1880 31 11 ) ) PUNCT iajs-1880 31 12 and and CCONJ iajs-1880 31 13 cell cell NOUN iajs-1880 31 14 mediated mediate VERB iajs-1880 31 15 immunity immunity NOUN iajs-1880 31 16 ( ( PUNCT iajs-1880 31 17 c.m.i c.m.i NOUN iajs-1880 31 18 . . PUNCT iajs-1880 31 19 ) ) PUNCT iajs-1880 32 1 components component NOUN iajs-1880 32 2 of of ADP iajs-1880 32 3 adaptive adaptive ADJ iajs-1880 32 4 responses response NOUN iajs-1880 32 5 are be AUX iajs-1880 32 6 needed need VERB iajs-1880 32 7 because because SCONJ iajs-1880 32 8 this this DET iajs-1880 32 9 parasite parasite NOUN iajs-1880 32 10 in in ADP iajs-1880 32 11 intracellular intracellular ADJ iajs-1880 32 12 pathogen pathogen NOUN iajs-1880 32 13 , , PUNCT iajs-1880 32 14 but but CCONJ iajs-1880 32 15 also also ADV iajs-1880 32 16 move move VERB iajs-1880 32 17 through through ADP iajs-1880 32 18 extracellular extracellular ADJ iajs-1880 32 19 space space NOUN iajs-1880 32 20 to to PART iajs-1880 32 21 find find VERB iajs-1880 32 22 new new ADJ iajs-1880 32 23 host host NOUN iajs-1880 32 24 cell cell NOUN iajs-1880 33 1 [ [ X iajs-1880 33 2 11 11 NUM iajs-1880 33 3 ] ] PUNCT iajs-1880 33 4 . . PUNCT iajs-1880 34 1 the the DET iajs-1880 34 2 object object NOUN iajs-1880 34 3 of of ADP iajs-1880 34 4 this this DET iajs-1880 34 5 study study NOUN iajs-1880 34 6 is be AUX iajs-1880 34 7 to to PART iajs-1880 34 8 assess assess VERB iajs-1880 34 9 the the DET iajs-1880 34 10 correlation correlation NOUN iajs-1880 34 11 between between ADP iajs-1880 34 12 toxoplasmosis toxoplasmosis NOUN iajs-1880 34 13 and and CCONJ iajs-1880 34 14 diabetes diabetes NOUN iajs-1880 34 15 and and CCONJ iajs-1880 34 16 assess assess NOUN iajs-1880 34 17 determine determine VERB iajs-1880 34 18 the the DET iajs-1880 34 19 serum serum NOUN iajs-1880 34 20 levels level NOUN iajs-1880 34 21 of of ADP iajs-1880 34 22 chemokines chemokine NOUN iajs-1880 34 23 mcp-1 mcp-1 X iajs-1880 34 24 and and CCONJ iajs-1880 34 25 tgfβ tgfβ VERB iajs-1880 34 26 in in ADP iajs-1880 34 27 diabetic diabetic ADJ iajs-1880 34 28 patients patient NOUN iajs-1880 34 29 infected infect VERB iajs-1880 34 30 with with ADP iajs-1880 34 31 toxoplasmosis toxoplasmosis NOUN iajs-1880 34 32 and and CCONJ iajs-1880 34 33 control control NOUN iajs-1880 34 34 also also ADV iajs-1880 34 35 clarify clarify VERB iajs-1880 34 36 their their PRON iajs-1880 34 37 correlation correlation NOUN iajs-1880 34 38 with with ADP iajs-1880 34 39 other other ADJ iajs-1880 34 40 clinical clinical ADJ iajs-1880 34 41 parameters parameter NOUN iajs-1880 34 42 . . PUNCT iajs-1880 35 1 ihsciconf ihsciconf PROPN iajs-1880 35 2 2017 2017 NUM iajs-1880 35 3 special special ADJ iajs-1880 35 4 issue issue NOUN iajs-1880 35 5 ibn ibn PROPN iajs-1880 35 6 al al PROPN iajs-1880 35 7 - - PUNCT iajs-1880 35 8 haitham haitham PROPN iajs-1880 35 9 journal journal PROPN iajs-1880 35 10 for for ADP iajs-1880 35 11 pure pure ADJ iajs-1880 35 12 and and CCONJ iajs-1880 35 13 applied apply VERB iajs-1880 35 14 science science NOUN iajs-1880 35 15 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 35 16 for for ADP iajs-1880 35 17 more more ADJ iajs-1880 35 18 information information NOUN iajs-1880 35 19 about about ADP iajs-1880 35 20 the the DET iajs-1880 35 21 conference conference NOUN iajs-1880 35 22 please please INTJ iajs-1880 35 23 visit visit VERB iajs-1880 35 24 the the DET iajs-1880 35 25 websites website NOUN iajs-1880 35 26 : : PUNCT iajs-1880 35 27 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 35 28           SPACE iajs-1880 35 29 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 35 30     SPACE iajs-1880 35 31 biology|541 biology|541 NOUN iajs-1880 35 32         SPACE iajs-1880 35 33 2 2 NUM iajs-1880 35 34 . . PUNCT iajs-1880 35 35 materials material NOUN iajs-1880 35 36 and and CCONJ iajs-1880 35 37 methods method NOUN iajs-1880 35 38 one one NUM iajs-1880 35 39 hundred hundred NUM iajs-1880 35 40 and and CCONJ iajs-1880 35 41 twenty twenty NUM iajs-1880 35 42 blood blood NOUN iajs-1880 35 43 samples sample NOUN iajs-1880 35 44 of of ADP iajs-1880 35 45 diabetic diabetic ADJ iajs-1880 35 46 patients patient NOUN iajs-1880 35 47 were be AUX iajs-1880 35 48 collected collect VERB iajs-1880 35 49 , , PUNCT iajs-1880 35 50 their their PRON iajs-1880 35 51 age age NOUN iajs-1880 35 52 ranging range VERB iajs-1880 35 53 from from ADP iajs-1880 35 54 12 12 NUM iajs-1880 35 55 to76 to76 PROPN iajs-1880 35 56 years year NOUN iajs-1880 35 57 with with ADP iajs-1880 35 58 mean mean NOUN iajs-1880 35 59 50.9 50.9 NUM iajs-1880 35 60 ± ± NUM iajs-1880 35 61 13.8 13.8 NUM iajs-1880 35 62 from from ADP iajs-1880 35 63 the the DET iajs-1880 35 64 imamein imamein NOUN iajs-1880 35 65 kadhimein kadhimein PROPN iajs-1880 35 66 medical medical ADJ iajs-1880 35 67 city city NOUN iajs-1880 35 68 in in ADP iajs-1880 35 69 baghdad baghdad PROPN iajs-1880 35 70 , , PUNCT iajs-1880 35 71 iraq iraq PROPN iajs-1880 35 72 , , PUNCT iajs-1880 35 73 during during ADP iajs-1880 35 74 the the DET iajs-1880 35 75 period period NOUN iajs-1880 35 76 from from ADP iajs-1880 35 77 september september PROPN iajs-1880 35 78 until until ADP iajs-1880 35 79 the the DET iajs-1880 35 80 end end NOUN iajs-1880 35 81 of of ADP iajs-1880 35 82 december december PROPN iajs-1880 35 83 2016 2016 NUM iajs-1880 35 84 , , PUNCT iajs-1880 35 85 after after ADP iajs-1880 35 86 that that SCONJ iajs-1880 35 87 they they PRON iajs-1880 35 88 were be AUX iajs-1880 35 89 diagnosed diagnose VERB iajs-1880 35 90 by by ADP iajs-1880 35 91 a a DET iajs-1880 35 92 specialized specialized ADJ iajs-1880 35 93 physician physician NOUN iajs-1880 35 94 and and CCONJ iajs-1880 35 95 50 50 NUM iajs-1880 35 96 blood blood NOUN iajs-1880 35 97 samples sample NOUN iajs-1880 35 98 of of ADP iajs-1880 35 99 healthy healthy ADJ iajs-1880 35 100 individuals individual NOUN iajs-1880 35 101 collected collect VERB iajs-1880 35 102 as as ADP iajs-1880 35 103 controls control NOUN iajs-1880 35 104 . . PUNCT iajs-1880 36 1 five five NUM iajs-1880 36 2 milliliters milliliter NOUN iajs-1880 36 3 of of ADP iajs-1880 36 4 venous venous ADJ iajs-1880 36 5 blood blood NOUN iajs-1880 36 6 were be AUX iajs-1880 36 7 collected collect VERB iajs-1880 36 8 using use VERB iajs-1880 36 9 5 5 NUM iajs-1880 36 10 ml ml ADV iajs-1880 36 11 disposable disposable ADJ iajs-1880 36 12 syringe syringe NOUN iajs-1880 36 13 and and CCONJ iajs-1880 36 14 then then ADV iajs-1880 36 15 transferred transfer VERB iajs-1880 36 16 immediately immediately ADV iajs-1880 36 17 to to ADP iajs-1880 36 18 gel gel NOUN iajs-1880 36 19 tube tube NOUN iajs-1880 36 20 and and CCONJ iajs-1880 36 21 left leave VERB iajs-1880 36 22 to to PART iajs-1880 36 23 clot clot VERB iajs-1880 36 24 for for ADP iajs-1880 36 25 15 15 NUM iajs-1880 36 26 minutes minute NOUN iajs-1880 36 27 at at ADP iajs-1880 36 28 room room NOUN iajs-1880 36 29 temperature temperature NOUN iajs-1880 36 30 ( ( PUNCT iajs-1880 36 31 20 20 NUM iajs-1880 36 32 - - SYM iajs-1880 36 33 25 25 NUM iajs-1880 36 34 ° ° PROPN iajs-1880 36 35 c c NOUN iajs-1880 36 36 ) ) PUNCT iajs-1880 36 37 , , PUNCT iajs-1880 36 38 samples sample NOUN iajs-1880 36 39 were be AUX iajs-1880 36 40 centrifuged centrifuge VERB iajs-1880 36 41 at at ADP iajs-1880 36 42 2500 2500 NUM iajs-1880 36 43 to to PART iajs-1880 36 44 3000 3000 NUM iajs-1880 36 45 rpm rpm NOUN iajs-1880 36 46 for for ADP iajs-1880 36 47 10 10 NUM iajs-1880 36 48 min min NOUN iajs-1880 36 49 period period NOUN iajs-1880 36 50 to to PART iajs-1880 36 51 separate separate ADJ iajs-1880 36 52 serum serum NOUN iajs-1880 36 53 . . PUNCT iajs-1880 37 1 some some PRON iajs-1880 37 2 of of ADP iajs-1880 37 3 serum serum NOUN iajs-1880 37 4 used use VERB iajs-1880 37 5 to to PART iajs-1880 37 6 diagnose diagnose VERB iajs-1880 37 7 diabetes diabetes NOUN iajs-1880 37 8 by by ADP iajs-1880 37 9 using use VERB iajs-1880 37 10 fasting fast VERB iajs-1880 37 11 and and CCONJ iajs-1880 37 12 random random ADJ iajs-1880 37 13 blood blood NOUN iajs-1880 37 14 glucose glucose NOUN iajs-1880 37 15 tests test NOUN iajs-1880 37 16 ( ( PUNCT iajs-1880 37 17 labkit labkit PROPN iajs-1880 37 18 , , PUNCT iajs-1880 37 19 spain spain PROPN iajs-1880 37 20 ) ) PUNCT iajs-1880 37 21 then then ADV iajs-1880 37 22 t. t. PROPN iajs-1880 37 23 gondii gondii PROPN iajs-1880 37 24 infection infection NOUN iajs-1880 37 25 was be AUX iajs-1880 37 26 diagnosed diagnose VERB iajs-1880 37 27 by by ADP iajs-1880 37 28 immulite immulite ADJ iajs-1880 37 29 torch torch NOUN iajs-1880 37 30 assay assay NOUN iajs-1880 37 31 ( ( PUNCT iajs-1880 37 32 flex flex ADJ iajs-1880 37 33 reagent reagent ADJ iajs-1880 37 34 cartridge cartridge NOUN iajs-1880 37 35 igm igm NOUN iajs-1880 37 36 and and CCONJ iajs-1880 37 37 igg igg PROPN iajs-1880 37 38 , , PUNCT iajs-1880 37 39 siemens siemens PROPN iajs-1880 37 40 , , PUNCT iajs-1880 37 41 germany germany PROPN iajs-1880 37 42 ) ) PUNCT iajs-1880 37 43 and and CCONJ iajs-1880 37 44 the the DET iajs-1880 37 45 residual residual ADJ iajs-1880 37 46 of of ADP iajs-1880 37 47 serum serum NOUN iajs-1880 37 48 stored store VERB iajs-1880 37 49 in in ADP iajs-1880 37 50 eppendrof eppendrof ADJ iajs-1880 37 51 tubes tube NOUN iajs-1880 37 52 until until SCONJ iajs-1880 37 53 used use VERB iajs-1880 37 54 at at ADP iajs-1880 37 55 -20cº -20cº PROPN iajs-1880 37 56 for for ADP iajs-1880 37 57 measuring measure VERB iajs-1880 37 58 chemokines chemokine NOUN iajs-1880 37 59 levels level NOUN iajs-1880 37 60 . . PUNCT iajs-1880 38 1 one one NUM iajs-1880 38 2 hundred hundred NUM iajs-1880 38 3 samples sample NOUN iajs-1880 38 4 were be AUX iajs-1880 38 5 selected select VERB iajs-1880 38 6 to to PART iajs-1880 38 7 detection detection VERB iajs-1880 38 8 chemokine chemokine ADJ iajs-1880 38 9 levels level NOUN iajs-1880 38 10 by by ADP iajs-1880 38 11 sandwich sandwich NOUN iajs-1880 38 12 elisa elisa PROPN iajs-1880 38 13 method method NOUN iajs-1880 38 14 : : PUNCT iajs-1880 38 15 according accord VERB iajs-1880 38 16 to to ADP iajs-1880 38 17 t.gondii t.gondii ADV iajs-1880 38 18 diagnostic diagnostic ADJ iajs-1880 38 19 test test NOUN iajs-1880 38 20 the the DET iajs-1880 38 21 samples sample NOUN iajs-1880 38 22 were be AUX iajs-1880 38 23 divided divide VERB iajs-1880 38 24 to to ADP iajs-1880 38 25 50 50 NUM iajs-1880 38 26 patients patient NOUN iajs-1880 38 27 have have VERB iajs-1880 38 28 diabetes diabetes NOUN iajs-1880 38 29 with with ADP iajs-1880 38 30 toxoplasmosis toxoplasmosis NOUN iajs-1880 38 31 , , PUNCT iajs-1880 38 32 50 50 NUM iajs-1880 38 33 patients patient NOUN iajs-1880 38 34 have have VERB iajs-1880 38 35 diabetes diabetes NOUN iajs-1880 38 36 without without ADP iajs-1880 38 37 toxoplasmosis toxoplasmosis NOUN iajs-1880 38 38 , , PUNCT iajs-1880 38 39 and and CCONJ iajs-1880 38 40 25 25 NUM iajs-1880 38 41 healthy healthy ADJ iajs-1880 38 42 controls control NOUN iajs-1880 38 43 . . PUNCT iajs-1880 39 1 monocyte monocyte PROPN iajs-1880 39 2 chemoattractant chemoattractant NOUN iajs-1880 39 3 protien-1 protien-1 PROPN iajs-1880 39 4 and and CCONJ iajs-1880 39 5 transforming transform VERB iajs-1880 39 6 growth growth NOUN iajs-1880 39 7 factor factor NOUN iajs-1880 39 8 - - PUNCT iajs-1880 39 9 β β NOUN iajs-1880 39 10 levels level NOUN iajs-1880 39 11 have have AUX iajs-1880 39 12 been be AUX iajs-1880 39 13 estimated estimate VERB iajs-1880 39 14 by by ADP iajs-1880 39 15 ( ( PUNCT iajs-1880 39 16 elisa elisa NOUN iajs-1880 39 17 ) ) PUNCT iajs-1880 39 18 technique technique NOUN iajs-1880 39 19 enzyme enzyme NOUN iajs-1880 39 20 immunoassay immunoassay NOUN iajs-1880 39 21 using use VERB iajs-1880 39 22 the the DET iajs-1880 39 23 manufacturer manufacturer NOUN iajs-1880 39 24 instruction instruction NOUN iajs-1880 39 25 as as SCONJ iajs-1880 39 26 supplied supply VERB iajs-1880 39 27 with with ADP iajs-1880 39 28 the the DET iajs-1880 39 29 kit kit NOUN iajs-1880 39 30 from from ADP iajs-1880 39 31 peprotech peprotech NOUN iajs-1880 39 32 , , PUNCT iajs-1880 39 33 usa usa PROPN iajs-1880 39 34 . . PUNCT iajs-1880 40 1 the the DET iajs-1880 40 2 data datum NOUN iajs-1880 40 3 are be AUX iajs-1880 40 4 presented present VERB iajs-1880 40 5 as as ADP iajs-1880 40 6 a a DET iajs-1880 40 7 mean mean ADJ iajs-1880 40 8 ± ± NUM iajs-1880 40 9 sd sd NOUN iajs-1880 40 10 . . PUNCT iajs-1880 41 1 chi chi ADJ iajs-1880 41 2 - - PUNCT iajs-1880 41 3 square square PROPN iajs-1880 41 4 test test NOUN iajs-1880 41 5 was be AUX iajs-1880 41 6 used use VERB iajs-1880 41 7 to to PART iajs-1880 41 8 analyze analyze VERB iajs-1880 41 9 the the DET iajs-1880 41 10 results result NOUN iajs-1880 41 11 . . PUNCT iajs-1880 42 1 least least ADJ iajs-1880 42 2 significant significant ADJ iajs-1880 42 3 difference difference NOUN iajs-1880 42 4 ( ( PUNCT iajs-1880 42 5 lsd lsd NOUN iajs-1880 42 6 ) ) PUNCT iajs-1880 42 7 test test NOUN iajs-1880 42 8 was be AUX iajs-1880 42 9 used use VERB iajs-1880 42 10 to to ADP iajs-1880 42 11 significant significant ADJ iajs-1880 42 12 compare compare NOUN iajs-1880 42 13 . . PUNCT iajs-1880 43 1 a a DET iajs-1880 43 2 p p NOUN iajs-1880 43 3 - - PUNCT iajs-1880 43 4 value value NOUN iajs-1880 43 5 of of ADP iajs-1880 43 6 < < X iajs-1880 43 7 0.05 0.05 NUM iajs-1880 43 8 was be AUX iajs-1880 43 9 statistically statistically ADV iajs-1880 43 10 significant significant ADJ iajs-1880 43 11 considered consider VERB iajs-1880 43 12 . . PUNCT iajs-1880 44 1 3 3 X iajs-1880 44 2 . . X iajs-1880 44 3 results result VERB iajs-1880 44 4 the the DET iajs-1880 44 5 present present ADJ iajs-1880 44 6 results result NOUN iajs-1880 44 7 of of ADP iajs-1880 44 8 170 170 NUM iajs-1880 44 9 samples sample NOUN iajs-1880 44 10 of of ADP iajs-1880 44 11 toxo toxo ADJ iajs-1880 44 12 igm igm NOUN iajs-1880 44 13 in in ADP iajs-1880 44 14 immulite immulite ADJ iajs-1880 44 15 2000 2000 NUM iajs-1880 44 16 torch torch NOUN iajs-1880 44 17 assay assay VERB iajs-1880 44 18 in in ADP iajs-1880 44 19 table table NOUN iajs-1880 44 20 ( ( PUNCT iajs-1880 44 21 1 1 NUM iajs-1880 44 22 ) ) PUNCT iajs-1880 44 23 clarified clarify VERB iajs-1880 44 24 that that SCONJ iajs-1880 44 25 all all PRON iajs-1880 44 26 of of ADP iajs-1880 44 27 170 170 NUM iajs-1880 44 28 ( ( PUNCT iajs-1880 44 29 100 100 NUM iajs-1880 44 30 % % NOUN iajs-1880 44 31 ) ) PUNCT iajs-1880 44 32 samples sample NOUN iajs-1880 44 33 are be AUX iajs-1880 44 34 seronegative seronegative ADJ iajs-1880 44 35 response response NOUN iajs-1880 44 36 for for ADP iajs-1880 44 37 previous previous ADJ iajs-1880 44 38 assay assay NOUN iajs-1880 44 39 . . PUNCT iajs-1880 45 1 no no DET iajs-1880 45 2 significant significant ADJ iajs-1880 45 3 differences difference NOUN iajs-1880 45 4 showed show VERB iajs-1880 45 5 in in ADP iajs-1880 45 6 toxo toxo ADJ iajs-1880 45 7 igm igm PROPN iajs-1880 45 8 immulite immulite ADJ iajs-1880 45 9 2000 2000 NUM iajs-1880 45 10 torch torch NOUN iajs-1880 45 11 assay assay VERB iajs-1880 45 12 . . PUNCT iajs-1880 46 1 table table NOUN iajs-1880 46 2 ( ( PUNCT iajs-1880 46 3 1 1 NUM iajs-1880 46 4 ): ): PUNCT iajs-1880 46 5 distribution distribution NOUN iajs-1880 46 6 of of ADP iajs-1880 46 7 t. t. NOUN iajs-1880 46 8 gondii gondii NOUN iajs-1880 46 9 infection infection NOUN iajs-1880 46 10 according accord VERB iajs-1880 46 11 to to ADP iajs-1880 46 12 toxo toxo ADJ iajs-1880 46 13 igm igm NOUN iajs-1880 46 14 iu iu ADP iajs-1880 46 15 / / SYM iajs-1880 46 16 ml ml X iajs-1880 46 17 immulite immulite ADJ iajs-1880 46 18 torch torch NOUN iajs-1880 46 19 assays assay NOUN iajs-1880 46 20 in in ADP iajs-1880 46 21 studied study VERB iajs-1880 46 22 groups group NOUN iajs-1880 46 23 diagnosis diagnosis NOUN iajs-1880 46 24 response response NOUN iajs-1880 46 25 for for ADP iajs-1880 46 26 toxoplasmosis toxoplasmosis NOUN iajs-1880 46 27 diabetic diabetic ADJ iajs-1880 46 28 patients patient NOUN iajs-1880 46 29 control control VERB iajs-1880 46 30 p p ADJ iajs-1880 46 31 - - PUNCT iajs-1880 46 32 value value NOUN iajs-1880 46 33 sig sig NOUN iajs-1880 46 34 . . PUNCT iajs-1880 47 1 ( ( PUNCT iajs-1880 47 2 * * NOUN iajs-1880 47 3 ) ) PUNCT iajs-1880 47 4 no no INTJ iajs-1880 47 5 . . PUNCT iajs-1880 48 1 % % INTJ iajs-1880 49 1 no no INTJ iajs-1880 49 2 . . PUNCT iajs-1880 50 1 % % INTJ iajs-1880 50 2     SPACE iajs-1880 50 3 flex flex ADJ iajs-1880 50 4 reagent reagent ADJ iajs-1880 50 5 cartridge cartridge NOUN iajs-1880 50 6 igm igm PROPN iajs-1880 50 7     SPACE iajs-1880 50 8 + + PROPN iajs-1880 50 9 ve ve VERB iajs-1880 50 10 0 0 NUM iajs-1880 50 11 0.00 0.00 NUM iajs-1880 50 12 0 0 NUM iajs-1880 50 13 0.00 0.00 NUM iajs-1880 50 14 1.00 1.00 NUM iajs-1880 50 15 ns ns NUM iajs-1880 50 16 ve ve PROPN iajs-1880 50 17 120 120 NUM iajs-1880 50 18 100 100 NUM iajs-1880 50 19 50 50 NUM iajs-1880 50 20 100 100 NUM iajs-1880 50 21 total total NOUN iajs-1880 50 22 120 120 NUM iajs-1880 50 23 50 50 NUM iajs-1880 50 24 ihsciconf ihsciconf NOUN iajs-1880 50 25 2017 2017 NUM iajs-1880 50 26 special special ADJ iajs-1880 50 27 issue issue NOUN iajs-1880 50 28 ibn ibn PROPN iajs-1880 50 29 al al PROPN iajs-1880 50 30 - - PUNCT iajs-1880 50 31 haitham haitham PROPN iajs-1880 50 32 journal journal PROPN iajs-1880 50 33 for for ADP iajs-1880 50 34 pure pure ADJ iajs-1880 50 35 and and CCONJ iajs-1880 50 36 applied apply VERB iajs-1880 50 37 science science NOUN iajs-1880 50 38 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 50 39 for for ADP iajs-1880 50 40 more more ADJ iajs-1880 50 41 information information NOUN iajs-1880 50 42 about about ADP iajs-1880 50 43 the the DET iajs-1880 50 44 conference conference NOUN iajs-1880 50 45 please please INTJ iajs-1880 50 46 visit visit VERB iajs-1880 50 47 the the DET iajs-1880 50 48 websites website NOUN iajs-1880 50 49 : : PUNCT iajs-1880 50 50 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 50 51           SPACE iajs-1880 50 52 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 50 53     SPACE iajs-1880 50 54 biology|542 biology|542 ADJ iajs-1880 50 55         SPACE iajs-1880 50 56 table table NOUN iajs-1880 50 57 ( ( PUNCT iajs-1880 50 58 2 2 NUM iajs-1880 50 59 ) ) PUNCT iajs-1880 50 60 illustrates illustrate VERB iajs-1880 50 61 that that SCONJ iajs-1880 50 62 50 50 NUM iajs-1880 50 63 patients patient NOUN iajs-1880 50 64 from from ADP iajs-1880 50 65 120 120 NUM iajs-1880 50 66 ( ( PUNCT iajs-1880 50 67 41.67 41.67 NUM iajs-1880 50 68 % % NOUN iajs-1880 50 69 ) ) PUNCT iajs-1880 50 70 patients patient NOUN iajs-1880 50 71 are be AUX iajs-1880 50 72 seropositive seropositive ADJ iajs-1880 50 73 for for ADP iajs-1880 50 74 toxo toxo NOUN iajs-1880 50 75 igg igg NOUN iajs-1880 50 76 in in ADP iajs-1880 50 77 immulite immulite ADJ iajs-1880 50 78 2000 2000 NUM iajs-1880 50 79 torch torch NOUN iajs-1880 50 80 assay assay NOUN iajs-1880 50 81 which which PRON iajs-1880 50 82 infected infect VERB iajs-1880 50 83 diabetes diabetes NOUN iajs-1880 50 84 and and CCONJ iajs-1880 50 85 toxoplasmosis toxoplasmosis NOUN iajs-1880 50 86 and and CCONJ iajs-1880 50 87 70 70 NUM iajs-1880 50 88 ( ( PUNCT iajs-1880 50 89 58.33 58.33 NUM iajs-1880 50 90 % % NOUN iajs-1880 50 91 ) ) PUNCT iajs-1880 50 92 patients patient NOUN iajs-1880 50 93 are be AUX iajs-1880 50 94 seronegative seronegative ADJ iajs-1880 50 95 for for ADP iajs-1880 50 96 toxo toxo ADJ iajs-1880 50 97 igg igg NOUN iajs-1880 50 98 in in ADP iajs-1880 50 99 immulite immulite ADJ iajs-1880 50 100 2000 2000 NUM iajs-1880 50 101 torch torch NOUN iajs-1880 50 102 assay assay NOUN iajs-1880 50 103 which which PRON iajs-1880 50 104 infected infect VERB iajs-1880 50 105 diabetes diabetes NOUN iajs-1880 50 106 only only ADV iajs-1880 50 107 , , PUNCT iajs-1880 50 108 while while SCONJ iajs-1880 50 109 50 50 NUM iajs-1880 50 110 ( ( PUNCT iajs-1880 50 111 100 100 NUM iajs-1880 50 112 % % NOUN iajs-1880 50 113 ) ) PUNCT iajs-1880 50 114 volunteers volunteer NOUN iajs-1880 50 115 have have VERB iajs-1880 50 116 negative negative ADJ iajs-1880 50 117 response response NOUN iajs-1880 50 118 for for ADP iajs-1880 50 119 this this DET iajs-1880 50 120 assay assay NOUN iajs-1880 50 121 . . PUNCT iajs-1880 51 1 highly highly ADV iajs-1880 51 2 significant significant ADJ iajs-1880 51 3 differences difference NOUN iajs-1880 51 4 explained explain VERB iajs-1880 51 5 in in ADP iajs-1880 51 6 this this DET iajs-1880 51 7 assay assay NOUN iajs-1880 51 8 ( ( PUNCT iajs-1880 51 9 p p NOUN iajs-1880 51 10 ≤ ≤ NUM iajs-1880 51 11 0.0001 0.0001 NUM iajs-1880 51 12 ) ) PUNCT iajs-1880 51 13 . . PUNCT iajs-1880 52 1 table table NOUN iajs-1880 52 2 ( ( PUNCT iajs-1880 52 3 2 2 NUM iajs-1880 52 4 ): ): PUNCT iajs-1880 52 5 distribution distribution NOUN iajs-1880 52 6 of of ADP iajs-1880 52 7 t. t. NOUN iajs-1880 52 8 gondii gondii NOUN iajs-1880 52 9 infection infection NOUN iajs-1880 52 10 according accord VERB iajs-1880 52 11 to to ADP iajs-1880 52 12 toxo toxo PROPN iajs-1880 52 13 igg igg PROPN iajs-1880 52 14 iu iu ADP iajs-1880 52 15 / / SYM iajs-1880 52 16 ml ml X iajs-1880 52 17 immulite immulite ADJ iajs-1880 52 18 torch torch NOUN iajs-1880 52 19 assays assay NOUN iajs-1880 52 20 in in ADP iajs-1880 52 21 studied study VERB iajs-1880 52 22 groups group NOUN iajs-1880 52 23 table table NOUN iajs-1880 52 24 ( ( PUNCT iajs-1880 52 25 3 3 NUM iajs-1880 52 26 ) ) PUNCT iajs-1880 52 27 show show NOUN iajs-1880 52 28 comparisons comparison NOUN iajs-1880 52 29 of of ADP iajs-1880 52 30 igm igm NOUN iajs-1880 52 31 levels level NOUN iajs-1880 52 32 in in ADP iajs-1880 52 33 studied study VERB iajs-1880 52 34 groups group NOUN iajs-1880 52 35 estimated estimate VERB iajs-1880 52 36 as as ADP iajs-1880 52 37 iu iu NOUN iajs-1880 52 38 / / SYM iajs-1880 52 39 ml ml ADP iajs-1880 52 40 such such ADJ iajs-1880 52 41 group group NOUN iajs-1880 52 42 of of ADP iajs-1880 52 43 patients patient NOUN iajs-1880 52 44 that that PRON iajs-1880 52 45 suffering suffer VERB iajs-1880 52 46 from from ADP iajs-1880 52 47 diabetes diabetes NOUN iajs-1880 52 48 and and CCONJ iajs-1880 52 49 infected infect VERB iajs-1880 52 50 with with ADP iajs-1880 52 51 toxoplasmosis toxoplasmosis NOUN iajs-1880 52 52 has have VERB iajs-1880 52 53 highest high ADJ iajs-1880 52 54 level level NOUN iajs-1880 52 55 0.386 0.386 NUM iajs-1880 52 56 ± ± NUM iajs-1880 52 57 0.03 0.03 NUM iajs-1880 52 58 then then ADV iajs-1880 52 59 group group NOUN iajs-1880 52 60 of of ADP iajs-1880 52 61 diabetic diabetic ADJ iajs-1880 52 62 patients patient NOUN iajs-1880 52 63 has have VERB iajs-1880 52 64 0.366 0.366 NUM iajs-1880 52 65 ± ± NUM iajs-1880 52 66 0.02 0.02 NUM iajs-1880 52 67 and and CCONJ iajs-1880 52 68 control control NOUN iajs-1880 52 69 group group NOUN iajs-1880 52 70 has have VERB iajs-1880 52 71 less less ADJ iajs-1880 52 72 level level NOUN iajs-1880 52 73 of of ADP iajs-1880 52 74 igm igm NOUN iajs-1880 52 75 0.437 0.437 NUM iajs-1880 52 76 ± ± NUM iajs-1880 52 77 0.03 0.03 NUM iajs-1880 52 78 with with ADP iajs-1880 52 79 highly highly ADV iajs-1880 52 80 significant significant ADJ iajs-1880 52 81 differences difference NOUN iajs-1880 52 82 , , PUNCT iajs-1880 52 83 also also ADV iajs-1880 52 84 the the DET iajs-1880 52 85 same same ADJ iajs-1880 52 86 table table NOUN iajs-1880 52 87 show show VERB iajs-1880 52 88 the the DET iajs-1880 52 89 highest high ADJ iajs-1880 52 90 and and CCONJ iajs-1880 52 91 lowest low ADJ iajs-1880 52 92 value value NOUN iajs-1880 52 93 of of ADP iajs-1880 52 94 igm igm NOUN iajs-1880 52 95 level level NOUN iajs-1880 52 96 for for ADP iajs-1880 52 97 each each DET iajs-1880 52 98 group group NOUN iajs-1880 52 99 , , PUNCT iajs-1880 52 100 while while SCONJ iajs-1880 52 101 table table NOUN iajs-1880 52 102 ( ( PUNCT iajs-1880 52 103 4 4 X iajs-1880 52 104 ) ) PUNCT iajs-1880 52 105 show show NOUN iajs-1880 52 106 comparisons comparison NOUN iajs-1880 52 107 of of ADP iajs-1880 52 108 igg igg PROPN iajs-1880 52 109 levels level NOUN iajs-1880 52 110 in in ADP iajs-1880 52 111 studied study VERB iajs-1880 52 112 groups group NOUN iajs-1880 52 113 estimated estimate VERB iajs-1880 52 114 by by ADP iajs-1880 52 115 iu iu NOUN iajs-1880 52 116 / / SYM iajs-1880 52 117 ml ml NOUN iajs-1880 52 118 . . PUNCT iajs-1880 52 119 group group NOUN iajs-1880 52 120 of of ADP iajs-1880 52 121 diabetic diabetic ADJ iajs-1880 52 122 patients patient NOUN iajs-1880 52 123 with with ADP iajs-1880 52 124 toxoplasmosis toxoplasmosis NOUN iajs-1880 52 125 has have VERB iajs-1880 52 126 highest high ADJ iajs-1880 52 127 level level NOUN iajs-1880 52 128 of of ADP iajs-1880 52 129 igg igg PROPN iajs-1880 52 130 106.17 106.17 NUM iajs-1880 52 131 ± ± NUM iajs-1880 52 132 12.67 12.67 NUM iajs-1880 52 133 followed follow VERB iajs-1880 52 134 by by ADP iajs-1880 52 135 diabetic diabetic ADJ iajs-1880 52 136 patients patient NOUN iajs-1880 52 137 group group NOUN iajs-1880 52 138 has have VERB iajs-1880 52 139 3.68 3.68 NUM iajs-1880 52 140 ± ± NUM iajs-1880 52 141 0.09 0.09 NUM iajs-1880 52 142 and and CCONJ iajs-1880 52 143 healthy healthy ADJ iajs-1880 52 144 volunteers volunteer NOUN iajs-1880 52 145 group group NOUN iajs-1880 52 146 has have VERB iajs-1880 52 147 less less ADJ iajs-1880 52 148 level level NOUN iajs-1880 52 149 3.89 3.89 NUM iajs-1880 52 150 ± ± NOUN iajs-1880 52 151 0.13 0.13 NUM iajs-1880 52 152 with with ADP iajs-1880 52 153 highly highly ADV iajs-1880 52 154 significant significant ADJ iajs-1880 52 155 differences difference NOUN iajs-1880 52 156 ( ( PUNCT iajs-1880 52 157 p p NOUN iajs-1880 52 158 ≤ ≤ NUM iajs-1880 52 159 0.0001 0.0001 NUM iajs-1880 52 160 ) ) PUNCT iajs-1880 52 161 , , PUNCT iajs-1880 52 162 also also ADV iajs-1880 52 163 the the DET iajs-1880 52 164 same same ADJ iajs-1880 52 165 table table NOUN iajs-1880 52 166 illustrates illustrate VERB iajs-1880 52 167 highest high ADJ iajs-1880 52 168 and and CCONJ iajs-1880 52 169 less less ADJ iajs-1880 52 170 value value NOUN iajs-1880 52 171 of of ADP iajs-1880 52 172 igg igg NOUN iajs-1880 52 173 level level NOUN iajs-1880 52 174 for for ADP iajs-1880 52 175 each each DET iajs-1880 52 176 group group NOUN iajs-1880 52 177 . . PUNCT iajs-1880 53 1 diagnosis diagnosis NOUN iajs-1880 53 2 response response NOUN iajs-1880 53 3 for for ADP iajs-1880 53 4 toxoplasmosis toxoplasmosis NOUN iajs-1880 53 5 diabetic diabetic ADJ iajs-1880 53 6 patients patient NOUN iajs-1880 53 7 control control VERB iajs-1880 53 8 p p ADJ iajs-1880 53 9 - - PUNCT iajs-1880 53 10 value value NOUN iajs-1880 53 11 sig sig NOUN iajs-1880 53 12 . . PUNCT iajs-1880 54 1 ( ( PUNCT iajs-1880 54 2 * * NOUN iajs-1880 54 3 ) ) PUNCT iajs-1880 54 4 no no INTJ iajs-1880 54 5 . . PUNCT iajs-1880 55 1 % % INTJ iajs-1880 56 1 no no INTJ iajs-1880 56 2 . . PUNCT iajs-1880 57 1 % % INTJ iajs-1880 57 2     SPACE iajs-1880 57 3 flex flex ADJ iajs-1880 57 4 reagent reagent ADJ iajs-1880 57 5 cartridge cartridge NOUN iajs-1880 57 6 igg igg PROPN iajs-1880 57 7     SPACE iajs-1880 57 8 + + PROPN iajs-1880 57 9 ve ve PROPN iajs-1880 57 10 50 50 NUM iajs-1880 57 11 41.67 41.67 NUM iajs-1880 57 12 0 0 NUM iajs-1880 57 13 0.00 0.00 NUM iajs-1880 57 14 0.0001 0.0001 NUM iajs-1880 57 15 * * PUNCT iajs-1880 57 16 * * NOUN iajs-1880 57 17     SPACE iajs-1880 57 18 ve ve VERB iajs-1880 57 19 70 70 NUM iajs-1880 57 20 58.33 58.33 NUM iajs-1880 57 21 50 50 NUM iajs-1880 57 22 100 100 NUM iajs-1880 57 23 total total NOUN iajs-1880 57 24 120 120 NUM iajs-1880 57 25 50 50 NUM iajs-1880 57 26 ihsciconf ihsciconf NOUN iajs-1880 57 27 2017 2017 NUM iajs-1880 57 28 special special ADJ iajs-1880 57 29 issue issue NOUN iajs-1880 57 30 ibn ibn PROPN iajs-1880 57 31 al al PROPN iajs-1880 57 32 - - PUNCT iajs-1880 57 33 haitham haitham PROPN iajs-1880 57 34 journal journal PROPN iajs-1880 57 35 for for ADP iajs-1880 57 36 pure pure ADJ iajs-1880 57 37 and and CCONJ iajs-1880 57 38 applied apply VERB iajs-1880 57 39 science science NOUN iajs-1880 57 40 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 57 41 for for ADP iajs-1880 57 42 more more ADJ iajs-1880 57 43 information information NOUN iajs-1880 57 44 about about ADP iajs-1880 57 45 the the DET iajs-1880 57 46 conference conference NOUN iajs-1880 57 47 please please INTJ iajs-1880 57 48 visit visit VERB iajs-1880 57 49 the the DET iajs-1880 57 50 websites website NOUN iajs-1880 57 51 : : PUNCT iajs-1880 57 52 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 57 53           SPACE iajs-1880 57 54 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 57 55     SPACE iajs-1880 57 56 biology|543 biology|543 ADJ iajs-1880 57 57         SPACE iajs-1880 57 58 table table NOUN iajs-1880 57 59 ( ( PUNCT iajs-1880 57 60 3 3 NUM iajs-1880 57 61 ): ): PUNCT iajs-1880 57 62 levels level NOUN iajs-1880 57 63 of of ADP iajs-1880 57 64 toxo toxo ADJ iajs-1880 57 65 igm igm NOUN iajs-1880 57 66 ( ( PUNCT iajs-1880 57 67 iu iu NOUN iajs-1880 57 68 / / SYM iajs-1880 57 69 ml ml NOUN iajs-1880 57 70 ) ) PUNCT iajs-1880 57 71 in in ADP iajs-1880 57 72 studied study VERB iajs-1880 57 73 groups group NOUN iajs-1880 57 74 with with ADP iajs-1880 57 75 statistical statistical ADJ iajs-1880 57 76 description description NOUN iajs-1880 57 77 . . PUNCT iajs-1880 58 1 groups group NOUN iajs-1880 58 2 no no INTJ iajs-1880 58 3 . . PUNCT iajs-1880 59 1 mean mean VERB iajs-1880 59 2 iu iu VERB iajs-1880 59 3 / / SYM iajs-1880 59 4 ml ml NOUN iajs-1880 59 5 std std PROPN iajs-1880 59 6 . . PUNCT iajs-1880 60 1 dev dev PROPN iajs-1880 60 2 . . PUNCT iajs-1880 61 1 std std NOUN iajs-1880 61 2 . . PUNCT iajs-1880 61 3 error error NOUN iajs-1880 61 4 lower low ADJ iajs-1880 61 5 value value NOUN iajs-1880 61 6 upper upper ADJ iajs-1880 61 7 value value NOUN iajs-1880 61 8 diabetic diabetic ADJ iajs-1880 61 9 patients patient NOUN iajs-1880 61 10 infected infect VERB iajs-1880 61 11 with with ADP iajs-1880 61 12 toxoplasmosis toxoplasmosis NOUN iajs-1880 61 13 50 50 NUM iajs-1880 61 14 0.386 0.386 NUM iajs-1880 61 15 0.21 0.21 NUM iajs-1880 61 16 0.03 0.03 NUM iajs-1880 61 17 0.1 0.1 NUM iajs-1880 61 18 0.8 0.8 NUM iajs-1880 61 19 diabetic diabetic ADJ iajs-1880 61 20 patients patient NOUN iajs-1880 61 21 70 70 NUM iajs-1880 61 22 0.366 0.366 NUM iajs-1880 61 23 0.16 0.16 NUM iajs-1880 61 24 0.02 0.02 NUM iajs-1880 61 25 0.1 0.1 NUM iajs-1880 61 26 0.8 0.8 NUM iajs-1880 61 27 control control NOUN iajs-1880 61 28 50 50 NUM iajs-1880 61 29 0.437 0.437 NUM iajs-1880 61 30 0.17 0.17 NUM iajs-1880 61 31 0.03 0.03 NUM iajs-1880 61 32 0.2 0.2 NUM iajs-1880 61 33 0.8 0.8 NUM iajs-1880 61 34 lsd lsd NOUN iajs-1880 61 35 - - PUNCT iajs-1880 61 36 value value NOUN iajs-1880 61 37 15.371 15.371 NUM iajs-1880 61 38 * * NOUN iajs-1880 61 39 * * PUNCT iajs-1880 61 40 p p NUM iajs-1880 61 41 - - PUNCT iajs-1880 61 42 value value NOUN iajs-1880 61 43 0.0001 0.0001 NUM iajs-1880 61 44 table table NOUN iajs-1880 61 45 ( ( PUNCT iajs-1880 61 46 4 4 NUM iajs-1880 61 47 ): ): PUNCT iajs-1880 61 48 levels level NOUN iajs-1880 61 49 of of ADP iajs-1880 61 50 toxo toxo ADJ iajs-1880 61 51 igg igg NOUN iajs-1880 61 52 ( ( PUNCT iajs-1880 61 53 iu iu PROPN iajs-1880 61 54 / / SYM iajs-1880 61 55 ml ml NOUN iajs-1880 61 56 ) ) PUNCT iajs-1880 61 57 in in ADP iajs-1880 61 58 studied study VERB iajs-1880 61 59 groups group NOUN iajs-1880 61 60 with with ADP iajs-1880 61 61 statistical statistical ADJ iajs-1880 61 62 description description NOUN iajs-1880 61 63 groups group NOUN iajs-1880 61 64 no no INTJ iajs-1880 61 65 . . PUNCT iajs-1880 62 1 mean mean VERB iajs-1880 63 1 iu iu VERB iajs-1880 63 2 / / SYM iajs-1880 63 3 ml ml NOUN iajs-1880 63 4 std std PROPN iajs-1880 63 5 . . PUNCT iajs-1880 64 1 dev dev PROPN iajs-1880 64 2 . . PUNCT iajs-1880 65 1 std std NOUN iajs-1880 65 2 . . PUNCT iajs-1880 65 3 error error NOUN iajs-1880 65 4 lower low ADJ iajs-1880 65 5 value value NOUN iajs-1880 65 6 upper upper ADJ iajs-1880 65 7 value value NOUN iajs-1880 65 8 diabetic diabetic ADJ iajs-1880 65 9 patients patient NOUN iajs-1880 65 10 infected infect VERB iajs-1880 65 11 with with ADP iajs-1880 65 12 toxoplasmosis toxoplasmosis NOUN iajs-1880 66 1 50 50 NUM iajs-1880 66 2 106.17 106.17 NUM iajs-1880 66 3 89.65 89.65 NUM iajs-1880 66 4 12.67 12.67 NUM iajs-1880 66 5 13.4 13.4 NUM iajs-1880 66 6 260 260 NUM iajs-1880 66 7 diabetic diabetic ADJ iajs-1880 66 8 patients patient NOUN iajs-1880 66 9 70 70 NUM iajs-1880 66 10 3.68 3.68 NUM iajs-1880 66 11 0.82 0.82 NUM iajs-1880 66 12 0.09 0.09 NUM iajs-1880 66 13 2.3 2.3 NUM iajs-1880 66 14 5.2 5.2 NUM iajs-1880 66 15 control control NOUN iajs-1880 66 16 50 50 NUM iajs-1880 66 17 3.89 3.89 NUM iajs-1880 66 18 0.73 0.73 NUM iajs-1880 66 19 0.13 0.13 NUM iajs-1880 66 20 3.1 3.1 NUM iajs-1880 66 21 5.1 5.1 NUM iajs-1880 66 22 lsd lsd NOUN iajs-1880 66 23 - - PUNCT iajs-1880 66 24 value value NOUN iajs-1880 66 25 21.873 21.873 NUM iajs-1880 66 26 * * NOUN iajs-1880 66 27 * * PUNCT iajs-1880 66 28 p p NUM iajs-1880 66 29 - - PUNCT iajs-1880 66 30 value value NOUN iajs-1880 66 31 0.0001 0.0001 NUM iajs-1880 66 32 table table NOUN iajs-1880 66 33 ( ( PUNCT iajs-1880 66 34 5 5 NUM iajs-1880 66 35 ) ) PUNCT iajs-1880 66 36 showed show VERB iajs-1880 66 37 that that PRON iajs-1880 66 38 group group NOUN iajs-1880 66 39 of of ADP iajs-1880 66 40 diabetes diabetes NOUN iajs-1880 66 41 patients patient NOUN iajs-1880 66 42 has have VERB iajs-1880 66 43 highest high ADJ iajs-1880 66 44 value value NOUN iajs-1880 66 45 of of ADP iajs-1880 66 46 fasting fast VERB iajs-1880 66 47 blood blood NOUN iajs-1880 66 48 glucose glucose NOUN iajs-1880 66 49 188.31 188.31 NUM iajs-1880 66 50 ± ± NUM iajs-1880 66 51 72.12 72.12 NUM iajs-1880 66 52 pg pg NOUN iajs-1880 66 53 / / SYM iajs-1880 66 54 ml ml PROPN iajs-1880 66 55 , , PUNCT iajs-1880 66 56 group group NOUN iajs-1880 66 57 of of ADP iajs-1880 66 58 diabetes diabetes NOUN iajs-1880 66 59 patients patient NOUN iajs-1880 66 60 with with ADP iajs-1880 66 61 toxoplasmosis toxoplasmosis NOUN iajs-1880 66 62 has have VERB iajs-1880 66 63 155.42 155.42 NUM iajs-1880 66 64 ± ± NUM iajs-1880 66 65 5.84 5.84 NUM iajs-1880 66 66 pg pg NOUN iajs-1880 66 67 / / SYM iajs-1880 66 68 ml ml PROPN iajs-1880 66 69 and and CCONJ iajs-1880 66 70 healthy healthy ADJ iajs-1880 66 71 control control NOUN iajs-1880 66 72 group group NOUN iajs-1880 66 73 has have AUX iajs-1880 66 74 lowest low ADJ iajs-1880 66 75 level level NOUN iajs-1880 66 76 111.41 111.41 NUM iajs-1880 66 77 ± ± NOUN iajs-1880 66 78 10.48 10.48 NUM iajs-1880 66 79 pg pg NOUN iajs-1880 66 80 / / SYM iajs-1880 66 81 ml ml NOUN iajs-1880 66 82 with with ADP iajs-1880 66 83 highly highly ADV iajs-1880 66 84 significant significant ADJ iajs-1880 66 85 differences difference NOUN iajs-1880 66 86 among among ADP iajs-1880 66 87 studied studied ADJ iajs-1880 66 88 groups group NOUN iajs-1880 66 89 ( ( PUNCT iajs-1880 66 90 p p NOUN iajs-1880 66 91 ≤ ≤ NUM iajs-1880 66 92 0.0001 0.0001 NUM iajs-1880 66 93 ) ) PUNCT iajs-1880 66 94 . . PUNCT iajs-1880 67 1 ihsciconf ihsciconf PROPN iajs-1880 67 2 2017 2017 NUM iajs-1880 67 3 special special ADJ iajs-1880 67 4 issue issue NOUN iajs-1880 67 5 ibn ibn PROPN iajs-1880 67 6 al al PROPN iajs-1880 67 7 - - PUNCT iajs-1880 67 8 haitham haitham PROPN iajs-1880 67 9 journal journal PROPN iajs-1880 67 10 for for ADP iajs-1880 67 11 pure pure ADJ iajs-1880 67 12 and and CCONJ iajs-1880 67 13 applied apply VERB iajs-1880 67 14 science science NOUN iajs-1880 67 15 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 67 16 for for ADP iajs-1880 67 17 more more ADJ iajs-1880 67 18 information information NOUN iajs-1880 67 19 about about ADP iajs-1880 67 20 the the DET iajs-1880 67 21 conference conference NOUN iajs-1880 67 22 please please INTJ iajs-1880 67 23 visit visit VERB iajs-1880 67 24 the the DET iajs-1880 67 25 websites website NOUN iajs-1880 67 26 : : PUNCT iajs-1880 67 27 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 67 28           SPACE iajs-1880 67 29 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 67 30     SPACE iajs-1880 67 31 biology|544 biology|544 ADJ iajs-1880 67 32         SPACE iajs-1880 67 33 table table NOUN iajs-1880 67 34 ( ( PUNCT iajs-1880 67 35 5 5 NUM iajs-1880 67 36 ): ): PUNCT iajs-1880 67 37 levels level NOUN iajs-1880 67 38 of of ADP iajs-1880 67 39 fbg fbg PROPN iajs-1880 67 40 in in ADP iajs-1880 67 41 studied study VERB iajs-1880 67 42 groups group NOUN iajs-1880 67 43 with with ADP iajs-1880 67 44 their their PRON iajs-1880 67 45 comparisons comparison NOUN iajs-1880 67 46 . . PUNCT iajs-1880 68 1 groups group NOUN iajs-1880 68 2 no no INTJ iajs-1880 68 3 . . PUNCT iajs-1880 69 1 mean mean VERB iajs-1880 69 2 pg pg VERB iajs-1880 69 3 / / SYM iajs-1880 69 4 ml ml VERB iajs-1880 69 5 std std PROPN iajs-1880 69 6 . . PUNCT iajs-1880 70 1 dev dev PROPN iajs-1880 70 2 . . PUNCT iajs-1880 71 1 std std NOUN iajs-1880 71 2 . . PUNCT iajs-1880 71 3 error error NOUN iajs-1880 71 4 lsd lsd NOUN iajs-1880 71 5 - - PUNCT iajs-1880 71 6 value value NOUN iajs-1880 71 7 p p NOUN iajs-1880 71 8 - - PUNCT iajs-1880 71 9 value value NOUN iajs-1880 71 10 diabetes diabetes NOUN iajs-1880 71 11 patients patient NOUN iajs-1880 71 12 with with ADP iajs-1880 71 13 toxoplasmosis toxoplasmosis NOUN iajs-1880 71 14 50 50 NUM iajs-1880 71 15 155.42 155.42 NUM iajs-1880 71 16 51.84 51.84 NUM iajs-1880 71 17 7.33 7.33 NUM iajs-1880 71 18 24.617 24.617 NUM iajs-1880 71 19 0.0001 0.0001 NUM iajs-1880 71 20 * * PUNCT iajs-1880 71 21 * * NOUN iajs-1880 71 22 diabetes diabetes NOUN iajs-1880 71 23 patients patient VERB iajs-1880 71 24 70 70 NUM iajs-1880 71 25 188.31 188.31 NUM iajs-1880 71 26 72.12 72.12 NUM iajs-1880 71 27 8.55 8.55 NUM iajs-1880 71 28 control control NOUN iajs-1880 71 29 50 50 NUM iajs-1880 71 30 111.41 111.41 NUM iajs-1880 71 31 10.48 10.48 NUM iajs-1880 71 32 1.94 1.94 NUM iajs-1880 71 33 while while SCONJ iajs-1880 71 34 results result NOUN iajs-1880 71 35 of of ADP iajs-1880 71 36 table table NOUN iajs-1880 71 37 ( ( PUNCT iajs-1880 71 38 6 6 NUM iajs-1880 71 39 ) ) PUNCT iajs-1880 71 40 illustrate illustrate VERB iajs-1880 71 41 the the DET iajs-1880 71 42 highest high ADJ iajs-1880 71 43 value value NOUN iajs-1880 71 44 of of ADP iajs-1880 71 45 random random ADJ iajs-1880 71 46 blood blood NOUN iajs-1880 71 47 glucose glucose NOUN iajs-1880 71 48 estimated estimate VERB iajs-1880 71 49 in in ADP iajs-1880 71 50 pg pg PROPN iajs-1880 71 51 / / SYM iajs-1880 71 52 ml ml X iajs-1880 71 53 of of ADP iajs-1880 71 54 diabetes diabetes NOUN iajs-1880 71 55 patients patient NOUN iajs-1880 71 56 246.31 246.31 NUM iajs-1880 71 57 ± ± NUM iajs-1880 71 58 87.39 87.39 NUM iajs-1880 71 59 pg pg NOUN iajs-1880 71 60 / / SYM iajs-1880 71 61 ml ml VERB iajs-1880 71 62 then then ADV iajs-1880 71 63 followed follow VERB iajs-1880 71 64 by by ADP iajs-1880 71 65 205.05 205.05 NUM iajs-1880 71 66 ± ± NUM iajs-1880 71 67 70.72 70.72 NUM iajs-1880 71 68 pg pg NOUN iajs-1880 71 69 / / SYM iajs-1880 71 70 ml ml PROPN iajs-1880 71 71 of of ADP iajs-1880 71 72 diabetes diabetes NOUN iajs-1880 71 73 patients patient NOUN iajs-1880 71 74 with with ADP iajs-1880 71 75 toxoplasmosis toxoplasmosis NOUN iajs-1880 71 76 and and CCONJ iajs-1880 71 77 141.58 141.58 NUM iajs-1880 71 78 ± ± NUM iajs-1880 71 79 14.30 14.30 NUM iajs-1880 71 80 of of ADP iajs-1880 71 81 healthy healthy ADJ iajs-1880 71 82 control control NOUN iajs-1880 71 83 individuals individual NOUN iajs-1880 71 84 , , PUNCT iajs-1880 71 85 highly highly ADV iajs-1880 71 86 significant significant ADJ iajs-1880 71 87 differences difference NOUN iajs-1880 71 88 appear appear VERB iajs-1880 71 89 in in ADP iajs-1880 71 90 these these DET iajs-1880 71 91 results result NOUN iajs-1880 71 92 ( ( PUNCT iajs-1880 71 93 p p NOUN iajs-1880 71 94 ≤ ≤ NUM iajs-1880 71 95 0.0001 0.0001 NUM iajs-1880 71 96 ) ) PUNCT iajs-1880 71 97 . . PUNCT iajs-1880 72 1 table table NOUN iajs-1880 72 2 ( ( PUNCT iajs-1880 72 3 6 6 NUM iajs-1880 72 4 ): ): PUNCT iajs-1880 72 5 levels level NOUN iajs-1880 72 6 of of ADP iajs-1880 72 7 rbg rbg NOUN iajs-1880 72 8 in in ADP iajs-1880 72 9 studied study VERB iajs-1880 72 10 groups group NOUN iajs-1880 72 11 with with ADP iajs-1880 72 12 their their PRON iajs-1880 72 13 comparisons comparison NOUN iajs-1880 72 14 . . PUNCT iajs-1880 73 1 groups group NOUN iajs-1880 73 2 no no INTJ iajs-1880 73 3 . . PUNCT iajs-1880 74 1 mean mean VERB iajs-1880 74 2 pg pg VERB iajs-1880 74 3 / / SYM iajs-1880 74 4 ml ml VERB iajs-1880 74 5 std std PROPN iajs-1880 74 6 . . PUNCT iajs-1880 75 1 dev dev PROPN iajs-1880 75 2 . . PUNCT iajs-1880 76 1 std std NOUN iajs-1880 76 2 . . PUNCT iajs-1880 76 3 error error NOUN iajs-1880 76 4 lsd lsd NOUN iajs-1880 76 5 - - PUNCT iajs-1880 76 6 value value NOUN iajs-1880 76 7 p p NOUN iajs-1880 76 8 - - PUNCT iajs-1880 76 9 value value NOUN iajs-1880 76 10 diabetes diabetes NOUN iajs-1880 76 11 patients patient NOUN iajs-1880 76 12 with with ADP iajs-1880 76 13 toxoplasmosis toxoplasmosis NOUN iajs-1880 76 14 50 50 NUM iajs-1880 76 15 205.05 205.05 NUM iajs-1880 76 16 70.72 70.72 NUM iajs-1880 76 17 10.00 10.00 NUM iajs-1880 76 18 30.884 30.884 NUM iajs-1880 76 19 0.0001 0.0001 NUM iajs-1880 76 20 * * PUNCT iajs-1880 76 21 * * NOUN iajs-1880 76 22 diabetes diabetes NOUN iajs-1880 76 23 patients patient VERB iajs-1880 76 24 70 70 NUM iajs-1880 76 25 246.31 246.31 NUM iajs-1880 76 26 87.39 87.39 NUM iajs-1880 76 27 10.37 10.37 NUM iajs-1880 76 28 control control NOUN iajs-1880 76 29 50 50 NUM iajs-1880 76 30 141.58 141.58 NUM iajs-1880 76 31 14.30 14.30 NUM iajs-1880 76 32 2.65 2.65 NUM iajs-1880 76 33 table table NOUN iajs-1880 76 34 ( ( PUNCT iajs-1880 76 35 7 7 NUM iajs-1880 76 36 ) ) PUNCT iajs-1880 76 37 clarified clarify VERB iajs-1880 76 38 the the DET iajs-1880 76 39 results result NOUN iajs-1880 76 40 of of ADP iajs-1880 76 41 mcp-1 mcp-1 NOUN iajs-1880 76 42 levels level NOUN iajs-1880 76 43 in in ADP iajs-1880 76 44 studied study VERB iajs-1880 76 45 groups group NOUN iajs-1880 76 46 that that PRON iajs-1880 76 47 ’s ’s AUX iajs-1880 76 48 found find VERB iajs-1880 76 49 in in ADP iajs-1880 76 50 mean mean PROPN iajs-1880 76 51 ± ± PROPN iajs-1880 76 52 sd sd NOUN iajs-1880 76 53 of of ADP iajs-1880 76 54 diabetic diabetic ADJ iajs-1880 76 55 patients patient NOUN iajs-1880 76 56 with with ADP iajs-1880 76 57 toxoplasmosis toxoplasmosis PROPN iajs-1880 76 58 169.66 169.66 NUM iajs-1880 76 59 ± ± NUM iajs-1880 76 60 131.35 131.35 NUM iajs-1880 76 61 pg pg NOUN iajs-1880 76 62 / / SYM iajs-1880 76 63 ml ml NOUN iajs-1880 76 64 ranging range VERB iajs-1880 76 65 from from ADP iajs-1880 76 66 29.39 29.39 NUM iajs-1880 76 67 to to ADP iajs-1880 76 68 449.16 449.16 NUM iajs-1880 76 69 pg pg NOUN iajs-1880 76 70 / / SYM iajs-1880 76 71 ml ml NOUN iajs-1880 77 1 and and CCONJ iajs-1880 77 2 it it PRON iajs-1880 77 3 was be AUX iajs-1880 77 4 higher high ADJ iajs-1880 77 5 than than ADP iajs-1880 77 6 diabetic diabetic ADJ iajs-1880 77 7 patients patient NOUN iajs-1880 77 8 group group NOUN iajs-1880 77 9 119.77 119.77 NUM iajs-1880 77 10 ± ± NOUN iajs-1880 77 11 95.78 95.78 NUM iajs-1880 77 12 pg pg NOUN iajs-1880 77 13 / / SYM iajs-1880 77 14 ml ml NOUN iajs-1880 77 15 ranging range VERB iajs-1880 77 16 from from ADP iajs-1880 77 17 20.44 20.44 NUM iajs-1880 77 18 to to ADP iajs-1880 77 19 296.61 296.61 NUM iajs-1880 77 20 pg pg NOUN iajs-1880 77 21 / / SYM iajs-1880 77 22 ml ml X iajs-1880 77 23 in in ADP iajs-1880 77 24 comparison comparison NOUN iajs-1880 77 25 with with ADP iajs-1880 77 26 healthy healthy ADJ iajs-1880 77 27 control control NOUN iajs-1880 77 28 group group NOUN iajs-1880 77 29 62.31 62.31 NUM iajs-1880 77 30 ± ± NUM iajs-1880 77 31 54.25 54.25 NUM iajs-1880 77 32 pg pg NOUN iajs-1880 77 33 / / SYM iajs-1880 77 34 ml ml NOUN iajs-1880 77 35 ranging range VERB iajs-1880 77 36 from from ADP iajs-1880 77 37 8.7 8.7 NUM iajs-1880 77 38 to to ADP iajs-1880 77 39 173.82 173.82 NUM iajs-1880 77 40 pg pg NOUN iajs-1880 77 41 / / SYM iajs-1880 77 42 ml ml NOUN iajs-1880 77 43 , , PUNCT iajs-1880 77 44 also also ADV iajs-1880 77 45 highly highly ADV iajs-1880 77 46 significant significant ADJ iajs-1880 77 47 differences difference NOUN iajs-1880 77 48 was be AUX iajs-1880 77 49 recorded record VERB iajs-1880 77 50 ( ( PUNCT iajs-1880 77 51 p p X iajs-1880 77 52 < < X iajs-1880 77 53 0.01 0.01 NUM iajs-1880 77 54 ) ) PUNCT iajs-1880 77 55 . . PUNCT iajs-1880 78 1 ihsciconf ihsciconf PROPN iajs-1880 78 2 2017 2017 NUM iajs-1880 78 3 special special ADJ iajs-1880 78 4 issue issue NOUN iajs-1880 78 5 ibn ibn PROPN iajs-1880 78 6 al al PROPN iajs-1880 78 7 - - PUNCT iajs-1880 78 8 haitham haitham PROPN iajs-1880 78 9 journal journal PROPN iajs-1880 78 10 for for ADP iajs-1880 78 11 pure pure ADJ iajs-1880 78 12 and and CCONJ iajs-1880 78 13 applied apply VERB iajs-1880 78 14 science science NOUN iajs-1880 78 15 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 78 16 for for ADP iajs-1880 78 17 more more ADJ iajs-1880 78 18 information information NOUN iajs-1880 78 19 about about ADP iajs-1880 78 20 the the DET iajs-1880 78 21 conference conference NOUN iajs-1880 78 22 please please INTJ iajs-1880 78 23 visit visit VERB iajs-1880 78 24 the the DET iajs-1880 78 25 websites website NOUN iajs-1880 78 26 : : PUNCT iajs-1880 78 27 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 78 28           SPACE iajs-1880 78 29 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 78 30     SPACE iajs-1880 78 31 biology|545 biology|545 ADJ iajs-1880 78 32         SPACE iajs-1880 78 33 table table NOUN iajs-1880 78 34 ( ( PUNCT iajs-1880 78 35 7 7 NUM iajs-1880 78 36 ): ): PUNCT iajs-1880 78 37 concentrations concentration NOUN iajs-1880 78 38 of of ADP iajs-1880 78 39 mcp-1 mcp-1 X iajs-1880 78 40 ( ( PUNCT iajs-1880 78 41 pg pg NOUN iajs-1880 78 42 / / SYM iajs-1880 78 43 ml ml NOUN iajs-1880 78 44 ) ) PUNCT iajs-1880 78 45 in in ADP iajs-1880 78 46 sera sera NOUN iajs-1880 78 47 of of ADP iajs-1880 78 48 studied study VERB iajs-1880 78 49 groups group NOUN iajs-1880 78 50 results result NOUN iajs-1880 78 51 of of ADP iajs-1880 78 52 table table NOUN iajs-1880 78 53 ( ( PUNCT iajs-1880 78 54 8) 8) NUM iajs-1880 78 55 revealed reveal VERB iajs-1880 78 56 that that SCONJ iajs-1880 78 57 the the DET iajs-1880 78 58 mean mean ADJ iajs-1880 78 59 difference difference NOUN iajs-1880 78 60 between between ADP iajs-1880 78 61 diabetic diabetic ADJ iajs-1880 78 62 patients patient NOUN iajs-1880 78 63 with with ADP iajs-1880 78 64 and and CCONJ iajs-1880 78 65 without without ADP iajs-1880 78 66 toxoplasmosis toxoplasmosis NOUN iajs-1880 78 67 was be AUX iajs-1880 78 68 significant significant ADJ iajs-1880 78 69 49.89 49.89 NUM iajs-1880 78 70 pg pg NOUN iajs-1880 78 71 / / SYM iajs-1880 78 72 ml ml ADP iajs-1880 78 73 , , PUNCT iajs-1880 78 74 as as ADV iajs-1880 78 75 well well ADV iajs-1880 78 76 as as ADP iajs-1880 78 77 mean mean ADJ iajs-1880 78 78 difference difference NOUN iajs-1880 78 79 between between ADP iajs-1880 78 80 diabetic diabetic ADJ iajs-1880 78 81 patients patient NOUN iajs-1880 78 82 with with ADP iajs-1880 78 83 toxoplasmosis toxoplasmosis NOUN iajs-1880 78 84 and and CCONJ iajs-1880 78 85 healthy healthy ADJ iajs-1880 78 86 control control NOUN iajs-1880 78 87 was be AUX iajs-1880 78 88 highly highly ADV iajs-1880 78 89 significant significant ADJ iajs-1880 78 90 107.35 107.35 NUM iajs-1880 78 91 pg pg NOUN iajs-1880 78 92 / / SYM iajs-1880 78 93 ml ml NOUN iajs-1880 78 94 , , PUNCT iajs-1880 78 95 also also ADV iajs-1880 78 96 mean mean VERB iajs-1880 78 97 difference difference NOUN iajs-1880 78 98 between between ADP iajs-1880 78 99 diabetic diabetic ADJ iajs-1880 78 100 patients patient NOUN iajs-1880 78 101 without without ADP iajs-1880 78 102 toxoplasmosis toxoplasmosis NOUN iajs-1880 78 103 and and CCONJ iajs-1880 78 104 healthy healthy ADJ iajs-1880 78 105 control control NOUN iajs-1880 78 106 was be AUX iajs-1880 78 107 highly highly ADV iajs-1880 78 108 significant significant ADJ iajs-1880 78 109 57.46 57.46 NUM iajs-1880 78 110 pg pg NOUN iajs-1880 78 111 / / SYM iajs-1880 78 112 ml ml NOUN iajs-1880 78 113 . . PUNCT iajs-1880 78 114     SPACE iajs-1880 78 115 table table NOUN iajs-1880 78 116 ( ( PUNCT iajs-1880 78 117 8) 8) NUM iajs-1880 78 118 : : PUNCT iajs-1880 78 119 comparisons comparison NOUN iajs-1880 78 120 of of ADP iajs-1880 78 121 mcp-1 mcp-1 NOUN iajs-1880 78 122 levels level NOUN iajs-1880 78 123 ( ( PUNCT iajs-1880 78 124 pg pg NOUN iajs-1880 78 125 / / SYM iajs-1880 78 126 ml ml VERB iajs-1880 78 127 ) ) PUNCT iajs-1880 78 128 estimated estimate VERB iajs-1880 78 129 in in ADP iajs-1880 78 130 sera sera NOUN iajs-1880 78 131 of of ADP iajs-1880 78 132 studied study VERB iajs-1880 78 133 groups group NOUN iajs-1880 78 134 . . PUNCT iajs-1880 79 1 table table NOUN iajs-1880 79 2 ( ( PUNCT iajs-1880 79 3 9 9 NUM iajs-1880 79 4 ) ) PUNCT iajs-1880 79 5 , , PUNCT iajs-1880 79 6 illustrates illustrate VERB iajs-1880 79 7 the the DET iajs-1880 79 8 results result NOUN iajs-1880 79 9 of of ADP iajs-1880 79 10 tgf tgf PROPN iajs-1880 79 11 - - PUNCT iajs-1880 79 12 β β PROPN iajs-1880 79 13 levels level NOUN iajs-1880 79 14 in in ADP iajs-1880 79 15 studied study VERB iajs-1880 79 16 groups group NOUN iajs-1880 79 17 that that PRON iajs-1880 79 18 found find VERB iajs-1880 79 19 the the DET iajs-1880 79 20 mean mean ADJ iajs-1880 79 21 ± ± PROPN iajs-1880 79 22 sd sd NOUN iajs-1880 79 23 of of ADP iajs-1880 79 24 diabetic diabetic ADJ iajs-1880 79 25 patients patient NOUN iajs-1880 79 26 with with ADP iajs-1880 79 27 toxoplasmosis toxoplasmosis NOUN iajs-1880 79 28 0.242 0.242 NUM iajs-1880 79 29 ± ± NUM iajs-1880 79 30 0.53 0.53 NUM iajs-1880 79 31 pg pg NOUN iajs-1880 79 32 / / SYM iajs-1880 79 33 ml ml NOUN iajs-1880 79 34 ranging range VERB iajs-1880 79 35 from from ADP iajs-1880 79 36 0.149 0.149 NUM iajs-1880 79 37 to to ADP iajs-1880 79 38 0.995pg 0.995pg PROPN iajs-1880 79 39 / / SYM iajs-1880 79 40 ml ml PROPN iajs-1880 79 41 has have VERB iajs-1880 79 42 higher high ADJ iajs-1880 79 43 tgf tgf PROPN iajs-1880 79 44 - - PUNCT iajs-1880 79 45 β β NOUN iajs-1880 79 46 level level NOUN iajs-1880 79 47 than than ADP iajs-1880 79 48 diabetic diabetic ADJ iajs-1880 79 49 patients patient NOUN iajs-1880 79 50 group group NOUN iajs-1880 79 51 0.23 0.23 NUM iajs-1880 79 52 ± ± NUM iajs-1880 79 53 0.076 0.076 NUM iajs-1880 79 54 pg pg PROPN iajs-1880 79 55 / / SYM iajs-1880 79 56 ml ml ADP iajs-1880 79 57 their their PRON iajs-1880 79 58 ranging range VERB iajs-1880 79 59 values value NOUN iajs-1880 79 60 from from ADP iajs-1880 79 61 0.133 0.133 NUM iajs-1880 79 62 to to ADP iajs-1880 79 63 0.346 0.346 NUM iajs-1880 79 64 pg pg NOUN iajs-1880 79 65 / / SYM iajs-1880 79 66 ml ml X iajs-1880 79 67 in in ADP iajs-1880 79 68 comparison comparison NOUN iajs-1880 79 69 with with ADP iajs-1880 79 70 healthy healthy ADJ iajs-1880 79 71 control control NOUN iajs-1880 79 72 group group NOUN iajs-1880 79 73 0.102 0.102 NUM iajs-1880 79 74 ± ± NUM iajs-1880 79 75 0.12 0.12 NUM iajs-1880 79 76 their their PRON iajs-1880 79 77 values value NOUN iajs-1880 79 78 from from ADP iajs-1880 79 79 0.012 0.012 NUM iajs-1880 79 80 to to ADP iajs-1880 79 81 0.352 0.352 NUM iajs-1880 79 82 pg pg NOUN iajs-1880 79 83 / / SYM iajs-1880 79 84 ml ml ADP iajs-1880 79 85 , , PUNCT iajs-1880 79 86 with with ADP iajs-1880 79 87 highly highly ADV iajs-1880 79 88 significant significant ADJ iajs-1880 79 89 differences difference NOUN iajs-1880 79 90 shown show VERB iajs-1880 79 91 ( ( PUNCT iajs-1880 79 92 p p NOUN iajs-1880 79 93 ≤ ≤ NUM iajs-1880 79 94 0.0001 0.0001 NUM iajs-1880 79 95 ) ) PUNCT iajs-1880 79 96 . . PUNCT iajs-1880 80 1 groups group NOUN iajs-1880 80 2 no no INTJ iajs-1880 80 3 . . PUNCT iajs-1880 81 1 mean mean VERB iajs-1880 81 2 ( ( PUNCT iajs-1880 81 3 pg pg NOUN iajs-1880 81 4 / / SYM iajs-1880 81 5 ml ml NOUN iajs-1880 81 6 ) ) PUNCT iajs-1880 81 7 std std PROPN iajs-1880 81 8 . . PUNCT iajs-1880 81 9 dev dev PROPN iajs-1880 81 10 . . PUNCT iajs-1880 82 1 std std NOUN iajs-1880 82 2 . . PUNCT iajs-1880 82 3 error error NOUN iajs-1880 82 4 lower low ADJ iajs-1880 82 5 value value NOUN iajs-1880 82 6 upper upper ADJ iajs-1880 82 7 value value NOUN iajs-1880 82 8 diabetes diabetes NOUN iajs-1880 82 9 patients patient NOUN iajs-1880 82 10 with with ADP iajs-1880 82 11 toxoplasmosis toxoplasmosis NOUN iajs-1880 82 12 50 50 NUM iajs-1880 82 13 169.66 169.66 NUM iajs-1880 82 14 131.35 131.35 NUM iajs-1880 82 15 18.57 18.57 NUM iajs-1880 82 16 29.39 29.39 NUM iajs-1880 82 17 449.16 449.16 NUM iajs-1880 82 18 diabetes diabetes NOUN iajs-1880 82 19 patients patient VERB iajs-1880 82 20 50 50 NUM iajs-1880 82 21 119.77 119.77 NUM iajs-1880 82 22 95.78 95.78 NUM iajs-1880 82 23 21.41 21.41 NUM iajs-1880 82 24 20.44 20.44 NUM iajs-1880 82 25 296.61 296.61 NUM iajs-1880 82 26 control control NOUN iajs-1880 82 27 25 25 NUM iajs-1880 82 28 62.31 62.31 NUM iajs-1880 82 29 54.25 54.25 NUM iajs-1880 82 30 12.13 12.13 NUM iajs-1880 82 31 8.79 8.79 NUM iajs-1880 82 32 173.82 173.82 NUM iajs-1880 82 33 lsd lsd NOUN iajs-1880 82 34 - - PUNCT iajs-1880 82 35 value value NOUN iajs-1880 82 36 62.511 62.511 NUM iajs-1880 82 37 * * PUNCT iajs-1880 82 38 * * PUNCT iajs-1880 82 39 p p X iajs-1880 82 40 - - PUNCT iajs-1880 82 41 value value NOUN iajs-1880 82 42 0.0017 0.0017 NUM iajs-1880 82 43 parameter parameter NOUN iajs-1880 82 44 group group NOUN iajs-1880 82 45 1 1 NUM iajs-1880 82 46 group group NOUN iajs-1880 82 47 2 2 NUM iajs-1880 82 48 mean mean NOUN iajs-1880 82 49 diff diff NOUN iajs-1880 82 50 . . PUNCT iajs-1880 83 1 p p X iajs-1880 83 2 - - PUNCT iajs-1880 83 3 value value NOUN iajs-1880 83 4 sig sig NOUN iajs-1880 83 5 . . PUNCT iajs-1880 84 1 ( ( PUNCT iajs-1880 84 2 * * NOUN iajs-1880 84 3 ) ) PUNCT iajs-1880 84 4 mcp-1 mcp-1 PRON iajs-1880 84 5 concentration concentration NOUN iajs-1880 84 6 ( ( PUNCT iajs-1880 84 7 pg pg NOUN iajs-1880 84 8 / / SYM iajs-1880 84 9 ml ml NOUN iajs-1880 84 10 ) ) PUNCT iajs-1880 84 11 diabetes diabetes NOUN iajs-1880 84 12 patients patient NOUN iajs-1880 84 13 with with ADP iajs-1880 84 14 toxoplasmosis toxoplasmosis NOUN iajs-1880 84 15 diabetes diabetes NOUN iajs-1880 84 16 patients patient VERB iajs-1880 84 17 49.89 49.89 NUM iajs-1880 84 18 0.0382 0.0382 NUM iajs-1880 84 19 * * PUNCT iajs-1880 84 20 control control NOUN iajs-1880 84 21 107.35 107.35 NUM iajs-1880 84 22 0.0001 0.0001 NUM iajs-1880 84 23 * * PUNCT iajs-1880 84 24 * * NOUN iajs-1880 84 25 diabetes diabetes NOUN iajs-1880 84 26 patients patient NOUN iajs-1880 84 27 control control VERB iajs-1880 84 28 57.46 57.46 NUM iajs-1880 84 29 0.0026 0.0026 NUM iajs-1880 84 30 * * PUNCT iajs-1880 84 31 * * PUNCT iajs-1880 84 32 ihsciconf ihsciconf PROPN iajs-1880 84 33 2017 2017 NUM iajs-1880 84 34 special special ADJ iajs-1880 84 35 issue issue NOUN iajs-1880 84 36 ibn ibn PROPN iajs-1880 84 37 al al PROPN iajs-1880 84 38 - - PUNCT iajs-1880 84 39 haitham haitham PROPN iajs-1880 84 40 journal journal PROPN iajs-1880 84 41 for for ADP iajs-1880 84 42 pure pure ADJ iajs-1880 84 43 and and CCONJ iajs-1880 84 44 applied apply VERB iajs-1880 84 45 science science NOUN iajs-1880 84 46 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 84 47 for for ADP iajs-1880 84 48 more more ADJ iajs-1880 84 49 information information NOUN iajs-1880 84 50 about about ADP iajs-1880 84 51 the the DET iajs-1880 84 52 conference conference NOUN iajs-1880 84 53 please please INTJ iajs-1880 84 54 visit visit VERB iajs-1880 84 55 the the DET iajs-1880 84 56 websites website NOUN iajs-1880 84 57 : : PUNCT iajs-1880 84 58 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 84 59           SPACE iajs-1880 84 60 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 84 61     SPACE iajs-1880 84 62 biology|546 biology|546 VERB iajs-1880 84 63         SPACE iajs-1880 84 64 table table NOUN iajs-1880 84 65 ( ( PUNCT iajs-1880 84 66 9 9 NUM iajs-1880 84 67 ): ): PUNCT iajs-1880 84 68 concentrations concentration NOUN iajs-1880 84 69 of of ADP iajs-1880 84 70 tgf tgf PROPN iajs-1880 84 71 - - PUNCT iajs-1880 84 72 β β PROPN iajs-1880 84 73 ( ( PUNCT iajs-1880 84 74 pg pg NOUN iajs-1880 84 75 / / SYM iajs-1880 84 76 ml ml VERB iajs-1880 84 77 ) ) PUNCT iajs-1880 84 78 in in ADP iajs-1880 84 79 sera sera NOUN iajs-1880 84 80 of of ADP iajs-1880 84 81 studied study VERB iajs-1880 84 82 group group NOUN iajs-1880 84 83 . . PUNCT iajs-1880 85 1 table table NOUN iajs-1880 85 2 ( ( PUNCT iajs-1880 85 3 10 10 NUM iajs-1880 85 4 ) ) PUNCT iajs-1880 85 5 illustrates illustrate VERB iajs-1880 85 6 the the DET iajs-1880 85 7 mean mean ADJ iajs-1880 85 8 difference difference NOUN iajs-1880 85 9 ( ( PUNCT iajs-1880 85 10 pg pg NOUN iajs-1880 85 11 / / SYM iajs-1880 85 12 ml ml VERB iajs-1880 85 13 ) ) PUNCT iajs-1880 85 14 among among ADP iajs-1880 85 15 studied studied ADJ iajs-1880 85 16 groups group NOUN iajs-1880 85 17 have have VERB iajs-1880 85 18 a a DET iajs-1880 85 19 significant significant ADJ iajs-1880 85 20 difference difference NOUN iajs-1880 85 21 ( ( PUNCT iajs-1880 85 22 p p X iajs-1880 85 23 < < X iajs-1880 85 24 0.01 0.01 NUM iajs-1880 85 25 ) ) PUNCT iajs-1880 85 26 . . PUNCT iajs-1880 86 1 table table NOUN iajs-1880 86 2 ( ( PUNCT iajs-1880 86 3 10 10 NUM iajs-1880 86 4 ): ): PUNCT iajs-1880 86 5 comparisons comparison NOUN iajs-1880 86 6 of of ADP iajs-1880 86 7 tgf tgf PROPN iajs-1880 86 8 - - PUNCT iajs-1880 86 9 β β PROPN iajs-1880 86 10 levels level NOUN iajs-1880 86 11 ( ( PUNCT iajs-1880 86 12 pg pg NOUN iajs-1880 86 13 / / SYM iajs-1880 86 14 ml ml VERB iajs-1880 86 15 ) ) PUNCT iajs-1880 86 16 estimated estimate VERB iajs-1880 86 17 in in ADP iajs-1880 86 18 sera sera NOUN iajs-1880 86 19 of of ADP iajs-1880 86 20 studied study VERB iajs-1880 86 21 groups group NOUN iajs-1880 86 22 . . PUNCT iajs-1880 87 1 4 4 X iajs-1880 87 2 . . X iajs-1880 87 3 discussion discussion NOUN iajs-1880 87 4 a a DET iajs-1880 87 5 possible possible ADJ iajs-1880 87 6 correlation correlation NOUN iajs-1880 87 7 between between ADP iajs-1880 87 8 toxoplasmosis toxoplasmosis NOUN iajs-1880 87 9 and and CCONJ iajs-1880 87 10 diabetes diabetes NOUN iajs-1880 87 11 involve involve VERB iajs-1880 87 12 clinical clinical ADJ iajs-1880 87 13 significances significance NOUN iajs-1880 87 14 , , PUNCT iajs-1880 87 15 shedding shed VERB iajs-1880 87 16 light light NOUN iajs-1880 87 17 on on ADP iajs-1880 87 18 the the DET iajs-1880 87 19 complicated complicated ADJ iajs-1880 87 20 pathogenesis pathogenesis NOUN iajs-1880 87 21 of of ADP iajs-1880 87 22 diabetes diabetes NOUN iajs-1880 87 23 . . PUNCT iajs-1880 88 1 generally generally ADV iajs-1880 88 2 , , PUNCT iajs-1880 88 3 the the DET iajs-1880 88 4 current current ADJ iajs-1880 88 5 hypothesis hypothesis NOUN iajs-1880 88 6 supposes suppose VERB iajs-1880 88 7 that that SCONJ iajs-1880 88 8 toxoplasmosis toxoplasmosis NOUN iajs-1880 88 9 increases increase VERB iajs-1880 88 10 the the DET iajs-1880 88 11 capability capability NOUN iajs-1880 88 12 to to PART iajs-1880 88 13 infect infect VERB iajs-1880 88 14 with with ADP iajs-1880 88 15 diabetes diabetes NOUN iajs-1880 88 16 and and CCONJ iajs-1880 88 17 , , PUNCT iajs-1880 88 18 on on ADP iajs-1880 88 19 the the DET iajs-1880 88 20 other other ADJ iajs-1880 88 21 hand hand NOUN iajs-1880 88 22 , , PUNCT iajs-1880 88 23 diabetic diabetic ADJ iajs-1880 88 24 patients patient NOUN iajs-1880 88 25 are be AUX iajs-1880 88 26 abler abler ADJ iajs-1880 88 27 to to PART iajs-1880 88 28 infect infect VERB iajs-1880 88 29 with with ADP iajs-1880 88 30 toxoplasmosis toxoplasmosis NOUN iajs-1880 88 31 [ [ X iajs-1880 88 32 12,13 12,13 NUM iajs-1880 88 33 ] ] PUNCT iajs-1880 88 34 . . PUNCT iajs-1880 89 1 newly newly ADV iajs-1880 89 2 , , PUNCT iajs-1880 89 3 the the DET iajs-1880 89 4 immulite immulite ADJ iajs-1880 89 5 2000 2000 NUM iajs-1880 89 6 torch torch NOUN iajs-1880 89 7 assay assay VERB iajs-1880 89 8 , , PUNCT iajs-1880 89 9 an an DET iajs-1880 89 10 automated automate VERB iajs-1880 89 11 toxoplasma toxoplasma NOUN iajs-1880 89 12 quantitative quantitative ADJ iajs-1880 89 13 igm igm PROPN iajs-1880 89 14 and and CCONJ iajs-1880 89 15 igg igg PROPN iajs-1880 89 16 test test NOUN iajs-1880 89 17 , , PUNCT iajs-1880 89 18 has have AUX iajs-1880 89 19 been be AUX iajs-1880 89 20 presented present VERB iajs-1880 89 21 , , PUNCT iajs-1880 89 22 which which PRON iajs-1880 89 23 measures measure VERB iajs-1880 89 24 toxo toxo ADJ iajs-1880 89 25 igm igm NOUN iajs-1880 89 26 and and CCONJ iajs-1880 89 27 igg igg PROPN iajs-1880 89 28 in in ADP iajs-1880 89 29 international international ADJ iajs-1880 89 30 units unit NOUN iajs-1880 89 31 per per ADP iajs-1880 89 32 milliliter milliliter NOUN iajs-1880 89 33 ( ( PUNCT iajs-1880 89 34 iu iu NOUN iajs-1880 89 35 / / SYM iajs-1880 89 36 ml ml NOUN iajs-1880 89 37 ) ) PUNCT iajs-1880 89 38 of of ADP iajs-1880 89 39 serum serum NOUN iajs-1880 89 40 . . PUNCT iajs-1880 90 1 this this DET iajs-1880 90 2 assay assay NOUN iajs-1880 90 3 is be AUX iajs-1880 90 4 simple simple ADJ iajs-1880 90 5 , , PUNCT iajs-1880 90 6 comparatively comparatively ADV iajs-1880 90 7 inexpensive inexpensive ADJ iajs-1880 90 8 and and CCONJ iajs-1880 90 9 rapid rapid ADJ iajs-1880 90 10 needful needful ADJ iajs-1880 90 11 60–90 60–90 NUM iajs-1880 90 12 minutes minute NOUN iajs-1880 90 13 for for ADP iajs-1880 90 14 completion completion NOUN iajs-1880 90 15 [ [ X iajs-1880 90 16 14 14 NUM iajs-1880 90 17 ] ] PUNCT iajs-1880 90 18 . . PUNCT iajs-1880 91 1 groups group NOUN iajs-1880 91 2 no no INTJ iajs-1880 91 3 . . PUNCT iajs-1880 92 1 mean mean VERB iajs-1880 92 2 ( ( PUNCT iajs-1880 92 3 pg pg NOUN iajs-1880 92 4 / / SYM iajs-1880 92 5 ml ml NOUN iajs-1880 92 6 ) ) PUNCT iajs-1880 92 7 std std PROPN iajs-1880 92 8 . . PUNCT iajs-1880 92 9 dev dev PROPN iajs-1880 92 10 . . PUNCT iajs-1880 93 1 std std NOUN iajs-1880 93 2 . . PUNCT iajs-1880 93 3 error error NOUN iajs-1880 93 4 lower low ADJ iajs-1880 93 5 value value NOUN iajs-1880 93 6 upper upper ADJ iajs-1880 93 7 value value NOUN iajs-1880 93 8 diabetes diabetes NOUN iajs-1880 93 9 patients patient NOUN iajs-1880 93 10 with with ADP iajs-1880 93 11 toxoplasmosis toxoplasmosis NOUN iajs-1880 93 12 50 50 NUM iajs-1880 93 13 0.53 0.53 NUM iajs-1880 93 14 0.242 0.242 NUM iajs-1880 93 15 0.034 0.034 NUM iajs-1880 93 16 0.149 0.149 NUM iajs-1880 93 17 0.995 0.995 NUM iajs-1880 93 18 diabetes diabetes NOUN iajs-1880 93 19 patients patient VERB iajs-1880 93 20 50 50 NUM iajs-1880 93 21 0.23 0.23 NUM iajs-1880 93 22 0.076 0.076 NUM iajs-1880 93 23 0.017 0.017 NUM iajs-1880 93 24 0.133 0.133 NUM iajs-1880 93 25 0.346 0.346 NUM iajs-1880 93 26 control control NOUN iajs-1880 93 27 25 25 NUM iajs-1880 93 28 0.12 0.12 NUM iajs-1880 93 29 0.102 0.102 NUM iajs-1880 93 30 0.022 0.022 NUM iajs-1880 93 31 0.012 0.012 NUM iajs-1880 93 32 0.352 0.352 NUM iajs-1880 93 33 lsd lsd NOUN iajs-1880 93 34 - - PUNCT iajs-1880 93 35 value value NOUN iajs-1880 93 36 0.1074 0.1074 NUM iajs-1880 93 37 * * PUNCT iajs-1880 93 38 * * PUNCT iajs-1880 93 39 p p NOUN iajs-1880 93 40 - - PUNCT iajs-1880 93 41 value value NOUN iajs-1880 93 42 0.0001 0.0001 NUM iajs-1880 93 43 parameter parameter NOUN iajs-1880 93 44 group group NOUN iajs-1880 93 45 1 1 NUM iajs-1880 93 46 group group NOUN iajs-1880 93 47 2 2 NUM iajs-1880 93 48 mean mean NOUN iajs-1880 93 49 diff diff NOUN iajs-1880 93 50 . . PUNCT iajs-1880 94 1 p p X iajs-1880 94 2 - - PUNCT iajs-1880 94 3 value value NOUN iajs-1880 94 4 sig sig NOUN iajs-1880 94 5 . . PUNCT iajs-1880 95 1 ( ( PUNCT iajs-1880 95 2 * * PUNCT iajs-1880 95 3 ) ) PUNCT iajs-1880 95 4 tgf tgf PROPN iajs-1880 95 5 - - PUNCT iajs-1880 95 6 β β NOUN iajs-1880 95 7 concentration concentration NOUN iajs-1880 95 8 ( ( PUNCT iajs-1880 95 9 pg pg NOUN iajs-1880 95 10 / / SYM iajs-1880 95 11 ml ml NOUN iajs-1880 95 12 ) ) PUNCT iajs-1880 95 13 diabetes diabetes NOUN iajs-1880 95 14 patients patient NOUN iajs-1880 95 15 with with ADP iajs-1880 95 16 toxoplasmosis toxoplasmosis NOUN iajs-1880 95 17 diabetes diabetes NOUN iajs-1880 95 18 patients patient VERB iajs-1880 95 19 0.3 0.3 NUM iajs-1880 95 20 0.0037 0.0037 NUM iajs-1880 95 21 * * PUNCT iajs-1880 95 22 * * PUNCT iajs-1880 95 23 control control NOUN iajs-1880 95 24 0.41 0.41 NUM iajs-1880 95 25 0.0001 0.0001 NUM iajs-1880 95 26 * * PUNCT iajs-1880 95 27 * * NOUN iajs-1880 95 28 diabetes diabetes NOUN iajs-1880 95 29 patients patient NOUN iajs-1880 95 30 control control VERB iajs-1880 95 31 0.11 0.11 NUM iajs-1880 95 32 0.0492 0.0492 NUM iajs-1880 95 33 * * PUNCT iajs-1880 95 34 ihsciconf ihsciconf PROPN iajs-1880 95 35 2017 2017 NUM iajs-1880 95 36 special special ADJ iajs-1880 95 37 issue issue NOUN iajs-1880 95 38 ibn ibn PROPN iajs-1880 95 39 al al PROPN iajs-1880 95 40 - - PUNCT iajs-1880 95 41 haitham haitham PROPN iajs-1880 95 42 journal journal PROPN iajs-1880 95 43 for for ADP iajs-1880 95 44 pure pure ADJ iajs-1880 95 45 and and CCONJ iajs-1880 95 46 applied apply VERB iajs-1880 95 47 science science NOUN iajs-1880 95 48 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 95 49 for for ADP iajs-1880 95 50 more more ADJ iajs-1880 95 51 information information NOUN iajs-1880 95 52 about about ADP iajs-1880 95 53 the the DET iajs-1880 95 54 conference conference NOUN iajs-1880 95 55 please please INTJ iajs-1880 95 56 visit visit VERB iajs-1880 95 57 the the DET iajs-1880 95 58 websites website NOUN iajs-1880 95 59 : : PUNCT iajs-1880 95 60 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 95 61           SPACE iajs-1880 95 62 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 95 63     SPACE iajs-1880 95 64 biology|547 biology|547 NOUN iajs-1880 95 65         SPACE iajs-1880 95 66 the the DET iajs-1880 95 67 previous previous ADJ iajs-1880 95 68 results result NOUN iajs-1880 95 69 of of ADP iajs-1880 95 70 igm igm PROPN iajs-1880 95 71 and and CCONJ iajs-1880 95 72 igg igg PROPN iajs-1880 95 73 abs ab NOUN iajs-1880 95 74 agreement agreement NOUN iajs-1880 95 75 with with ADP iajs-1880 95 76 shirbazou shirbazou NOUN iajs-1880 95 77 et et PROPN iajs-1880 95 78 al al PROPN iajs-1880 95 79 . . PUNCT iajs-1880 96 1 [ [ X iajs-1880 96 2 5 5 NUM iajs-1880 96 3 ] ] PUNCT iajs-1880 96 4 study study NOUN iajs-1880 96 5 that that PRON iajs-1880 96 6 showed show VERB iajs-1880 96 7 the the DET iajs-1880 96 8 prevalence prevalence NOUN iajs-1880 96 9 of of ADP iajs-1880 96 10 igg igg PROPN iajs-1880 96 11 and and CCONJ iajs-1880 96 12 igm igm PROPN iajs-1880 96 13 abs ab NOUN iajs-1880 96 14 in in ADP iajs-1880 96 15 diabetic diabetic ADJ iajs-1880 96 16 patients patient NOUN iajs-1880 96 17 were be AUX iajs-1880 96 18 ( ( PUNCT iajs-1880 96 19 56.6 56.6 NUM iajs-1880 96 20 % % NOUN iajs-1880 96 21 ) ) PUNCT iajs-1880 96 22 and and CCONJ iajs-1880 96 23 ( ( PUNCT iajs-1880 96 24 2.4 2.4 NUM iajs-1880 96 25 % % NOUN iajs-1880 96 26 ) ) PUNCT iajs-1880 96 27 while while SCONJ iajs-1880 96 28 in in ADP iajs-1880 96 29 control control NOUN iajs-1880 96 30 were be AUX iajs-1880 96 31 ( ( PUNCT iajs-1880 96 32 22.4 22.4 NUM iajs-1880 96 33 % % NOUN iajs-1880 96 34 ) ) PUNCT iajs-1880 96 35 and and CCONJ iajs-1880 96 36 ( ( PUNCT iajs-1880 96 37 1.6 1.6 NUM iajs-1880 96 38 % % NOUN iajs-1880 96 39 ) ) PUNCT iajs-1880 96 40 respectively respectively ADV iajs-1880 96 41 , , PUNCT iajs-1880 96 42 as as ADV iajs-1880 96 43 well well ADV iajs-1880 96 44 as as ADP iajs-1880 96 45 agreement agreement NOUN iajs-1880 96 46 with with ADP iajs-1880 96 47 results result NOUN iajs-1880 96 48 of of ADP iajs-1880 96 49 gokce gokce PROPN iajs-1880 96 50 et et PROPN iajs-1880 96 51 al al PROPN iajs-1880 96 52 . . PUNCT iajs-1880 97 1 [ [ X iajs-1880 97 2 15 15 NUM iajs-1880 97 3 ] ] PUNCT iajs-1880 97 4 that that PRON iajs-1880 97 5 studied study VERB iajs-1880 97 6 serologic serologic ADJ iajs-1880 97 7 detection detection NOUN iajs-1880 97 8 of of ADP iajs-1880 97 9 anti anti ADJ iajs-1880 97 10 - - ADJ iajs-1880 97 11 toxoplasma toxoplasma ADJ iajs-1880 97 12 infection infection NOUN iajs-1880 97 13 in in ADP iajs-1880 97 14 91 91 NUM iajs-1880 97 15 diabetic diabetic ADJ iajs-1880 97 16 patients patient NOUN iajs-1880 97 17 and and CCONJ iajs-1880 97 18 93 93 NUM iajs-1880 97 19 healthy healthy ADJ iajs-1880 97 20 control control NOUN iajs-1880 97 21 which which PRON iajs-1880 97 22 found find VERB iajs-1880 97 23 the the DET iajs-1880 97 24 prevalence prevalence NOUN iajs-1880 97 25 of of ADP iajs-1880 97 26 igg igg PROPN iajs-1880 97 27 ab ab PROPN iajs-1880 97 28 of of ADP iajs-1880 97 29 t. t. PROPN iajs-1880 97 30 gondii gondii NOUN iajs-1880 97 31 was be AUX iajs-1880 97 32 55 55 NUM iajs-1880 97 33 ( ( PUNCT iajs-1880 97 34 60.43 60.43 NUM iajs-1880 97 35 % % NOUN iajs-1880 97 36 ) ) PUNCT iajs-1880 97 37 while while SCONJ iajs-1880 97 38 in in ADP iajs-1880 97 39 healthy healthy ADJ iajs-1880 97 40 control control NOUN iajs-1880 97 41 was be AUX iajs-1880 97 42 36 36 NUM iajs-1880 97 43 ( ( PUNCT iajs-1880 97 44 38.7 38.7 NUM iajs-1880 97 45 % % NOUN iajs-1880 97 46 ) ) PUNCT iajs-1880 97 47 , , PUNCT iajs-1880 97 48 also also ADV iajs-1880 97 49 compatible compatible ADJ iajs-1880 97 50 with with ADP iajs-1880 97 51 results result NOUN iajs-1880 97 52 of of ADP iajs-1880 97 53 el el NOUN iajs-1880 97 54 - - PUNCT iajs-1880 97 55 awady awady PROPN iajs-1880 97 56 et et PROPN iajs-1880 97 57 al al PROPN iajs-1880 97 58 . . PUNCT iajs-1880 98 1 [ [ X iajs-1880 98 2 14 14 NUM iajs-1880 98 3 ] ] PUNCT iajs-1880 98 4 that that PRON iajs-1880 98 5 studied study VERB iajs-1880 98 6 seroprevalence seroprevalence NOUN iajs-1880 98 7 of of ADP iajs-1880 98 8 toxoplasmosis toxoplasmosis NOUN iajs-1880 98 9 in in ADP iajs-1880 98 10 110 110 NUM iajs-1880 98 11 diabetic diabetic ADJ iajs-1880 98 12 pregnant pregnant ADJ iajs-1880 98 13 women woman NOUN iajs-1880 98 14 and and CCONJ iajs-1880 98 15 110 110 NUM iajs-1880 98 16 non non X iajs-1880 98 17 diabetic diabetic ADJ iajs-1880 98 18 pregnant pregnant ADJ iajs-1880 98 19 women woman NOUN iajs-1880 98 20 which which PRON iajs-1880 98 21 found find VERB iajs-1880 98 22 47 47 NUM iajs-1880 98 23 ( ( PUNCT iajs-1880 98 24 42.7 42.7 NUM iajs-1880 98 25 % % NOUN iajs-1880 98 26 ) ) PUNCT iajs-1880 98 27 of of ADP iajs-1880 98 28 diabetic diabetic ADJ iajs-1880 98 29 pregnant pregnant ADJ iajs-1880 98 30 women woman NOUN iajs-1880 98 31 were be AUX iajs-1880 98 32 seropositive seropositive ADJ iajs-1880 98 33 for for ADP iajs-1880 98 34 anti anti ADJ iajs-1880 98 35 - - ADJ iajs-1880 98 36 toxoplasma toxoplasma ADJ iajs-1880 98 37 igg igg PROPN iajs-1880 98 38 and and CCONJ iajs-1880 98 39 3 3 NUM iajs-1880 98 40 ( ( PUNCT iajs-1880 98 41 2.7 2.7 NUM iajs-1880 98 42 % % NOUN iajs-1880 98 43 ) ) PUNCT iajs-1880 98 44 seropositive seropositive ADJ iajs-1880 98 45 for for ADP iajs-1880 98 46 igm igm PROPN iajs-1880 98 47 ab ab PROPN iajs-1880 98 48 as as ADV iajs-1880 98 49 well well ADV iajs-1880 98 50 as as ADP iajs-1880 98 51 24 24 NUM iajs-1880 98 52 ( ( PUNCT iajs-1880 98 53 21.81 21.81 NUM iajs-1880 98 54 % % NOUN iajs-1880 98 55 ) ) PUNCT iajs-1880 98 56 of of ADP iajs-1880 98 57 healthy healthy ADJ iajs-1880 98 58 non non ADJ iajs-1880 98 59 diabetic diabetic ADJ iajs-1880 98 60 pregnant pregnant ADJ iajs-1880 98 61 women woman NOUN iajs-1880 98 62 were be AUX iajs-1880 98 63 seropositive seropositive ADJ iajs-1880 98 64 for for ADP iajs-1880 98 65 igg igg PROPN iajs-1880 98 66 ab ab PROPN iajs-1880 99 1 but but CCONJ iajs-1880 99 2 there there PRON iajs-1880 99 3 is be VERB iajs-1880 99 4 no no DET iajs-1880 99 5 detection detection NOUN iajs-1880 99 6 for for ADP iajs-1880 99 7 igm igm PROPN iajs-1880 99 8 ab ab PROPN iajs-1880 99 9 . . PUNCT iajs-1880 100 1 these these DET iajs-1880 100 2 findings finding NOUN iajs-1880 100 3 discovered discover VERB iajs-1880 100 4 the the DET iajs-1880 100 5 prevalence prevalence NOUN iajs-1880 100 6 rate rate NOUN iajs-1880 100 7 of of ADP iajs-1880 100 8 igg igg PROPN iajs-1880 100 9 ab ab PROPN iajs-1880 100 10 was be AUX iajs-1880 100 11 directly directly ADV iajs-1880 100 12 related relate VERB iajs-1880 100 13 with with ADP iajs-1880 100 14 duration duration NOUN iajs-1880 100 15 of of ADP iajs-1880 100 16 diabetes diabetes NOUN iajs-1880 100 17 because because SCONJ iajs-1880 100 18 of of ADP iajs-1880 100 19 the the DET iajs-1880 100 20 weakened weaken VERB iajs-1880 100 21 immune immune ADJ iajs-1880 100 22 system system NOUN iajs-1880 100 23 of of ADP iajs-1880 100 24 diabetic diabetic ADJ iajs-1880 100 25 patients patient NOUN iajs-1880 100 26 which which PRON iajs-1880 100 27 also also ADV iajs-1880 100 28 proposed propose VERB iajs-1880 100 29 that that SCONJ iajs-1880 100 30 toxoplasmosis toxoplasmosis NOUN iajs-1880 100 31 patients patient NOUN iajs-1880 100 32 are be AUX iajs-1880 100 33 more more ADV iajs-1880 100 34 susceptible susceptible ADJ iajs-1880 100 35 to to PART iajs-1880 100 36 be be AUX iajs-1880 100 37 diabetics diabetic NOUN iajs-1880 100 38 than than ADP iajs-1880 100 39 those those PRON iajs-1880 100 40 without without ADP iajs-1880 100 41 . . PUNCT iajs-1880 101 1 demolition demolition NOUN iajs-1880 101 2 of of ADP iajs-1880 101 3 the the DET iajs-1880 101 4 pancreas pancreas NOUN iajs-1880 101 5 occurs occur VERB iajs-1880 101 6 in in ADP iajs-1880 101 7 three three NUM iajs-1880 101 8 stages stage NOUN iajs-1880 101 9 of of ADP iajs-1880 101 10 t. t. NOUN iajs-1880 101 11 gondii gondii NOUN iajs-1880 101 12 : : PUNCT iajs-1880 102 1 1 1 X iajs-1880 102 2 . . X iajs-1880 102 3 hyperactive hyperactive ADJ iajs-1880 102 4 stage stage NOUN iajs-1880 102 5 ( ( PUNCT iajs-1880 102 6 hyper hyper NOUN iajs-1880 102 7 - - NOUN iajs-1880 102 8 period period NOUN iajs-1880 102 9 ) ) PUNCT iajs-1880 102 10 in in ADP iajs-1880 102 11 which which PRON iajs-1880 102 12 β β NOUN iajs-1880 102 13 - - NOUN iajs-1880 102 14 cell cell NOUN iajs-1880 102 15 obliteration obliteration NOUN iajs-1880 102 16 of of ADP iajs-1880 102 17 nerve nerve NOUN iajs-1880 102 18 cells cell NOUN iajs-1880 102 19 and and CCONJ iajs-1880 102 20 less less ADJ iajs-1880 102 21 interference interference NOUN iajs-1880 102 22 in in ADP iajs-1880 102 23 the the DET iajs-1880 102 24 insect insect NOUN iajs-1880 102 25 in in ADP iajs-1880 102 26 a a DET iajs-1880 102 27 hyperactive hyperactive ADJ iajs-1880 102 28 state state NOUN iajs-1880 102 29 of of ADP iajs-1880 102 30 the the DET iajs-1880 102 31 pancreas pancrea NOUN iajs-1880 102 32 , , PUNCT iajs-1880 102 33 sometimes sometimes ADV iajs-1880 102 34 insulin insulin NOUN iajs-1880 102 35 secretion secretion NOUN iajs-1880 102 36 is be AUX iajs-1880 102 37 excessive excessive ADJ iajs-1880 102 38 , , PUNCT iajs-1880 102 39 frequently frequently ADV iajs-1880 102 40 resulting result VERB iajs-1880 102 41 in in ADP iajs-1880 102 42 low low ADJ iajs-1880 102 43 or or CCONJ iajs-1880 102 44 a a DET iajs-1880 102 45 too too ADV iajs-1880 102 46 low low ADJ iajs-1880 102 47 blood blood NOUN iajs-1880 102 48 sugar sugar NOUN iajs-1880 102 49 , , PUNCT iajs-1880 102 50 this this DET iajs-1880 102 51 stage stage NOUN iajs-1880 102 52 is be AUX iajs-1880 102 53 often often ADV iajs-1880 102 54 occurring occur VERB iajs-1880 102 55 during during ADP iajs-1880 102 56 adolescence adolescence NOUN iajs-1880 102 57 . . PUNCT iajs-1880 103 1 2 2 X iajs-1880 103 2 . . X iajs-1880 103 3 disordered disorder VERB iajs-1880 103 4 stage stage NOUN iajs-1880 103 5 ( ( PUNCT iajs-1880 103 6 compensatory compensatory ADJ iajs-1880 103 7 stage stage NOUN iajs-1880 103 8 ) ) PUNCT iajs-1880 103 9 , , PUNCT iajs-1880 103 10 in in ADP iajs-1880 103 11 which which PRON iajs-1880 103 12 neurons neuron NOUN iajs-1880 103 13 and and CCONJ iajs-1880 103 14 pancreatic pancreatic ADJ iajs-1880 103 15 β β NOUN iajs-1880 103 16 - - NOUN iajs-1880 103 17 cells cell NOUN iajs-1880 103 18 have have VERB iajs-1880 103 19 a a DET iajs-1880 103 20 great great ADJ iajs-1880 103 21 amount amount NOUN iajs-1880 103 22 of of ADP iajs-1880 103 23 damage damage NOUN iajs-1880 103 24 , , PUNCT iajs-1880 103 25 under under ADP iajs-1880 103 26 normal normal ADJ iajs-1880 103 27 conditions condition NOUN iajs-1880 103 28 , , PUNCT iajs-1880 103 29 insulin insulin NOUN iajs-1880 103 30 secretion secretion NOUN iajs-1880 103 31 will will AUX iajs-1880 103 32 be be AUX iajs-1880 103 33 insufficient insufficient ADJ iajs-1880 103 34 , , PUNCT iajs-1880 103 35 the the DET iajs-1880 103 36 body body NOUN iajs-1880 103 37 will will AUX iajs-1880 103 38 begin begin VERB iajs-1880 103 39 the the DET iajs-1880 103 40 compensative compensative ADJ iajs-1880 103 41 function function NOUN iajs-1880 103 42 . . PUNCT iajs-1880 104 1 so so ADV iajs-1880 104 2 , , PUNCT iajs-1880 104 3 when when SCONJ iajs-1880 104 4 few few ADJ iajs-1880 104 5 in in ADP iajs-1880 104 6 the the DET iajs-1880 104 7 disordered disordered ADJ iajs-1880 104 8 state state NOUN iajs-1880 104 9 , , PUNCT iajs-1880 104 10 this this DET iajs-1880 104 11 stage stage NOUN iajs-1880 104 12 of of ADP iajs-1880 104 13 insulin insulin NOUN iajs-1880 104 14 secretion secretion NOUN iajs-1880 104 15 over over ADP iajs-1880 104 16 time time NOUN iajs-1880 104 17 . . PUNCT iajs-1880 105 1 3 3 X iajs-1880 105 2 . . NOUN iajs-1880 105 3 decline decline NOUN iajs-1880 105 4 stage stage NOUN iajs-1880 105 5 ( ( PUNCT iajs-1880 105 6 recession recession NOUN iajs-1880 105 7 ) ) PUNCT iajs-1880 105 8 , , PUNCT iajs-1880 105 9 in in ADP iajs-1880 105 10 which which PRON iajs-1880 105 11 nerve nerve NOUN iajs-1880 105 12 cells cell NOUN iajs-1880 105 13 and and CCONJ iajs-1880 105 14 β β NOUN iajs-1880 105 15 - - NOUN iajs-1880 105 16 cells cell NOUN iajs-1880 105 17 destruction destruction NOUN iajs-1880 105 18 of of ADP iajs-1880 105 19 more more ADJ iajs-1880 105 20 compensatory compensatory ADJ iajs-1880 105 21 function function NOUN iajs-1880 105 22 reach reach VERB iajs-1880 105 23 to to ADP iajs-1880 105 24 its its PRON iajs-1880 105 25 limits limit NOUN iajs-1880 105 26 . . PUNCT iajs-1880 106 1 there there PRON iajs-1880 106 2 are be VERB iajs-1880 106 3 a a DET iajs-1880 106 4 number number NOUN iajs-1880 106 5 of of ADP iajs-1880 106 6 factors factor NOUN iajs-1880 106 7 such such ADJ iajs-1880 106 8 as as ADP iajs-1880 106 9 duration duration NOUN iajs-1880 106 10 of of ADP iajs-1880 106 11 diabetes diabetes NOUN iajs-1880 106 12 , , PUNCT iajs-1880 106 13 severity severity NOUN iajs-1880 106 14 of of ADP iajs-1880 106 15 noninfectious noninfectious ADJ iajs-1880 106 16 complications complication NOUN iajs-1880 106 17 , , PUNCT iajs-1880 106 18 abortion abortion NOUN iajs-1880 106 19 , , PUNCT iajs-1880 106 20 optical optical ADJ iajs-1880 106 21 disease disease NOUN iajs-1880 106 22 , , PUNCT iajs-1880 106 23 comorbidity comorbidity NOUN iajs-1880 106 24 , , PUNCT iajs-1880 106 25 co co NOUN iajs-1880 106 26 - - NOUN iajs-1880 106 27 infection infection NOUN iajs-1880 106 28 and and CCONJ iajs-1880 106 29 meat meat NOUN iajs-1880 106 30 consumption consumption NOUN iajs-1880 106 31 which which PRON iajs-1880 106 32 can can AUX iajs-1880 106 33 lead lead VERB iajs-1880 106 34 to to ADP iajs-1880 106 35 acute acute ADJ iajs-1880 106 36 infection infection NOUN iajs-1880 106 37 in in ADP iajs-1880 106 38 diabetic diabetic ADJ iajs-1880 106 39 patients patient NOUN iajs-1880 106 40 and and CCONJ iajs-1880 106 41 also also ADV iajs-1880 106 42 severe severe ADJ iajs-1880 106 43 complications complication NOUN iajs-1880 106 44 of of ADP iajs-1880 106 45 disease disease NOUN iajs-1880 106 46 ( ( PUNCT iajs-1880 106 47 16 16 NUM iajs-1880 106 48 ) ) PUNCT iajs-1880 106 49 . . PUNCT iajs-1880 107 1 the the DET iajs-1880 107 2 present present ADJ iajs-1880 107 3 results result NOUN iajs-1880 107 4 similar similar ADJ iajs-1880 107 5 to to ADP iajs-1880 107 6 results result NOUN iajs-1880 107 7 of of ADP iajs-1880 107 8 modrek modrek NOUN iajs-1880 107 9 et et PROPN iajs-1880 107 10 al al PROPN iajs-1880 107 11 . . PUNCT iajs-1880 108 1 [ [ X iajs-1880 108 2 16 16 NUM iajs-1880 108 3 ] ] PUNCT iajs-1880 108 4 that that PRON iajs-1880 108 5 investigate investigate VERB iajs-1880 108 6 of of ADP iajs-1880 108 7 igg igg PROPN iajs-1880 108 8 and and CCONJ iajs-1880 108 9 igm igm PROPN iajs-1880 108 10 in in ADP iajs-1880 108 11 205 205 NUM iajs-1880 108 12 serum serum NOUN iajs-1880 108 13 samples sample NOUN iajs-1880 108 14 of of ADP iajs-1880 108 15 diabetics diabetic NOUN iajs-1880 108 16 in in ADP iajs-1880 108 17 ali ali PROPN iajs-1880 108 18 asghar asghar PROPN iajs-1880 108 19 hospital hospital PROPN iajs-1880 108 20 in in ADP iajs-1880 108 21 zahedan zahedan PROPN iajs-1880 108 22 ( ( PUNCT iajs-1880 108 23 southeastern southeastern ADJ iajs-1880 108 24 iran iran PROPN iajs-1880 108 25 ) ) PUNCT iajs-1880 108 26 with with ADP iajs-1880 108 27 age age NOUN iajs-1880 108 28 ( ( PUNCT iajs-1880 108 29 13 13 NUM iajs-1880 108 30 – – SYM iajs-1880 108 31 60 60 NUM iajs-1880 108 32 ) ) PUNCT iajs-1880 108 33 years year NOUN iajs-1880 108 34 which which PRON iajs-1880 108 35 found find VERB iajs-1880 108 36 131 131 NUM iajs-1880 108 37 diabetic diabetic ADJ iajs-1880 108 38 patients patient NOUN iajs-1880 108 39 had have AUX iajs-1880 108 40 fasting fast VERB iajs-1880 108 41 blood blood NOUN iajs-1880 108 42 glucose glucose NOUN iajs-1880 108 43 levels level NOUN iajs-1880 108 44 between between ADP iajs-1880 108 45 121 121 NUM iajs-1880 108 46 300 300 NUM iajs-1880 108 47 mg mg PROPN iajs-1880 108 48 / / SYM iajs-1880 108 49 dl dl PROPN iajs-1880 108 50 that that SCONJ iajs-1880 108 51 79 79 NUM iajs-1880 108 52 diabetics diabetic NOUN iajs-1880 108 53 have have VERB iajs-1880 108 54 anti anti ADJ iajs-1880 108 55 toxoplasma toxoplasma PROPN iajs-1880 108 56 igg igg PROPN iajs-1880 108 57 ( ( PUNCT iajs-1880 108 58 63.2 63.2 NUM iajs-1880 108 59 % % NOUN iajs-1880 108 60 ) ) PUNCT iajs-1880 108 61 and and CCONJ iajs-1880 108 62 52 52 NUM iajs-1880 108 63 diabetics diabetic NOUN iajs-1880 108 64 have have VERB iajs-1880 108 65 antitoxoplasma antitoxoplasma NOUN iajs-1880 108 66 igm igm PROPN iajs-1880 108 67 ( ( PUNCT iajs-1880 108 68 71.3 71.3 NUM iajs-1880 108 69 % % NOUN iajs-1880 108 70 ) ) PUNCT iajs-1880 108 71 with with ADP iajs-1880 108 72 significant significant ADJ iajs-1880 108 73 differences difference NOUN iajs-1880 108 74 ( ( PUNCT iajs-1880 108 75 p p X iajs-1880 108 76 < < X iajs-1880 108 77 0.05 0.05 NUM iajs-1880 108 78 ) ) PUNCT iajs-1880 108 79 . . PUNCT iajs-1880 109 1 monocyte monocyte PROPN iajs-1880 109 2 chemoattractant chemoattractant NOUN iajs-1880 109 3 protein protein NOUN iajs-1880 109 4 ( ( PUNCT iajs-1880 109 5 mcp)-1 mcp)-1 PROPN iajs-1880 109 6 is be AUX iajs-1880 109 7 a a DET iajs-1880 109 8 chemokine chemokine ADJ iajs-1880 109 9 with with ADP iajs-1880 109 10 chemoattractant chemoattractant NOUN iajs-1880 109 11 characteristics characteristic NOUN iajs-1880 109 12 for for ADP iajs-1880 109 13 monocytes monocyte NOUN iajs-1880 109 14 , , PUNCT iajs-1880 109 15 memory memory NOUN iajs-1880 109 16 t t NOUN iajs-1880 109 17 cells cell NOUN iajs-1880 109 18 , , PUNCT iajs-1880 109 19 mast mast NOUN iajs-1880 109 20 cells cell NOUN iajs-1880 109 21 , , PUNCT iajs-1880 109 22 natural natural ADJ iajs-1880 109 23 killer killer NOUN iajs-1880 109 24 cells cell NOUN iajs-1880 109 25 , , PUNCT iajs-1880 109 26 and and CCONJ iajs-1880 109 27 basophils basophil NOUN iajs-1880 109 28 [ [ X iajs-1880 109 29 17 17 NUM iajs-1880 109 30 ] ] PUNCT iajs-1880 109 31 . . PUNCT iajs-1880 110 1 it it PRON iajs-1880 110 2 is be AUX iajs-1880 110 3 involved involve VERB iajs-1880 110 4 in in ADP iajs-1880 110 5 the the DET iajs-1880 110 6 cellular cellular ADJ iajs-1880 110 7 recruitment recruitment NOUN iajs-1880 110 8 and and CCONJ iajs-1880 110 9 activation activation NOUN iajs-1880 110 10 of of ADP iajs-1880 110 11 several several ADJ iajs-1880 110 12 leukocytes leukocyte NOUN iajs-1880 110 13 such such ADJ iajs-1880 110 14 as as ADP iajs-1880 110 15 monocytes monocyte NOUN iajs-1880 110 16 / / SYM iajs-1880 110 17 macrophages macrophage NOUN iajs-1880 110 18 , , PUNCT iajs-1880 110 19 polymorphonuclear polymorphonuclear NOUN iajs-1880 110 20 cells cell NOUN iajs-1880 110 21 , , PUNCT iajs-1880 110 22 and and CCONJ iajs-1880 110 23 lymphocyte lymphocyte ADJ iajs-1880 110 24 infiltration infiltration NOUN iajs-1880 110 25 to to ADP iajs-1880 110 26 the the DET iajs-1880 110 27 sites site NOUN iajs-1880 110 28 of of ADP iajs-1880 110 29 infection infection NOUN iajs-1880 110 30 [ [ X iajs-1880 110 31 18 18 NUM iajs-1880 110 32 ] ] PUNCT iajs-1880 110 33 . . PUNCT iajs-1880 111 1 mcp-1 mcp-1 SYM iajs-1880 111 2 secretion secretion NOUN iajs-1880 111 3 may may AUX iajs-1880 111 4 participate participate VERB iajs-1880 111 5 to to ADP iajs-1880 111 6 the the DET iajs-1880 111 7 monocytes monocyte NOUN iajs-1880 111 8 and and CCONJ iajs-1880 111 9 lymphocytes lymphocyte VERB iajs-1880 111 10 recruitment recruitment NOUN iajs-1880 111 11 and and CCONJ iajs-1880 111 12 therefore therefore ADV iajs-1880 111 13 contribute contribute VERB iajs-1880 111 14 in in ADP iajs-1880 111 15 the the DET iajs-1880 111 16 control control NOUN iajs-1880 111 17 of of ADP iajs-1880 111 18 t. t. NOUN iajs-1880 111 19 gondii gondii NOUN iajs-1880 111 20 pathogenesis pathogenesis NOUN iajs-1880 111 21 and and CCONJ iajs-1880 111 22 its its PRON iajs-1880 111 23 infection infection NOUN iajs-1880 111 24 [ [ X iajs-1880 111 25 19 19 NUM iajs-1880 111 26 ] ] PUNCT iajs-1880 111 27 . . PUNCT iajs-1880 112 1 study study NOUN iajs-1880 112 2 of of ADP iajs-1880 112 3 ali ali PROPN iajs-1880 113 1 [ [ X iajs-1880 113 2 20 20 NUM iajs-1880 113 3 ] ] PUNCT iajs-1880 113 4 revealed reveal VERB iajs-1880 113 5 that that SCONJ iajs-1880 113 6 low low ADJ iajs-1880 113 7 levels level NOUN iajs-1880 113 8 of of ADP iajs-1880 113 9 mcp-1 mcp-1 X iajs-1880 113 10 ( ( PUNCT iajs-1880 113 11 ccl2 ccl2 PROPN iajs-1880 113 12 ) ) PUNCT iajs-1880 113 13 were be AUX iajs-1880 113 14 observed observe VERB iajs-1880 113 15 in in ADP iajs-1880 113 16 pregnant pregnant ADJ iajs-1880 113 17 women woman NOUN iajs-1880 113 18 with with ADP iajs-1880 113 19 acute acute ADJ iajs-1880 113 20 toxoplasmosis toxoplasmosis PROPN iajs-1880 113 21 because because SCONJ iajs-1880 113 22 live live ADJ iajs-1880 113 23 tachyzoite tachyzoite ADJ iajs-1880 113 24 forms form NOUN iajs-1880 113 25 of of ADP iajs-1880 113 26 t. t. PROPN iajs-1880 113 27 gondii gondii NOUN iajs-1880 113 28 inhibited inhibit VERB iajs-1880 113 29 the the DET iajs-1880 113 30 ihsciconf ihsciconf ADJ iajs-1880 113 31 2017 2017 NUM iajs-1880 113 32 special special ADJ iajs-1880 113 33 issue issue NOUN iajs-1880 113 34 ibn ibn PROPN iajs-1880 113 35 al al PROPN iajs-1880 113 36 - - PUNCT iajs-1880 113 37 haitham haitham PROPN iajs-1880 113 38 journal journal PROPN iajs-1880 113 39 for for ADP iajs-1880 113 40 pure pure ADJ iajs-1880 113 41 and and CCONJ iajs-1880 113 42 applied apply VERB iajs-1880 113 43 science science NOUN iajs-1880 113 44 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 113 45 for for ADP iajs-1880 113 46 more more ADJ iajs-1880 113 47 information information NOUN iajs-1880 113 48 about about ADP iajs-1880 113 49 the the DET iajs-1880 113 50 conference conference NOUN iajs-1880 113 51 please please INTJ iajs-1880 113 52 visit visit VERB iajs-1880 113 53 the the DET iajs-1880 113 54 websites website NOUN iajs-1880 113 55 : : PUNCT iajs-1880 113 56 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 113 57           SPACE iajs-1880 113 58 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 113 59     SPACE iajs-1880 113 60 biology|548 biology|548 ADJ iajs-1880 113 61         SPACE iajs-1880 113 62 synthesis synthesis NOUN iajs-1880 113 63 of of ADP iajs-1880 113 64 mcp-1[21 mcp-1[21 NOUN iajs-1880 113 65 ] ] PUNCT iajs-1880 113 66 . . PUNCT iajs-1880 114 1 study study NOUN iajs-1880 114 2 of of ADP iajs-1880 114 3 tuaillon tuaillon NOUN iajs-1880 114 4 et et PROPN iajs-1880 114 5 al al PROPN iajs-1880 114 6 . . PUNCT iajs-1880 115 1 [ [ X iajs-1880 115 2 17 17 NUM iajs-1880 115 3 ] ] PUNCT iajs-1880 115 4 referred refer VERB iajs-1880 115 5 to to ADP iajs-1880 115 6 the the DET iajs-1880 115 7 well well ADV iajs-1880 115 8 - - PUNCT iajs-1880 115 9 known know VERB iajs-1880 115 10 metabolic metabolic NOUN iajs-1880 115 11 variations variation NOUN iajs-1880 115 12 that that PRON iajs-1880 115 13 happen happen VERB iajs-1880 115 14 in in ADP iajs-1880 115 15 diabetic diabetic ADJ iajs-1880 115 16 and and CCONJ iajs-1880 115 17 normal normal ADJ iajs-1880 115 18 subjects subject NOUN iajs-1880 115 19 . . PUNCT iajs-1880 116 1 healthy healthy ADJ iajs-1880 116 2 individuals individual NOUN iajs-1880 116 3 produce produce VERB iajs-1880 116 4 an an DET iajs-1880 116 5 " " PUNCT iajs-1880 116 6 accelerated accelerate VERB iajs-1880 116 7 starvation starvation NOUN iajs-1880 116 8 " " PUNCT iajs-1880 116 9 in in ADP iajs-1880 116 10 the the DET iajs-1880 116 11 fasting fast VERB iajs-1880 116 12 situation situation NOUN iajs-1880 116 13 , , PUNCT iajs-1880 116 14 with with ADP iajs-1880 116 15 a a DET iajs-1880 116 16 prior prior ADJ iajs-1880 116 17 and and CCONJ iajs-1880 116 18 more more ADV iajs-1880 116 19 profound profound ADJ iajs-1880 116 20 hypoglycemia hypoglycemia NOUN iajs-1880 116 21 and and CCONJ iajs-1880 116 22 an an DET iajs-1880 116 23 increased increase VERB iajs-1880 116 24 level level NOUN iajs-1880 116 25 of of ADP iajs-1880 116 26 fasting fast VERB iajs-1880 116 27 insulin insulin NOUN iajs-1880 116 28 ; ; PUNCT iajs-1880 116 29 however however SCONJ iajs-1880 116 30 diabetic diabetic ADJ iajs-1880 116 31 patients patient NOUN iajs-1880 116 32 elucidate elucidate VERB iajs-1880 116 33 elevated elevated ADJ iajs-1880 116 34 concentrations concentration NOUN iajs-1880 116 35 of of ADP iajs-1880 116 36 fasting fast VERB iajs-1880 116 37 insulin insulin NOUN iajs-1880 116 38 [ [ X iajs-1880 116 39 22 22 NUM iajs-1880 116 40 ] ] PUNCT iajs-1880 116 41 . . PUNCT iajs-1880 117 1 furthermore furthermore ADV iajs-1880 117 2 , , PUNCT iajs-1880 117 3 mcp-1 mcp-1 ADV iajs-1880 117 4 has have VERB iajs-1880 117 5 angiogenic angiogenic ADJ iajs-1880 117 6 effect effect NOUN iajs-1880 117 7 on on ADP iajs-1880 117 8 endothelial endothelial ADJ iajs-1880 117 9 cells cell NOUN iajs-1880 117 10 , , PUNCT iajs-1880 117 11 thus thus ADV iajs-1880 117 12 it it PRON iajs-1880 117 13 can can AUX iajs-1880 117 14 participate participate VERB iajs-1880 117 15 to to ADP iajs-1880 117 16 the the DET iajs-1880 117 17 development development NOUN iajs-1880 117 18 and and CCONJ iajs-1880 117 19 remodeling remodeling NOUN iajs-1880 117 20 of of ADP iajs-1880 117 21 adipose adipose ADJ iajs-1880 117 22 tissues tissue NOUN iajs-1880 117 23 [ [ X iajs-1880 117 24 23 23 NUM iajs-1880 117 25 ] ] PUNCT iajs-1880 117 26 . . PUNCT iajs-1880 118 1 high high ADJ iajs-1880 118 2 glucose glucose NOUN iajs-1880 118 3 processing processing NOUN iajs-1880 118 4 on on ADP iajs-1880 118 5 endothelial endothelial ADJ iajs-1880 118 6 cells cell NOUN iajs-1880 118 7 isolated isolate VERB iajs-1880 118 8 from from ADP iajs-1880 118 9 diabetic diabetic ADJ iajs-1880 118 10 subjects subject NOUN iajs-1880 118 11 produced produce VERB iajs-1880 118 12 in in ADP iajs-1880 118 13 about about ADV iajs-1880 118 14 40 40 NUM iajs-1880 118 15 - - SYM iajs-1880 118 16 70 70 NUM iajs-1880 118 17 % % NOUN iajs-1880 118 18 increase increase NOUN iajs-1880 118 19 releasing release VERB iajs-1880 118 20 of of ADP iajs-1880 118 21 mcp-1 mcp-1 NOUN iajs-1880 118 22 [ [ X iajs-1880 118 23 24 24 NUM iajs-1880 118 24 ] ] PUNCT iajs-1880 118 25 . . PUNCT iajs-1880 119 1 elevated elevated ADJ iajs-1880 119 2 serum serum PROPN iajs-1880 119 3 mcp-1 mcp-1 NOUN iajs-1880 119 4 levels level NOUN iajs-1880 119 5 could could AUX iajs-1880 119 6 contribute contribute VERB iajs-1880 119 7 to to ADP iajs-1880 119 8 the the DET iajs-1880 119 9 onset onset NOUN iajs-1880 119 10 and and CCONJ iajs-1880 119 11 progression progression NOUN iajs-1880 119 12 of of ADP iajs-1880 119 13 several several ADJ iajs-1880 119 14 complications complication NOUN iajs-1880 119 15 in in ADP iajs-1880 119 16 diabetes diabetes NOUN iajs-1880 119 17 . . PUNCT iajs-1880 120 1 thus thus ADV iajs-1880 120 2 , , PUNCT iajs-1880 120 3 serum serum PROPN iajs-1880 120 4 mcp-1 mcp-1 PART iajs-1880 120 5 may may AUX iajs-1880 120 6 serve serve VERB iajs-1880 120 7 as as ADP iajs-1880 120 8 a a DET iajs-1880 120 9 biomarker biomarker NOUN iajs-1880 120 10 of of ADP iajs-1880 120 11 inflammatory inflammatory ADJ iajs-1880 120 12 activity activity NOUN iajs-1880 120 13 and and CCONJ iajs-1880 120 14 helps help VERB iajs-1880 120 15 in in ADP iajs-1880 120 16 early early ADJ iajs-1880 120 17 detection detection NOUN iajs-1880 120 18 and and CCONJ iajs-1880 120 19 intervention intervention NOUN iajs-1880 120 20 of of ADP iajs-1880 120 21 diabetic diabetic ADJ iajs-1880 120 22 complications complication NOUN iajs-1880 120 23 [ [ X iajs-1880 120 24 25 25 NUM iajs-1880 120 25 ] ] PUNCT iajs-1880 120 26 . . PUNCT iajs-1880 121 1 results result NOUN iajs-1880 121 2 of of ADP iajs-1880 121 3 mcp-1 mcp-1 NOUN iajs-1880 121 4 levels level NOUN iajs-1880 121 5 weree weree VERB iajs-1880 121 6 similar similar ADJ iajs-1880 121 7 to to ADP iajs-1880 121 8 results result NOUN iajs-1880 121 9 of of ADP iajs-1880 121 10 waheed waheed PROPN iajs-1880 121 11 et et PROPN iajs-1880 121 12 al al PROPN iajs-1880 121 13 . . PUNCT iajs-1880 122 1 [ [ X iajs-1880 122 2 25 25 NUM iajs-1880 122 3 ] ] PUNCT iajs-1880 122 4 that that PRON iajs-1880 122 5 studied study VERB iajs-1880 122 6 mcp-1 mcp-1 PRON iajs-1880 122 7 level level NOUN iajs-1880 122 8 in in ADP iajs-1880 122 9 30 30 NUM iajs-1880 122 10 type type NOUN iajs-1880 122 11 2 2 NUM iajs-1880 122 12 diabetic diabetic ADJ iajs-1880 122 13 patints patint NOUN iajs-1880 122 14 and and CCONJ iajs-1880 122 15 20 20 NUM iajs-1880 122 16 healthy healthy ADJ iajs-1880 122 17 control control NOUN iajs-1880 122 18 which which PRON iajs-1880 122 19 found find VERB iajs-1880 122 20 mean mean NOUN iajs-1880 122 21 ± ± NUM iajs-1880 122 22 sd sd NOUN iajs-1880 122 23 of of ADP iajs-1880 122 24 patients patient NOUN iajs-1880 122 25 48.87 48.87 NUM iajs-1880 122 26 ± ± NUM iajs-1880 122 27 12.345 12.345 NUM iajs-1880 122 28 pg pg NOUN iajs-1880 122 29 / / SYM iajs-1880 122 30 ml ml NOUN iajs-1880 122 31 higher high ADJ iajs-1880 122 32 than than ADP iajs-1880 122 33 in in ADP iajs-1880 122 34 healthy healthy ADJ iajs-1880 122 35 control control NOUN iajs-1880 122 36 38.8 38.8 NUM iajs-1880 122 37 ± ± NUM iajs-1880 122 38 8.994 8.994 NUM iajs-1880 122 39 pg pg NOUN iajs-1880 122 40 / / SYM iajs-1880 122 41 ml ml NOUN iajs-1880 122 42 with with ADP iajs-1880 122 43 significant significant ADJ iajs-1880 122 44 differences difference NOUN iajs-1880 122 45 , , PUNCT iajs-1880 122 46 while while SCONJ iajs-1880 122 47 dissimilar dissimilar ADJ iajs-1880 122 48 with with ADP iajs-1880 122 49 results result NOUN iajs-1880 122 50 of of ADP iajs-1880 122 51 ali ali PROPN iajs-1880 122 52 [ [ X iajs-1880 122 53 20 20 NUM iajs-1880 122 54 ] ] PUNCT iajs-1880 122 55 that that PRON iajs-1880 122 56 studied study VERB iajs-1880 122 57 some some DET iajs-1880 122 58 cytokines cytokine NOUN iajs-1880 122 59 in in ADP iajs-1880 122 60 65 65 NUM iajs-1880 122 61 pregnant pregnant ADJ iajs-1880 122 62 women woman NOUN iajs-1880 122 63 infected infect VERB iajs-1880 122 64 with with ADP iajs-1880 122 65 acute acute ADJ iajs-1880 122 66 toxoplasmosis toxoplasmosis NOUN iajs-1880 122 67 and and CCONJ iajs-1880 122 68 50 50 NUM iajs-1880 122 69 healthy healthy ADJ iajs-1880 122 70 married married ADJ iajs-1880 122 71 women woman NOUN iajs-1880 122 72 ( ( PUNCT iajs-1880 122 73 nonpregnant nonpregnant NOUN iajs-1880 122 74 ) ) PUNCT iajs-1880 122 75 which which PRON iajs-1880 122 76 found find VERB iajs-1880 122 77 that that SCONJ iajs-1880 122 78 mean mean VERB iajs-1880 122 79 ± ± NUM iajs-1880 122 80 se se X iajs-1880 122 81 of of ADP iajs-1880 122 82 pregnant pregnant ADJ iajs-1880 122 83 women woman NOUN iajs-1880 122 84 14.46 14.46 NUM iajs-1880 122 85 ± ± NUM iajs-1880 122 86 1.38 1.38 NUM iajs-1880 122 87 pg pg NOUN iajs-1880 122 88 / / SYM iajs-1880 122 89 ml ml ADV iajs-1880 122 90 higher high ADJ iajs-1880 122 91 than than ADP iajs-1880 122 92 healthy healthy ADJ iajs-1880 122 93 non non ADJ iajs-1880 122 94 pregnant pregnant ADJ iajs-1880 122 95 women woman NOUN iajs-1880 122 96 11.25 11.25 NUM iajs-1880 122 97 ± ± NUM iajs-1880 122 98 0.24 0.24 NUM iajs-1880 122 99 pg pg NOUN iajs-1880 122 100 / / SYM iajs-1880 122 101 ml ml NOUN iajs-1880 122 102 without without ADP iajs-1880 122 103 any any DET iajs-1880 122 104 significant significant ADJ iajs-1880 122 105 differences difference NOUN iajs-1880 122 106 . . PUNCT iajs-1880 123 1 the the DET iajs-1880 123 2 results result NOUN iajs-1880 123 3 of of ADP iajs-1880 123 4 this this DET iajs-1880 123 5 study study NOUN iajs-1880 123 6 showed show VERB iajs-1880 123 7 that that SCONJ iajs-1880 123 8 tgf tgf PROPN iajs-1880 123 9 - - PUNCT iajs-1880 123 10 β β PROPN iajs-1880 123 11 levels level NOUN iajs-1880 123 12 rise rise VERB iajs-1880 123 13 in in ADP iajs-1880 123 14 diabetic diabetic ADJ iajs-1880 123 15 patients patient NOUN iajs-1880 123 16 with with ADP iajs-1880 123 17 toxoplasmosis toxoplasmosis NOUN iajs-1880 123 18 more more ADJ iajs-1880 123 19 than than ADP iajs-1880 123 20 in in ADP iajs-1880 123 21 other other ADJ iajs-1880 123 22 groups group NOUN iajs-1880 123 23 that that PRON iajs-1880 123 24 ’s ’s AUX iajs-1880 123 25 resemble resemble VERB iajs-1880 123 26 to to ADP iajs-1880 123 27 the the DET iajs-1880 123 28 results result NOUN iajs-1880 123 29 of of ADP iajs-1880 123 30 waheed waheed PROPN iajs-1880 123 31 et et PROPN iajs-1880 123 32 al al PROPN iajs-1880 123 33 . . PUNCT iajs-1880 124 1 [ [ X iajs-1880 124 2 25 25 NUM iajs-1880 124 3 ] ] PUNCT iajs-1880 124 4 that that PRON iajs-1880 124 5 studied study VERB iajs-1880 124 6 tgf tgf PROPN iajs-1880 124 7 - - PUNCT iajs-1880 124 8 β β PROPN iajs-1880 124 9 in in ADP iajs-1880 124 10 30 30 NUM iajs-1880 124 11 type type NOUN iajs-1880 124 12 2 2 NUM iajs-1880 124 13 diabetic diabetic ADJ iajs-1880 124 14 patients patient NOUN iajs-1880 124 15 and and CCONJ iajs-1880 124 16 20 20 NUM iajs-1880 124 17 healthy healthy ADJ iajs-1880 124 18 control control NOUN iajs-1880 124 19 which which PRON iajs-1880 124 20 found find VERB iajs-1880 124 21 mean mean NOUN iajs-1880 124 22 ± ± NUM iajs-1880 124 23 sd sd NOUN iajs-1880 124 24 of of ADP iajs-1880 124 25 patients patient NOUN iajs-1880 124 26 19.67 19.67 NUM iajs-1880 124 27 ± ± NUM iajs-1880 124 28 6.586 6.586 NUM iajs-1880 124 29 pg pg NOUN iajs-1880 124 30 / / SYM iajs-1880 124 31 ml ml NOUN iajs-1880 124 32 higher high ADJ iajs-1880 124 33 than than ADP iajs-1880 124 34 in in ADP iajs-1880 124 35 healthy healthy ADJ iajs-1880 124 36 control control NOUN iajs-1880 124 37 13.6 13.6 NUM iajs-1880 124 38 ± ± NUM iajs-1880 124 39 4.641 4.641 NUM iajs-1880 124 40 pg pg NOUN iajs-1880 124 41 / / SYM iajs-1880 124 42 ml ml NOUN iajs-1880 124 43 without without ADP iajs-1880 124 44 significant significant ADJ iajs-1880 124 45 difference difference NOUN iajs-1880 124 46 , , PUNCT iajs-1880 124 47 as as ADV iajs-1880 124 48 well well ADV iajs-1880 124 49 as as ADP iajs-1880 124 50 resemble resemble VERB iajs-1880 124 51 to to ADP iajs-1880 124 52 the the DET iajs-1880 124 53 results result NOUN iajs-1880 124 54 of of ADP iajs-1880 124 55 ali ali PROPN iajs-1880 124 56 [ [ X iajs-1880 124 57 20 20 NUM iajs-1880 124 58 ] ] PUNCT iajs-1880 124 59 that that PRON iajs-1880 124 60 studied study VERB iajs-1880 124 61 some some DET iajs-1880 124 62 cytokines cytokine NOUN iajs-1880 124 63 in in ADP iajs-1880 124 64 65 65 NUM iajs-1880 124 65 pregnant pregnant ADJ iajs-1880 124 66 women woman NOUN iajs-1880 124 67 infected infect VERB iajs-1880 124 68 with with ADP iajs-1880 124 69 acute acute ADJ iajs-1880 124 70 toxoplasmosis toxoplasmosis NOUN iajs-1880 124 71 and and CCONJ iajs-1880 124 72 50 50 NUM iajs-1880 124 73 healthy healthy ADJ iajs-1880 124 74 married married ADJ iajs-1880 124 75 women woman NOUN iajs-1880 124 76 ( ( PUNCT iajs-1880 124 77 non non ADJ iajs-1880 124 78 - - ADJ iajs-1880 124 79 pregnant pregnant ADJ iajs-1880 124 80 ) ) PUNCT iajs-1880 124 81 which which PRON iajs-1880 124 82 found find VERB iajs-1880 124 83 the the DET iajs-1880 124 84 level level NOUN iajs-1880 124 85 in in ADP iajs-1880 124 86 pregnant pregnant ADJ iajs-1880 124 87 women woman NOUN iajs-1880 124 88 was be AUX iajs-1880 124 89 20.99 20.99 NUM iajs-1880 124 90 ± ± NUM iajs-1880 124 91 4.13 4.13 NUM iajs-1880 124 92 pg pg NOUN iajs-1880 124 93 / / SYM iajs-1880 124 94 ml ml ADP iajs-1880 124 95 while while SCONJ iajs-1880 124 96 in in ADP iajs-1880 124 97 healthy healthy ADJ iajs-1880 124 98 control control NOUN iajs-1880 124 99 1.52 1.52 NUM iajs-1880 124 100 ± ± NUM iajs-1880 124 101 0.05 0.05 NUM iajs-1880 124 102 with with ADP iajs-1880 124 103 significant significant ADJ iajs-1880 124 104 differences difference NOUN iajs-1880 124 105 . . PUNCT iajs-1880 125 1 tgf tgf PROPN iajs-1880 125 2 - - PUNCT iajs-1880 125 3 β β PROPN iajs-1880 125 4 is be AUX iajs-1880 125 5 a a DET iajs-1880 125 6 cytokine cytokine NOUN iajs-1880 125 7 which which PRON iajs-1880 125 8 plays play VERB iajs-1880 125 9 key key ADJ iajs-1880 125 10 roles role NOUN iajs-1880 125 11 in in ADP iajs-1880 125 12 the the DET iajs-1880 125 13 regulation regulation NOUN iajs-1880 125 14 of of ADP iajs-1880 125 15 immune immune ADJ iajs-1880 125 16 cell cell NOUN iajs-1880 125 17 functions function NOUN iajs-1880 125 18 [ [ X iajs-1880 125 19 20 20 NUM iajs-1880 125 20 ] ] PUNCT iajs-1880 125 21 . . PUNCT iajs-1880 126 1 this this DET iajs-1880 126 2 cytokine cytokine NOUN iajs-1880 126 3 leads lead VERB iajs-1880 126 4 to to ADP iajs-1880 126 5 inhibition inhibition NOUN iajs-1880 126 6 of of ADP iajs-1880 126 7 b b NOUN iajs-1880 126 8 and and CCONJ iajs-1880 126 9 t t PROPN iajs-1880 126 10 lymphocytes lymphocyte VERB iajs-1880 126 11 proliferation proliferation NOUN iajs-1880 126 12 and and CCONJ iajs-1880 126 13 induces induce VERB iajs-1880 126 14 homeostasis homeostasis NOUN iajs-1880 126 15 [ [ X iajs-1880 126 16 26 26 NUM iajs-1880 126 17 ] ] PUNCT iajs-1880 126 18 . . PUNCT iajs-1880 127 1 tgf tgf PROPN iajs-1880 127 2 - - PUNCT iajs-1880 127 3 β β PROPN iajs-1880 127 4 also also ADV iajs-1880 127 5 contributes contribute VERB iajs-1880 127 6 to to ADP iajs-1880 127 7 tissue tissue NOUN iajs-1880 127 8 remodeling remodeling NOUN iajs-1880 127 9 which which PRON iajs-1880 127 10 occurs occur VERB iajs-1880 127 11 after after ADP iajs-1880 127 12 infections infection NOUN iajs-1880 127 13 and and CCONJ iajs-1880 127 14 injuries injury NOUN iajs-1880 127 15 , , PUNCT iajs-1880 127 16 this this DET iajs-1880 127 17 cytokine cytokine NOUN iajs-1880 127 18 contributes contribute VERB iajs-1880 127 19 to to ADP iajs-1880 127 20 development development NOUN iajs-1880 127 21 of of ADP iajs-1880 127 22 th17 th17 PROPN iajs-1880 127 23 and and CCONJ iajs-1880 127 24 t t PROPN iajs-1880 127 25 - - PUNCT iajs-1880 127 26 regulatory regulatory ADJ iajs-1880 127 27 lymphocytes lymphocyte NOUN iajs-1880 127 28 , , PUNCT iajs-1880 127 29 activation activation NOUN iajs-1880 127 30 and and CCONJ iajs-1880 127 31 [ [ X iajs-1880 127 32 27 27 NUM iajs-1880 127 33 ] ] PUNCT iajs-1880 127 34 . . PUNCT iajs-1880 128 1 tgf tgf PROPN iajs-1880 128 2 - - PUNCT iajs-1880 128 3 β β PROPN iajs-1880 128 4 secreted secrete VERB iajs-1880 128 5 from from ADP iajs-1880 128 6 monocytes monocyte NOUN iajs-1880 128 7 in in ADP iajs-1880 128 8 t2 t2 NOUN iajs-1880 128 9 dm dm PROPN iajs-1880 128 10 patients patient NOUN iajs-1880 128 11 have have AUX iajs-1880 128 12 been be AUX iajs-1880 128 13 reported report VERB iajs-1880 128 14 [ [ X iajs-1880 128 15 28 28 NUM iajs-1880 128 16 ] ] PUNCT iajs-1880 128 17 . . PUNCT iajs-1880 129 1 also also ADV iajs-1880 129 2 telejko telejko PROPN iajs-1880 129 3 assumed assume VERB iajs-1880 129 4 that that SCONJ iajs-1880 129 5 tgf tgf PROPN iajs-1880 129 6 - - PUNCT iajs-1880 129 7 β β PROPN iajs-1880 129 8 can can AUX iajs-1880 129 9 be be AUX iajs-1880 129 10 a a DET iajs-1880 129 11 key key ADJ iajs-1880 129 12 agent agent NOUN iajs-1880 129 13 accountable accountable ADJ iajs-1880 129 14 for for ADP iajs-1880 129 15 the the DET iajs-1880 129 16 modifications modification NOUN iajs-1880 129 17 in in ADP iajs-1880 129 18 circulating circulate VERB iajs-1880 129 19 mcp-1 mcp-1 DET iajs-1880 129 20 levels level NOUN iajs-1880 129 21 , , PUNCT iajs-1880 129 22 but but CCONJ iajs-1880 129 23 the the DET iajs-1880 129 24 action action NOUN iajs-1880 129 25 and and CCONJ iajs-1880 129 26 secretion secretion NOUN iajs-1880 129 27 of of ADP iajs-1880 129 28 this this DET iajs-1880 129 29 chemokine chemokine NOUN iajs-1880 129 30 in in ADP iajs-1880 129 31 diabetes diabetes NOUN iajs-1880 129 32 mellitus mellitus NOUN iajs-1880 129 33 require require VERB iajs-1880 129 34 more more ADJ iajs-1880 129 35 researches research NOUN iajs-1880 129 36 [ [ X iajs-1880 129 37 22 22 NUM iajs-1880 129 38 ] ] PUNCT iajs-1880 129 39 . . PUNCT iajs-1880 130 1 tgf tgf PROPN iajs-1880 130 2 - - PUNCT iajs-1880 130 3 β β PROPN iajs-1880 130 4 stimulates stimulate VERB iajs-1880 130 5 the the DET iajs-1880 130 6 synthesis synthesis NOUN iajs-1880 130 7 of of ADP iajs-1880 130 8 acute acute ADJ iajs-1880 130 9 phase phase NOUN iajs-1880 130 10 proteins protein NOUN iajs-1880 130 11 and and CCONJ iajs-1880 130 12 has have AUX iajs-1880 130 13 been be AUX iajs-1880 130 14 found find VERB iajs-1880 130 15 to to PART iajs-1880 130 16 be be AUX iajs-1880 130 17 over over ADV iajs-1880 130 18 expressed express VERB iajs-1880 130 19 in in ADP iajs-1880 130 20 the the DET iajs-1880 130 21 glomeruli glomeruli NOUN iajs-1880 130 22 of of ADP iajs-1880 130 23 patients patient NOUN iajs-1880 130 24 with with ADP iajs-1880 130 25 diabetes diabetes NOUN iajs-1880 130 26 nephropathy nephropathy NOUN iajs-1880 130 27 , , PUNCT iajs-1880 130 28 also also ADV iajs-1880 130 29 involved involve VERB iajs-1880 130 30 in in ADP iajs-1880 130 31 the the DET iajs-1880 130 32 induction induction NOUN iajs-1880 130 33 of of ADP iajs-1880 130 34 extracellular extracellular ADJ iajs-1880 130 35 matrix matrix NOUN iajs-1880 130 36 production production NOUN iajs-1880 130 37 [ [ X iajs-1880 130 38 29 29 NUM iajs-1880 130 39 ] ] PUNCT iajs-1880 130 40 . . PUNCT iajs-1880 131 1 lyons lyons PROPN iajs-1880 131 2 et et PROPN iajs-1880 131 3 al al PROPN iajs-1880 131 4 . . PUNCT iajs-1880 132 1 [ [ X iajs-1880 132 2 30 30 NUM iajs-1880 132 3 ] ] PUNCT iajs-1880 132 4 found find VERB iajs-1880 132 5 constituent constituent NOUN iajs-1880 132 6 expression expression NOUN iajs-1880 132 7 of of ADP iajs-1880 132 8 tgf tgf PROPN iajs-1880 132 9 - - PUNCT iajs-1880 132 10 β β PROPN iajs-1880 132 11 in in ADP iajs-1880 132 12 the the DET iajs-1880 132 13 eye eye NOUN iajs-1880 132 14 , , PUNCT iajs-1880 132 15 but but CCONJ iajs-1880 132 16 furthermore furthermore ADV iajs-1880 132 17 they they PRON iajs-1880 132 18 discovered discover VERB iajs-1880 132 19 that that SCONJ iajs-1880 132 20 ocular ocular ADJ iajs-1880 132 21 toxoplasmosis toxoplasmosis NOUN iajs-1880 132 22 considerably considerably ADV iajs-1880 132 23 increases increase VERB iajs-1880 132 24 transcripts transcript NOUN iajs-1880 132 25 tgf tgf PROPN iajs-1880 132 26 - - PUNCT iajs-1880 132 27 β β NOUN iajs-1880 132 28 levels level NOUN iajs-1880 132 29 , , PUNCT iajs-1880 132 30 whereas whereas SCONJ iajs-1880 132 31 this this DET iajs-1880 132 32 increase increase NOUN iajs-1880 132 33 in in ADP iajs-1880 132 34 tgf tgf PROPN iajs-1880 132 35 - - PUNCT iajs-1880 132 36 β β PROPN iajs-1880 132 37 levels level NOUN iajs-1880 132 38 can can AUX iajs-1880 132 39 help help VERB iajs-1880 132 40 to to PART iajs-1880 132 41 preserve preserve VERB iajs-1880 132 42 immune immune ADJ iajs-1880 132 43 privilege privilege NOUN iajs-1880 132 44 and and CCONJ iajs-1880 132 45 to to PART iajs-1880 132 46 decrease decrease VERB iajs-1880 132 47 damage damage NOUN iajs-1880 132 48 caused cause VERB iajs-1880 132 49 from from ADP iajs-1880 132 50 inflammation inflammation NOUN iajs-1880 132 51 , , PUNCT iajs-1880 132 52 also also ADV iajs-1880 132 53 it it PRON iajs-1880 132 54 can can AUX iajs-1880 132 55 have have VERB iajs-1880 132 56 useful useful ADJ iajs-1880 132 57 effects effect NOUN iajs-1880 132 58 on on ADP iajs-1880 132 59 the the DET iajs-1880 132 60 survival survival NOUN iajs-1880 132 61 of of ADP iajs-1880 132 62 t. t. PROPN iajs-1880 132 63 gondii gondii NOUN iajs-1880 132 64 and and CCONJ iajs-1880 132 65 its its PRON iajs-1880 132 66 proliferation proliferation NOUN iajs-1880 132 67 . . PUNCT iajs-1880 133 1 for for ADP iajs-1880 133 2 instance instance NOUN iajs-1880 133 3 , , PUNCT iajs-1880 133 4 tgf tgf PROPN iajs-1880 133 5 - - PUNCT iajs-1880 133 6 β β PROPN iajs-1880 133 7 has have AUX iajs-1880 133 8 been be AUX iajs-1880 133 9 revealed reveal VERB iajs-1880 133 10 not not PART iajs-1880 133 11 only only ADV iajs-1880 133 12 to to PART iajs-1880 133 13 decrease decrease VERB iajs-1880 133 14 the the DET iajs-1880 133 15 capability capability NOUN iajs-1880 133 16 of of ADP iajs-1880 133 17 nk nk PROPN iajs-1880 133 18 cells cell NOUN iajs-1880 133 19 , , PUNCT iajs-1880 133 20 a a DET iajs-1880 133 21 main main ADJ iajs-1880 133 22 source source NOUN iajs-1880 133 23 of of ADP iajs-1880 133 24 ifn ifn PROPN iajs-1880 133 25 - - PUNCT iajs-1880 133 26 γ γ NOUN iajs-1880 133 27 , , PUNCT iajs-1880 133 28 to to PART iajs-1880 133 29 react react VERB iajs-1880 133 30 to to ADP iajs-1880 133 31 t. t. NOUN iajs-1880 133 32 gondii gondii NOUN iajs-1880 133 33 but but CCONJ iajs-1880 133 34 also also ADV iajs-1880 133 35 to to ADP iajs-1880 133 36 markedly markedly ADV iajs-1880 133 37 downregulate downregulate VERB iajs-1880 133 38 ihsciconf ihsciconf PROPN iajs-1880 133 39 2017 2017 NUM iajs-1880 133 40 special special ADJ iajs-1880 133 41 issue issue NOUN iajs-1880 133 42 ibn ibn PROPN iajs-1880 133 43 al al PROPN iajs-1880 133 44 - - PUNCT iajs-1880 133 45 haitham haitham PROPN iajs-1880 133 46 journal journal PROPN iajs-1880 133 47 for for ADP iajs-1880 133 48 pure pure ADJ iajs-1880 133 49 and and CCONJ iajs-1880 133 50 applied apply VERB iajs-1880 133 51 science science NOUN iajs-1880 133 52 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 133 53 for for ADP iajs-1880 133 54 more more ADJ iajs-1880 133 55 information information NOUN iajs-1880 133 56 about about ADP iajs-1880 133 57 the the DET iajs-1880 133 58 conference conference NOUN iajs-1880 133 59 please please INTJ iajs-1880 133 60 visit visit VERB iajs-1880 133 61 the the DET iajs-1880 133 62 websites website NOUN iajs-1880 133 63 : : PUNCT iajs-1880 133 64 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 133 65           SPACE iajs-1880 133 66 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 133 67     SPACE iajs-1880 133 68 biology|549 biology|549 NOUN iajs-1880 133 69         SPACE iajs-1880 133 70 functions function NOUN iajs-1880 133 71 of of ADP iajs-1880 133 72 macrophage macrophage NOUN iajs-1880 133 73 , , PUNCT iajs-1880 133 74 including include VERB iajs-1880 133 75 their their PRON iajs-1880 133 76 capability capability NOUN iajs-1880 133 77 to to PART iajs-1880 133 78 create create VERB iajs-1880 133 79 nitric nitric ADJ iajs-1880 133 80 oxide oxide NOUN iajs-1880 133 81 and and CCONJ iajs-1880 133 82 indolamine indolamine NOUN iajs-1880 133 83 [ [ X iajs-1880 133 84 31 31 NUM iajs-1880 133 85 ] ] PUNCT iajs-1880 133 86 . . PUNCT iajs-1880 134 1 the the DET iajs-1880 134 2 production production NOUN iajs-1880 134 3 of of ADP iajs-1880 134 4 tgf tgf PROPN iajs-1880 134 5 - - PUNCT iajs-1880 134 6 β β PROPN iajs-1880 134 7 is be AUX iajs-1880 134 8 stimulated stimulate VERB iajs-1880 134 9 after after ADP iajs-1880 134 10 infection infection NOUN iajs-1880 134 11 with with ADP iajs-1880 134 12 t. t. NOUN iajs-1880 134 13 gondii gondii NOUN iajs-1880 134 14 [ [ X iajs-1880 134 15 32 32 NUM iajs-1880 134 16 ] ] PUNCT iajs-1880 134 17 . . PUNCT iajs-1880 135 1 tgf tgf PROPN iajs-1880 135 2 - - PUNCT iajs-1880 135 3 β β PROPN iajs-1880 135 4 raises raise VERB iajs-1880 135 5 toxoplasma toxoplasma NOUN iajs-1880 135 6 replication replication NOUN iajs-1880 135 7 on on ADP iajs-1880 135 8 cultured cultured ADJ iajs-1880 135 9 retinal retinal ADJ iajs-1880 135 10 cells cell NOUN iajs-1880 135 11 , , PUNCT iajs-1880 135 12 proposing propose VERB iajs-1880 135 13 that that SCONJ iajs-1880 135 14 cytokine cytokine NOUN iajs-1880 135 15 might might AUX iajs-1880 135 16 be be AUX iajs-1880 135 17 implicated implicate VERB iajs-1880 135 18 in in ADP iajs-1880 135 19 immunopathological immunopathological ADJ iajs-1880 135 20 phenomena phenomenon NOUN iajs-1880 135 21 [ [ X iajs-1880 135 22 33 33 NUM iajs-1880 135 23 ] ] PUNCT iajs-1880 135 24 . . PUNCT iajs-1880 136 1 reference reference NOUN iajs-1880 137 1 [ [ X iajs-1880 137 2 1 1 NUM iajs-1880 137 3 ] ] PUNCT iajs-1880 137 4 . . PUNCT iajs-1880 138 1 r.lynfield r.lynfield VERB iajs-1880 138 2 , , PUNCT iajs-1880 138 3 and and CCONJ iajs-1880 138 4 n.g n.g PROPN iajs-1880 138 5 . . PROPN iajs-1880 138 6 guerina guerina PROPN iajs-1880 138 7 , , PUNCT iajs-1880 138 8 toxoplasmosis toxoplasmosis PROPN iajs-1880 138 9 . . PUNCT iajs-1880 139 1 pedia pedia PROPN iajs-1880 139 2 . . PUNCT iajs-1880 140 1 rev rev PROPN iajs-1880 140 2 . . PROPN iajs-1880 140 3 , , PUNCT iajs-1880 140 4 18 18 NUM iajs-1880 140 5 ( ( PUNCT iajs-1880 140 6 13 13 NUM iajs-1880 140 7 ): ): PUNCT iajs-1880 140 8 75 75 NUM iajs-1880 140 9 - - SYM iajs-1880 140 10 83 83 NUM iajs-1880 140 11 . . PUNCT iajs-1880 140 12 1997 1997 NUM iajs-1880 140 13 . . PUNCT iajs-1880 141 1 [ [ X iajs-1880 141 2 2 2 NUM iajs-1880 141 3 ] ] PUNCT iajs-1880 141 4 . . PUNCT iajs-1880 142 1 j.dubey j.dubey PROPN iajs-1880 142 2 , , PUNCT iajs-1880 142 3 infectivity infectivity NOUN iajs-1880 142 4 and and CCONJ iajs-1880 142 5 pathogenicity pathogenicity NOUN iajs-1880 142 6 of of ADP iajs-1880 142 7 toxoplasma toxoplasma NOUN iajs-1880 142 8 gondii gondii NOUN iajs-1880 142 9 oocysts oocyst NOUN iajs-1880 142 10 for for ADP iajs-1880 142 11 cats cat NOUN iajs-1880 142 12 . . PUNCT iajs-1880 143 1 j. j. PROPN iajs-1880 143 2 parasitol parasitol PROPN iajs-1880 143 3 . . PUNCT iajs-1880 143 4 , , PUNCT iajs-1880 143 5 82 82 NUM iajs-1880 143 6 ( ( PUNCT iajs-1880 143 7 6 6 NUM iajs-1880 143 8 ): ): SYM iajs-1880 143 9 957 957 NUM iajs-1880 143 10 - - SYM iajs-1880 143 11 960 960 NUM iajs-1880 143 12 . . NUM iajs-1880 143 13 1996 1996 NUM iajs-1880 143 14 . . PUNCT iajs-1880 144 1 [ [ X iajs-1880 144 2 3 3 NUM iajs-1880 144 3 ] ] PUNCT iajs-1880 144 4 . . PUNCT iajs-1880 145 1 s.k s.k PROPN iajs-1880 145 2 . . PROPN iajs-1880 145 3 tawfiq tawfiq PROPN iajs-1880 145 4 , , PUNCT iajs-1880 145 5 some some DET iajs-1880 145 6 immunological immunological ADJ iajs-1880 145 7 aspects aspect NOUN iajs-1880 145 8 of of ADP iajs-1880 145 9 toxoplasmosis toxoplasmosis NOUN iajs-1880 145 10 in in ADP iajs-1880 145 11 pregnant pregnant ADJ iajs-1880 145 12 and and CCONJ iajs-1880 145 13 repeated repeat VERB iajs-1880 145 14 aborted aborted ADJ iajs-1880 145 15 women woman NOUN iajs-1880 145 16 . . PUNCT iajs-1880 146 1 m.sc m.sc PROPN iajs-1880 146 2 . . PUNCT iajs-1880 147 1 thesis thesis PROPN iajs-1880 147 2 , , PUNCT iajs-1880 147 3 coll coll PROPN iajs-1880 147 4 . . PROPN iajs-1880 147 5 of of ADP iajs-1880 147 6 med med PROPN iajs-1880 147 7 . . PUNCT iajs-1880 148 1 tikrit tikrit PROPN iajs-1880 148 2 univ:124 univ:124 PROPN iajs-1880 148 3 . . PROPN iajs-1880 148 4 2013 2013 NUM iajs-1880 148 5 . . PUNCT iajs-1880 149 1 [ [ X iajs-1880 149 2 4 4 NUM iajs-1880 149 3 ] ] PUNCT iajs-1880 149 4 . . PUNCT iajs-1880 150 1 kijlstra kijlstra PROPN iajs-1880 150 2 , , PUNCT iajs-1880 150 3 a. a. NOUN iajs-1880 150 4 and and CCONJ iajs-1880 150 5 jongert jongert PROPN iajs-1880 150 6 , , PUNCT iajs-1880 150 7 e. e. PROPN iajs-1880 150 8 ( ( PUNCT iajs-1880 150 9 2008 2008 NUM iajs-1880 150 10 ) ) PUNCT iajs-1880 150 11 . . PUNCT iajs-1880 151 1 control control NOUN iajs-1880 151 2 of of ADP iajs-1880 151 3 the the DET iajs-1880 151 4 risk risk NOUN iajs-1880 151 5 of of ADP iajs-1880 151 6 human human ADJ iajs-1880 151 7 toxoplasmosis toxoplasmosis NOUN iajs-1880 151 8 transmitted transmit VERB iajs-1880 151 9 by by ADP iajs-1880 151 10 meat meat NOUN iajs-1880 151 11 . . PUNCT iajs-1880 152 1 int int NOUN iajs-1880 152 2 . . PUNCT iajs-1880 153 1 j. j. PROPN iajs-1880 153 2 parasitol parasitol PROPN iajs-1880 153 3 . . PUNCT iajs-1880 153 4 , , PUNCT iajs-1880 153 5 38 38 NUM iajs-1880 153 6 ( ( PUNCT iajs-1880 153 7 12 12 NUM iajs-1880 153 8 ): ): PUNCT iajs-1880 153 9 1359 1359 NUM iajs-1880 153 10 - - SYM iajs-1880 153 11 1370 1370 NUM iajs-1880 153 12 . . PUNCT iajs-1880 154 1 [ [ X iajs-1880 154 2 5 5 NUM iajs-1880 154 3 ] ] PUNCT iajs-1880 154 4 . . PUNCT iajs-1880 154 5 sh.shirbazou sh.shirbazou PROPN iajs-1880 154 6 ; ; PUNCT iajs-1880 154 7 a. a. NOUN iajs-1880 154 8 delpisheh delpisheh PROPN iajs-1880 154 9 ; ; PUNCT iajs-1880 154 10 r. r. NOUN iajs-1880 154 11 mokhetari mokhetari NOUN iajs-1880 154 12 , , PUNCT iajs-1880 154 13 and and CCONJ iajs-1880 154 14 gh gh PROPN iajs-1880 154 15 . . PUNCT iajs-1880 154 16 tavakoli tavakoli PROPN iajs-1880 154 17 , , PUNCT iajs-1880 154 18 serologic serologic ADJ iajs-1880 154 19 detection detection NOUN iajs-1880 154 20 of of ADP iajs-1880 154 21 anti anti ADJ iajs-1880 154 22 - - ADJ iajs-1880 154 23 toxoplasma toxoplasma ADJ iajs-1880 154 24 gondii gondii NOUN iajs-1880 154 25 infection infection NOUN iajs-1880 154 26 in in ADP iajs-1880 154 27 diabetic diabetic ADJ iajs-1880 154 28 patients patient NOUN iajs-1880 154 29 . . PUNCT iajs-1880 155 1 iran iran PROPN iajs-1880 155 2 . . PUNCT iajs-1880 156 1 red red PROPN iajs-1880 156 2 crescent crescent PROPN iajs-1880 156 3 med med PROPN iajs-1880 156 4 . . PUNCT iajs-1880 157 1 j. j. PROPN iajs-1880 157 2 , , PUNCT iajs-1880 157 3 15 15 NUM iajs-1880 157 4 ( ( PUNCT iajs-1880 157 5 8) 8) NUM iajs-1880 157 6 : : PUNCT iajs-1880 157 7 701 701 NUM iajs-1880 157 8 - - SYM iajs-1880 157 9 703 703 NUM iajs-1880 157 10 . . PUNCT iajs-1880 157 11 2013 2013 NUM iajs-1880 157 12 . . PUNCT iajs-1880 158 1 [ [ X iajs-1880 158 2 6 6 NUM iajs-1880 158 3 ] ] PUNCT iajs-1880 158 4 . . PUNCT iajs-1880 159 1 s.keel s.keel NOUN iajs-1880 159 2 ; ; PUNCT iajs-1880 159 3 j.foreman j.foreman NOUN iajs-1880 159 4 ; ; PUNCT iajs-1880 159 5 j. j. PROPN iajs-1880 159 6 xie xie PROPN iajs-1880 159 7 ; ; PUNCT iajs-1880 159 8 p.v p.v PROPN iajs-1880 159 9 . . PROPN iajs-1880 159 10 wijngaarden wijngaarden PROPN iajs-1880 159 11 ; ; PUNCT iajs-1880 159 12 h.r h.r PROPN iajs-1880 159 13 . . PROPN iajs-1880 159 14 taylor taylor PROPN iajs-1880 159 15 , , PUNCT iajs-1880 159 16 and and CCONJ iajs-1880 159 17 dirani dirani PROPN iajs-1880 159 18 , , PUNCT iajs-1880 159 19 m. m. NOUN iajs-1880 159 20 the the DET iajs-1880 159 21 prevalence prevalence NOUN iajs-1880 159 22 of of ADP iajs-1880 159 23 self self NOUN iajs-1880 159 24 - - PUNCT iajs-1880 159 25 reported report VERB iajs-1880 159 26 diabetes diabetes NOUN iajs-1880 159 27 in in ADP iajs-1880 159 28 the the DET iajs-1880 159 29 australian australian ADJ iajs-1880 159 30 national national PROPN iajs-1880 159 31 eye eye PROPN iajs-1880 159 32 health health NOUN iajs-1880 159 33 survey survey NOUN iajs-1880 159 34 . . PUNCT iajs-1880 160 1 plos plos PROPN iajs-1880 160 2 one one NUM iajs-1880 160 3 , , PUNCT iajs-1880 160 4 12 12 NUM iajs-1880 160 5 ( ( PUNCT iajs-1880 160 6 1 1 NUM iajs-1880 160 7 ): ): PUNCT iajs-1880 160 8 1 1 NUM iajs-1880 160 9 - - SYM iajs-1880 160 10 10 10 NUM iajs-1880 160 11 . . PUNCT iajs-1880 160 12 2017 2017 NUM iajs-1880 160 13 . . PUNCT iajs-1880 161 1 [ [ X iajs-1880 161 2 7 7 NUM iajs-1880 161 3 ] ] PUNCT iajs-1880 161 4 . . PUNCT iajs-1880 162 1 american american ADJ iajs-1880 162 2 diabetes diabetes PROPN iajs-1880 162 3 association association PROPN iajs-1880 162 4 . . PUNCT iajs-1880 163 1 standards standard NOUN iajs-1880 163 2 of of ADP iajs-1880 163 3 medical medical ADJ iajs-1880 163 4 care care NOUN iajs-1880 163 5 in in ADP iajs-1880 163 6 diabetes diabetes NOUN iajs-1880 163 7 . . PUNCT iajs-1880 164 1 diabet diabet NOUN iajs-1880 164 2 . . PUNCT iajs-1880 165 1 car car NOUN iajs-1880 165 2 . . PUNCT iajs-1880 165 3 , , PUNCT iajs-1880 165 4 35 35 NUM iajs-1880 165 5 ( ( PUNCT iajs-1880 165 6 1 1 NUM iajs-1880 165 7 ): ): PUNCT iajs-1880 165 8 s11 s11 NOUN iajs-1880 165 9 - - PUNCT iajs-1880 165 10 s49 s49 NOUN iajs-1880 165 11 . . PUNCT iajs-1880 166 1 2012 2012 NUM iajs-1880 167 1 [ [ X iajs-1880 167 2 8 8 NUM iajs-1880 167 3 ] ] PUNCT iajs-1880 167 4 . . PUNCT iajs-1880 168 1 k.s k.s PROPN iajs-1880 168 2 . . PROPN iajs-1880 168 3 polonsky polonsky PROPN iajs-1880 168 4 , , PUNCT iajs-1880 168 5 lilly lilly ADJ iajs-1880 168 6 lecture lecture NOUN iajs-1880 168 7 1994 1994 NUM iajs-1880 168 8 . . PUNCT iajs-1880 169 1 the the DET iajs-1880 169 2 beta beta NOUN iajs-1880 169 3 - - PUNCT iajs-1880 169 4 cell cell NOUN iajs-1880 169 5 in in ADP iajs-1880 169 6 diabetes diabetes NOUN iajs-1880 169 7 : : PUNCT iajs-1880 169 8 from from ADP iajs-1880 169 9 molecular molecular ADJ iajs-1880 169 10 genetics genetic NOUN iajs-1880 169 11 to to ADP iajs-1880 169 12 clinical clinical ADJ iajs-1880 169 13 research research NOUN iajs-1880 169 14 . . PUNCT iajs-1880 170 1 diabetes diabetes NOUN iajs-1880 170 2 , , PUNCT iajs-1880 170 3 44 44 NUM iajs-1880 170 4 ( ( PUNCT iajs-1880 170 5 6 6 NUM iajs-1880 170 6 ): ): PUNCT iajs-1880 170 7 705 705 NUM iajs-1880 170 8 - - SYM iajs-1880 170 9 717 717 NUM iajs-1880 170 10 . . PUNCT iajs-1880 170 11 1995 1995 NUM iajs-1880 170 12 . . PUNCT iajs-1880 171 1 [ [ X iajs-1880 171 2 9 9 NUM iajs-1880 171 3 ] ] PUNCT iajs-1880 171 4 . . PUNCT iajs-1880 172 1 m.h m.h PROPN iajs-1880 172 2 . . PROPN iajs-1880 172 3 bessieres bessieres PROPN iajs-1880 172 4 ; ; PUNCT iajs-1880 172 5 a. a. NOUN iajs-1880 172 6 berrebi berrebi PROPN iajs-1880 172 7 ; ; PUNCT iajs-1880 172 8 m. m. PROPN iajs-1880 172 9 rolland rolland PROPN iajs-1880 172 10 ; ; PUNCT iajs-1880 172 11 m.c.bloom m.c.bloom NOUN iajs-1880 172 12 , , PUNCT iajs-1880 172 13 ; ; PUNCT iajs-1880 172 14 c. c. NOUN iajs-1880 172 15 roques roque NOUN iajs-1880 172 16 , , PUNCT iajs-1880 172 17 ; ; PUNCT iajs-1880 172 18 s. s. PROPN iajs-1880 172 19 cassaing cassaing PROPN iajs-1880 172 20 , , PUNCT iajs-1880 172 21 ; ; PUNCT iajs-1880 172 22 c. c. PROPN iajs-1880 172 23 courjault courjault PROPN iajs-1880 172 24 , , PUNCT iajs-1880 172 25 and and CCONJ iajs-1880 172 26 séguéla séguéla PROPN iajs-1880 172 27 j.p j.p PROPN iajs-1880 172 28 .. .. PROPN iajs-1880 172 29 neonatal neonatal ADJ iajs-1880 172 30 secreening secreene VERB iajs-1880 172 31 for for ADP iajs-1880 172 32 congenital congenital ADJ iajs-1880 172 33 toxoplasmosis toxoplasmosis NOUN iajs-1880 172 34 in in ADP iajs-1880 172 35 cohort cohort NOUN iajs-1880 172 36 of of ADP iajs-1880 172 37 165 165 NUM iajs-1880 172 38 women woman NOUN iajs-1880 172 39 on on ADP iajs-1880 172 40 others other NOUN iajs-1880 172 41 results result NOUN iajs-1880 172 42 of of ADP iajs-1880 172 43 neonatal neonatal ADJ iajs-1880 172 44 test test NOUN iajs-1880 172 45 . . PUNCT iajs-1880 173 1 eur eur PROPN iajs-1880 173 2 . . PUNCT iajs-1880 174 1 obst obst PROPN iajs-1880 174 2 . . PUNCT iajs-1880 175 1 gynecol gynecol PROPN iajs-1880 175 2 . . PUNCT iajs-1880 175 3 repord repord PROPN iajs-1880 175 4 . . PUNCT iajs-1880 176 1 biol biol PROPN iajs-1880 176 2 . . PUNCT iajs-1880 176 3 , , PUNCT iajs-1880 176 4 94 94 NUM iajs-1880 176 5 ( ( PUNCT iajs-1880 176 6 1 1 NUM iajs-1880 176 7 ): ): PUNCT iajs-1880 176 8 3745 3745 NUM iajs-1880 176 9 . . PUNCT iajs-1880 177 1 2001 2001 NUM iajs-1880 178 1 [ [ X iajs-1880 178 2 10 10 NUM iajs-1880 178 3 ] ] PUNCT iajs-1880 178 4 . . PUNCT iajs-1880 179 1 j.d j.d PROPN iajs-1880 179 2 . . PROPN iajs-1880 179 3 kravetz kravetz PROPN iajs-1880 179 4 , , PUNCT iajs-1880 179 5 and and CCONJ iajs-1880 179 6 d.g d.g PROPN iajs-1880 179 7 . . PROPN iajs-1880 179 8 federman federman NOUN iajs-1880 179 9 , , PUNCT iajs-1880 179 10 toxoplasmosis toxoplasmosis NOUN iajs-1880 179 11 in in ADP iajs-1880 179 12 pregnancy pregnancy NOUN iajs-1880 179 13 . . PUNCT iajs-1880 180 1 am be AUX iajs-1880 180 2 . . PUNCT iajs-1880 181 1 j. j. PROPN iajs-1880 181 2 med med PROPN iajs-1880 181 3 . . PROPN iajs-1880 181 4 , , PUNCT iajs-1880 181 5 118 118 NUM iajs-1880 181 6 ( ( PUNCT iajs-1880 181 7 3 3 NUM iajs-1880 181 8 ): ): PUNCT iajs-1880 181 9 212 212 NUM iajs-1880 181 10 - - SYM iajs-1880 181 11 216 216 NUM iajs-1880 181 12 . . PUNCT iajs-1880 181 13 2005 2005 NUM iajs-1880 181 14 . . PUNCT iajs-1880 182 1 [ [ X iajs-1880 182 2 11 11 NUM iajs-1880 182 3 ] ] PUNCT iajs-1880 182 4 . . PUNCT iajs-1880 183 1 i.f i.f PROPN iajs-1880 183 2 . . PROPN iajs-1880 183 3 charo charo PROPN iajs-1880 183 4 , , PUNCT iajs-1880 183 5 and and CCONJ iajs-1880 183 6 m.b m.b PROPN iajs-1880 183 7 . . PROPN iajs-1880 183 8 taubman taubman PROPN iajs-1880 183 9 , , PUNCT iajs-1880 183 10 chemokines chemokine NOUN iajs-1880 183 11 in in ADP iajs-1880 183 12 the the DET iajs-1880 183 13 pahogenesis pahogenesis NOUN iajs-1880 183 14 of of ADP iajs-1880 183 15 vascular vascular ADJ iajs-1880 183 16 disease disease NOUN iajs-1880 183 17 . . PUNCT iajs-1880 184 1 circ circ PROPN iajs-1880 184 2 . . PUNCT iajs-1880 185 1 res re NOUN iajs-1880 185 2 . . PROPN iajs-1880 185 3 , , PUNCT iajs-1880 185 4 95 95 NUM iajs-1880 185 5 ( ( PUNCT iajs-1880 185 6 9 9 NUM iajs-1880 185 7 ): ): PUNCT iajs-1880 185 8 858 858 NUM iajs-1880 185 9 - - SYM iajs-1880 185 10 866 866 NUM iajs-1880 185 11 . . PUNCT iajs-1880 185 12 2004 2004 NUM iajs-1880 185 13 . . PUNCT iajs-1880 186 1 [ [ X iajs-1880 186 2 12 12 NUM iajs-1880 186 3 ] ] PUNCT iajs-1880 186 4 . . PUNCT iajs-1880 187 1 j. j. PROPN iajs-1880 187 2 saki saki PROPN iajs-1880 187 3 ; ; PUNCT iajs-1880 187 4 s.shafieenia s.shafieenia PROPN iajs-1880 187 5 , , PUNCT iajs-1880 187 6 and and CCONJ iajs-1880 187 7 m. m. NOUN iajs-1880 187 8 foroutan foroutan PROPN iajs-1880 187 9 - - PUNCT iajs-1880 187 10 rad rad PROPN iajs-1880 187 11 , , PUNCT iajs-1880 187 12 seroprevalence seroprevalence NOUN iajs-1880 187 13 of of ADP iajs-1880 187 14 toxoplasmosis toxoplasmosis NOUN iajs-1880 187 15 in in ADP iajs-1880 187 16 diabetic diabetic ADJ iajs-1880 187 17 pregnant pregnant ADJ iajs-1880 187 18 women woman NOUN iajs-1880 187 19 in in ADP iajs-1880 187 20 southwesternof southwesternof PROPN iajs-1880 187 21 iran iran PROPN iajs-1880 187 22 . . PUNCT iajs-1880 188 1 j. j. PROPN iajs-1880 188 2 parasit parasit PROPN iajs-1880 188 3 . . PUNCT iajs-1880 189 1 dis dis PROPN iajs-1880 189 2 . . PROPN iajs-1880 189 3 , , PUNCT iajs-1880 189 4 40 40 NUM iajs-1880 189 5 ( ( PUNCT iajs-1880 189 6 4 4 NUM iajs-1880 189 7 ): ): PUNCT iajs-1880 189 8 1586 1586 NUM iajs-1880 189 9 - - SYM iajs-1880 189 10 1589 1589 NUM iajs-1880 189 11 . . PUNCT iajs-1880 190 1 2016 2016 NUM iajs-1880 190 2 . . PUNCT iajs-1880 191 1 [ [ X iajs-1880 191 2 13 13 NUM iajs-1880 191 3 ] ] PUNCT iajs-1880 191 4 . . PUNCT iajs-1880 192 1 j. j. PROPN iajs-1880 192 2 prandota prandota PROPN iajs-1880 192 3 , , PUNCT iajs-1880 192 4 t. t. ADJ iajs-1880 192 5 gondii gondii NOUN iajs-1880 192 6 infection infection NOUN iajs-1880 192 7 acquired acquire VERB iajs-1880 192 8 during during ADP iajs-1880 192 9 pregnancy pregnancy NOUN iajs-1880 192 10 and/or and/or CCONJ iajs-1880 192 11 after after ADP iajs-1880 192 12 birth birth NOUN iajs-1880 192 13 may may AUX iajs-1880 192 14 be be AUX iajs-1880 192 15 responsible responsible ADJ iajs-1880 192 16 for for ADP iajs-1880 192 17 development development NOUN iajs-1880 192 18 of of ADP iajs-1880 192 19 both both DET iajs-1880 192 20 type type NOUN iajs-1880 192 21 1 1 NUM iajs-1880 192 22 and and CCONJ iajs-1880 192 23 2 2 NUM iajs-1880 192 24 diabetes diabetes NOUN iajs-1880 192 25 mellitus mellitus NOUN iajs-1880 192 26 . . PUNCT iajs-1880 193 1 j. j. PROPN iajs-1880 193 2 diab diab PROPN iajs-1880 193 3 . . PUNCT iajs-1880 194 1 metab metab PROPN iajs-1880 194 2 . . PUNCT iajs-1880 194 3 , , PUNCT iajs-1880 194 4 4 4 NUM iajs-1880 194 5 ( ( PUNCT iajs-1880 194 6 2 2 NUM iajs-1880 194 7 ): ): PUNCT iajs-1880 194 8 155 155 NUM iajs-1880 194 9 . . PUNCT iajs-1880 194 10 2013 2013 NUM iajs-1880 194 11 . . PUNCT iajs-1880 195 1 [ [ X iajs-1880 195 2 14 14 NUM iajs-1880 195 3 ] ] SYM iajs-1880 195 4 . . PUNCT iajs-1880 196 1 a.a a.a PROPN iajs-1880 196 2 . . PROPN iajs-1880 196 3 el el PROPN iajs-1880 196 4 - - PUNCT iajs-1880 196 5 awady awady PROPN iajs-1880 196 6 ; ; PUNCT iajs-1880 196 7 a.m.a a.m.a ADJ iajs-1880 196 8 . . PUNCT iajs-1880 196 9 mahgoub mahgoub NOUN iajs-1880 196 10 ; ; PUNCT iajs-1880 196 11 n.m n.m PROPN iajs-1880 196 12 . . PROPN iajs-1880 196 13 naguib naguib PROPN iajs-1880 196 14 , , PUNCT iajs-1880 196 15 and and CCONJ iajs-1880 196 16 m.a.m m.a.m PROPN iajs-1880 196 17 . . PROPN iajs-1880 196 18 ismail ismail PROPN iajs-1880 196 19 , , PUNCT iajs-1880 196 20 comparative comparative ADJ iajs-1880 196 21 study study NOUN iajs-1880 196 22 on on ADP iajs-1880 196 23 the the DET iajs-1880 196 24 diagnostic diagnostic ADJ iajs-1880 196 25 value value NOUN iajs-1880 196 26 of of ADP iajs-1880 196 27 a a DET iajs-1880 196 28 recently recently ADV iajs-1880 196 29 introduced introduce VERB iajs-1880 196 30 quantitative quantitative ADJ iajs-1880 196 31 chemiluminescence chemiluminescence NOUN iajs-1880 196 32 , , PUNCT iajs-1880 196 33 a a DET iajs-1880 196 34 semi semi ADJ iajs-1880 196 35 quantitative quantitative ADJ iajs-1880 196 36 elisa elisa NOUN iajs-1880 196 37 and and CCONJ iajs-1880 196 38 an an DET iajs-1880 196 39 iha iha PROPN iajs-1880 196 40 titration titration NOUN iajs-1880 196 41 in in ADP iajs-1880 196 42 toxoplasma toxoplasma NOUN iajs-1880 196 43 gondii gondii NOUN iajs-1880 196 44 serology serology NOUN iajs-1880 196 45 . . PUNCT iajs-1880 197 1 kasr kasr PROPN iajs-1880 197 2 al al PROPN iajs-1880 197 3 ainy ainy PROPN iajs-1880 197 4 med me VERB iajs-1880 197 5 . . PUNCT iajs-1880 198 1 j. j. PROPN iajs-1880 198 2 , , PUNCT iajs-1880 198 3 15 15 NUM iajs-1880 198 4 ( ( PUNCT iajs-1880 198 5 12 12 NUM iajs-1880 198 6 ): ): PUNCT iajs-1880 198 7 11 11 NUM iajs-1880 198 8 - - SYM iajs-1880 198 9 16 16 NUM iajs-1880 198 10 . . PUNCT iajs-1880 198 11 2009 2009 NUM iajs-1880 198 12 . . PUNCT iajs-1880 199 1 ihsciconf ihsciconf PROPN iajs-1880 199 2 2017 2017 NUM iajs-1880 199 3 special special ADJ iajs-1880 199 4 issue issue NOUN iajs-1880 199 5 ibn ibn PROPN iajs-1880 199 6 al al PROPN iajs-1880 199 7 - - PUNCT iajs-1880 199 8 haitham haitham PROPN iajs-1880 199 9 journal journal PROPN iajs-1880 199 10 for for ADP iajs-1880 199 11 pure pure ADJ iajs-1880 199 12 and and CCONJ iajs-1880 199 13 applied apply VERB iajs-1880 199 14 science science NOUN iajs-1880 199 15 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 199 16 for for ADP iajs-1880 199 17 more more ADJ iajs-1880 199 18 information information NOUN iajs-1880 199 19 about about ADP iajs-1880 199 20 the the DET iajs-1880 199 21 conference conference NOUN iajs-1880 199 22 please please INTJ iajs-1880 199 23 visit visit VERB iajs-1880 199 24 the the DET iajs-1880 199 25 websites website NOUN iajs-1880 199 26 : : PUNCT iajs-1880 199 27 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 199 28           SPACE iajs-1880 199 29 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 199 30     SPACE iajs-1880 199 31 biology|550 biology|550 NOUN iajs-1880 199 32         SPACE iajs-1880 200 1 [ [ X iajs-1880 200 2 15 15 NUM iajs-1880 200 3 ] ] PUNCT iajs-1880 200 4 . . PUNCT iajs-1880 201 1 c.gokce c.gokce ADJ iajs-1880 201 2 ; ; PUNCT iajs-1880 201 3 s.yazar s.yazar NOUN iajs-1880 201 4 ; ; PUNCT iajs-1880 201 5 f.bayram f.bayram NOUN iajs-1880 201 6 ; ; PUNCT iajs-1880 201 7 k.gundogan k.gundogan NUM iajs-1880 201 8 ; ; PUNCT iajs-1880 201 9 q. q. PROPN iajs-1880 201 10 yaman yaman PROPN iajs-1880 201 11 , , PUNCT iajs-1880 201 12 and and CCONJ iajs-1880 201 13 i.sahin i.sahin ADJ iajs-1880 201 14 , , PUNCT iajs-1880 201 15 anti anti ADJ iajs-1880 201 16 - - ADJ iajs-1880 201 17 toxoplasma toxoplasma ADJ iajs-1880 201 18 gondii gondii NOUN iajs-1880 201 19 antibodies antibody NOUN iajs-1880 201 20 in in ADP iajs-1880 201 21 type type NOUN iajs-1880 201 22 2 2 NUM iajs-1880 201 23 diabetes diabetes NOUN iajs-1880 201 24 . . PUNCT iajs-1880 202 1 national national PROPN iajs-1880 202 2 med med PROPN iajs-1880 202 3 . . PUNCT iajs-1880 203 1 j. j. PROPN iajs-1880 203 2 ind ind PROPN iajs-1880 203 3 . . PROPN iajs-1880 203 4 , , PUNCT iajs-1880 203 5 21 21 NUM iajs-1880 203 6 ( ( PUNCT iajs-1880 203 7 1 1 NUM iajs-1880 203 8 ): ): PUNCT iajs-1880 203 9 1 1 NUM iajs-1880 203 10 - - SYM iajs-1880 203 11 51 51 NUM iajs-1880 203 12 . . PUNCT iajs-1880 203 13 2008 2008 NUM iajs-1880 203 14 . . PUNCT iajs-1880 204 1 [ [ X iajs-1880 204 2 16 16 NUM iajs-1880 204 3 ] ] PUNCT iajs-1880 204 4 . . PUNCT iajs-1880 205 1 m.j.modrek m.j.modrek PROPN iajs-1880 205 2 ; ; PUNCT iajs-1880 205 3 r. r. PROPN iajs-1880 205 4 saravani saravani PROPN iajs-1880 205 5 ; ; PUNCT iajs-1880 205 6 m.mousavi m.mousavi VERB iajs-1880 205 7 ; ; PUNCT iajs-1880 205 8 a.s a.s PROPN iajs-1880 205 9 . . PROPN iajs-1880 205 10 khorashad khorashad PROPN iajs-1880 205 11 , , PUNCT iajs-1880 205 12 and and CCONJ iajs-1880 205 13 m. m. NOUN iajs-1880 205 14 piri piri NOUN iajs-1880 205 15 , , PUNCT iajs-1880 205 16 investigation investigation NOUN iajs-1880 205 17 of of ADP iajs-1880 205 18 igg igg PROPN iajs-1880 205 19 and and CCONJ iajs-1880 205 20 igm igm PROPN iajs-1880 205 21 antibodies antibody NOUN iajs-1880 205 22 against against ADP iajs-1880 205 23 toxoplasma toxoplasma NOUN iajs-1880 205 24 gondii gondii NOUN iajs-1880 205 25 among among ADP iajs-1880 205 26 diabetic diabetic ADJ iajs-1880 205 27 patients patient NOUN iajs-1880 205 28 . . PUNCT iajs-1880 206 1 int int NOUN iajs-1880 206 2 . . PUNCT iajs-1880 207 1 j. j. PROPN iajs-1880 207 2 infect infect PROPN iajs-1880 207 3 . . PUNCT iajs-1880 207 4 , , PUNCT iajs-1880 207 5 2 2 NUM iajs-1880 207 6 ( ( PUNCT iajs-1880 207 7 3 3 NUM iajs-1880 207 8 ): ): PUNCT iajs-1880 207 9 1 1 NUM iajs-1880 207 10 - - SYM iajs-1880 207 11 5.2015 5.2015 NUM iajs-1880 207 12 . . PUNCT iajs-1880 208 1 [ [ X iajs-1880 208 2 17 17 NUM iajs-1880 208 3 ] ] PUNCT iajs-1880 208 4 . . PUNCT iajs-1880 209 1 n.tuaillonx n.tuaillonx PROPN iajs-1880 209 2 ; ; PUNCT iajs-1880 209 3 d.f d.f PROPN iajs-1880 209 4 . . PROPN iajs-1880 209 5 shen shen PROPN iajs-1880 209 6 ; ; PUNCT iajs-1880 209 7     SPACE iajs-1880 209 8 b. b. PROPN iajs-1880 209 9 ravi ravi PROPN iajs-1880 209 10 ; ; PUNCT iajs-1880 209 11 b. b. PROPN iajs-1880 209 12 berger berger PROPN iajs-1880 209 13 ; ; PUNCT iajs-1880 209 14 j. j. PROPN iajs-1880 209 15 barrett barrett PROPN iajs-1880 209 16 ; ; PUNCT iajs-1880 209 17 j. j. PROPN iajs-1880 209 18 rollins rollins PROPN iajs-1880 209 19 , , PUNCT iajs-1880 209 20 and and CCONJ iajs-1880 209 21 chi chi PROPN iajs-1880 209 22 - - PUNCT iajs-1880 209 23 chao chao PROPN iajs-1880 209 24 , , PUNCT iajs-1880 209 25 c. c. PROPN iajs-1880 209 26 mcp-1 mcp-1 NOUN iajs-1880 209 27 expression expression NOUN iajs-1880 209 28 in in ADP iajs-1880 209 29 endotoxin endotoxin NOUN iajs-1880 209 30 - - PUNCT iajs-1880 209 31 induced induce VERB iajs-1880 209 32 uveitis uveitis NOUN iajs-1880 209 33 . . PUNCT iajs-1880 210 1 invest invest VERB iajs-1880 210 2 . . PUNCT iajs-1880 211 1 ophthalmol ophthalmol PROPN iajs-1880 211 2 . . PUNCT iajs-1880 212 1 vis vis X iajs-1880 212 2 . . PUNCT iajs-1880 213 1 sci sci PROPN iajs-1880 213 2 . . PROPN iajs-1880 213 3 , , PUNCT iajs-1880 213 4 43 43 NUM iajs-1880 213 5 ( ( PUNCT iajs-1880 213 6 5 5 NUM iajs-1880 213 7 ): ): PUNCT iajs-1880 213 8 14931498 14931498 NUM iajs-1880 213 9 . . PUNCT iajs-1880 214 1 2002 2002 NUM iajs-1880 214 2 . . PUNCT iajs-1880 215 1 [ [ X iajs-1880 215 2 18 18 NUM iajs-1880 215 3 ] ] PUNCT iajs-1880 215 4 . . PUNCT iajs-1880 216 1 k. k. PROPN iajs-1880 216 2 rezende rezende PROPN iajs-1880 216 3 - - PUNCT iajs-1880 216 4 oliveira oliveira PROPN iajs-1880 216 5 ; ; PUNCT iajs-1880 216 6 n.m.silva n.m.silva PROPN iajs-1880 216 7 ; ; PUNCT iajs-1880 216 8 j.r j.r PROPN iajs-1880 216 9 . . PROPN iajs-1880 216 10 mineo mineo PROPN iajs-1880 216 11 , , PUNCT iajs-1880 216 12 and and CCONJ iajs-1880 216 13 j.v j.v PROPN iajs-1880 216 14 . . PROPN iajs-1880 216 15 rodrigues rodrigues PROPN iajs-1880 216 16 , , PUNCT iajs-1880 216 17 cytokines cytokine NOUN iajs-1880 216 18 and and CCONJ iajs-1880 216 19 chemokines chemokine VERB iajs-1880 216 20 production production NOUN iajs-1880 216 21 by by ADP iajs-1880 216 22 mononuclear mononuclear ADJ iajs-1880 216 23 cells cell NOUN iajs-1880 216 24 from from ADP iajs-1880 216 25 parturient parturient ADJ iajs-1880 216 26 women woman NOUN iajs-1880 216 27 after after ADP iajs-1880 216 28 stimulation stimulation NOUN iajs-1880 216 29 with with ADP iajs-1880 216 30 live live ADJ iajs-1880 216 31 toxoplasma toxoplasma NOUN iajs-1880 216 32 gondii gondii NOUN iajs-1880 216 33 . . PUNCT iajs-1880 217 1 placenta placenta PROPN iajs-1880 217 2 , , PUNCT iajs-1880 217 3 33 33 NUM iajs-1880 217 4 ( ( PUNCT iajs-1880 217 5 9 9 NUM iajs-1880 217 6 ): ): PUNCT iajs-1880 217 7 682 682 NUM iajs-1880 217 8 - - SYM iajs-1880 217 9 687 687 NUM iajs-1880 217 10 . . NUM iajs-1880 217 11 2012 2012 NUM iajs-1880 217 12 . . PUNCT iajs-1880 218 1 [ [ X iajs-1880 218 2 19 19 NUM iajs-1880 218 3 ] ] PUNCT iajs-1880 218 4 . . PUNCT iajs-1880 219 1 m.p.brenier m.p.brenier NOUN iajs-1880 219 2 - - PUNCT iajs-1880 219 3 pinchart pinchart ADJ iajs-1880 219 4 ; ; PUNCT iajs-1880 219 5 h. h. PROPN iajs-1880 219 6 pellouxx pellouxx PROPN iajs-1880 219 7 ; ; PUNCT iajs-1880 219 8 j. j. PROPN iajs-1880 219 9 simonx simonx PROPN iajs-1880 219 10 ; ; PUNCT iajs-1880 219 11 j. j. PROPN iajs-1880 219 12 ricard ricard PROPN iajs-1880 219 13 ; ; PUNCT iajs-1880 219 14 j.l j.l PROPN iajs-1880 219 15 . . PROPN iajs-1880 219 16 bosson bosson PROPN iajs-1880 219 17 , , PUNCT iajs-1880 219 18 and and CCONJ iajs-1880 219 19 ambroisethomas ambroisethomas PROPN iajs-1880 219 20 , , PUNCT iajs-1880 219 21 p. p. NOUN iajs-1880 219 22 toxoplasma toxoplasma NOUN iajs-1880 219 23 gondii gondii NOUN iajs-1880 219 24 induces induce VERB iajs-1880 219 25 the the DET iajs-1880 219 26 secretion secretion NOUN iajs-1880 219 27 of of ADP iajs-1880 219 28 monocyte monocyte NOUN iajs-1880 219 29 chemotactic chemotactic PROPN iajs-1880 219 30 protein-1 protein-1 PROPN iajs-1880 219 31 in in ADP iajs-1880 219 32 human human ADJ iajs-1880 219 33 fibroblasts fibroblast NOUN iajs-1880 219 34 , , PUNCT iajs-1880 219 35 in in ADP iajs-1880 219 36 vitro vitro X iajs-1880 219 37 . . PUNCT iajs-1880 219 38 mol mol PROPN iajs-1880 219 39 . . PROPN iajs-1880 219 40 cell cell NOUN iajs-1880 219 41 . . PUNCT iajs-1880 220 1 biochem biochem PROPN iajs-1880 220 2 . . PUNCT iajs-1880 221 1 , , PUNCT iajs-1880 221 2 209 209 NUM iajs-1880 221 3 ( ( PUNCT iajs-1880 221 4 1 1 NUM iajs-1880 221 5 - - SYM iajs-1880 221 6 2 2 NUM iajs-1880 221 7 ): ): PUNCT iajs-1880 221 8 79 79 NUM iajs-1880 221 9 - - SYM iajs-1880 221 10 87 87 NUM iajs-1880 221 11 . . PUNCT iajs-1880 221 12 2000 2000 NUM iajs-1880 221 13 . . PUNCT iajs-1880 222 1 [ [ X iajs-1880 222 2 20 20 NUM iajs-1880 222 3 ] ] PUNCT iajs-1880 222 4 . . PUNCT iajs-1880 223 1 w.r w.r PROPN iajs-1880 223 2 . . PROPN iajs-1880 223 3 ali ali PROPN iajs-1880 223 4 , , PUNCT iajs-1880 223 5 the the DET iajs-1880 223 6 role role NOUN iajs-1880 223 7 of of ADP iajs-1880 223 8 some some DET iajs-1880 223 9 cytokines cytokine NOUN iajs-1880 223 10 and and CCONJ iajs-1880 223 11 trace trace NOUN iajs-1880 223 12 elements element NOUN iajs-1880 223 13 in in ADP iajs-1880 223 14 pregnant pregnant ADJ iajs-1880 223 15 women woman NOUN iajs-1880 223 16 with with ADP iajs-1880 223 17 acute acute ADJ iajs-1880 223 18 toxoplasmosis toxoplasmosis PROPN iajs-1880 223 19 . . PUNCT iajs-1880 224 1 ibn ibn PROPN iajs-1880 224 2 al al PROPN iajs-1880 224 3 - - PUNCT iajs-1880 224 4 haitham haitham PROPN iajs-1880 224 5 j. j. PROPN iajs-1880 224 6 pure pure PROPN iajs-1880 224 7 app app PROPN iajs-1880 224 8 . . PUNCT iajs-1880 225 1 sci sci PROPN iajs-1880 225 2 . . PROPN iajs-1880 225 3 , , PUNCT iajs-1880 225 4 29 29 NUM iajs-1880 225 5 ( ( PUNCT iajs-1880 225 6 2 2 NUM iajs-1880 225 7 ): ): PUNCT iajs-1880 225 8 1 1 NUM iajs-1880 225 9 - - SYM iajs-1880 225 10 8 8 NUM iajs-1880 225 11 . . NOUN iajs-1880 225 12 2016 2016 NUM iajs-1880 225 13 . . PUNCT iajs-1880 226 1 [ [ X iajs-1880 226 2 21 21 NUM iajs-1880 226 3 ] ] PUNCT iajs-1880 226 4 . . PUNCT iajs-1880 227 1 g.mor g.mor NOUN iajs-1880 227 2 , , PUNCT iajs-1880 227 3 inflammation inflammation NOUN iajs-1880 227 4 and and CCONJ iajs-1880 227 5 pregnancy pregnancy NOUN iajs-1880 227 6 : : PUNCT iajs-1880 227 7 the the DET iajs-1880 227 8 role role NOUN iajs-1880 227 9 of of ADP iajs-1880 227 10 toll toll NOUN iajs-1880 227 11 - - PUNCT iajs-1880 227 12 like like ADJ iajs-1880 227 13 receptors receptor NOUN iajs-1880 227 14 in in ADP iajs-1880 227 15 trophoblastimmune trophoblastimmune NOUN iajs-1880 227 16 interaction interaction NOUN iajs-1880 227 17 . . PUNCT iajs-1880 228 1 ann ann PROPN iajs-1880 228 2 . . PUNCT iajs-1880 228 3 acad acad PROPN iajs-1880 228 4 . . PUNCT iajs-1880 229 1 sci sci PROPN iajs-1880 229 2 . . PROPN iajs-1880 229 3 , , PUNCT iajs-1880 229 4 1127 1127 NUM iajs-1880 229 5 : : PUNCT iajs-1880 229 6 121 121 NUM iajs-1880 229 7 - - SYM iajs-1880 229 8 128 128 NUM iajs-1880 229 9 . . PUNCT iajs-1880 229 10 2008 2008 NUM iajs-1880 229 11 . . PUNCT iajs-1880 230 1 [ [ X iajs-1880 230 2 22 22 NUM iajs-1880 230 3 ] ] PUNCT iajs-1880 230 4 . . PUNCT iajs-1880 231 1 b.telejko b.telejko NOUN iajs-1880 231 2 ; ; PUNCT iajs-1880 231 3 m.kuzmicki m.kuzmicki ADV iajs-1880 231 4 , , PUNCT iajs-1880 231 5 and and CCONJ iajs-1880 231 6 a. a. NOUN iajs-1880 231 7 zonenberg zonenberg PROPN iajs-1880 231 8 circulating circulate VERB iajs-1880 231 9 monocyte monocyte PROPN iajs-1880 231 10 chemoattractant chemoattractant NOUN iajs-1880 231 11 protein-1 protein-1 PROPN iajs-1880 231 12 in in ADP iajs-1880 231 13 women woman NOUN iajs-1880 231 14 with with ADP iajs-1880 231 15 gestational gestational ADJ iajs-1880 231 16 diabetes diabetes NOUN iajs-1880 231 17 . . PUNCT iajs-1880 232 1 folia folia PROPN iajs-1880 232 2 histochem histochem PROPN iajs-1880 232 3 . . PUNCT iajs-1880 233 1 cytobiol cytobiol PROPN iajs-1880 233 2 . . PUNCT iajs-1880 234 1 , , PUNCT iajs-1880 234 2 45 45 NUM iajs-1880 234 3 ( ( PUNCT iajs-1880 234 4 1 1 NUM iajs-1880 234 5 ): ): PUNCT iajs-1880 234 6 s153s156 s153s156 PROPN iajs-1880 234 7 . . PROPN iajs-1880 234 8 2007 2007 NUM iajs-1880 234 9 . . PUNCT iajs-1880 235 1 [ [ X iajs-1880 235 2 23 23 NUM iajs-1880 235 3 ] ] PUNCT iajs-1880 235 4 . . PUNCT iajs-1880 236 1 m.younce m.younce NOUN iajs-1880 236 2 ; ; PUNCT iajs-1880 236 3 t. t. NOUN iajs-1880 236 4 nasif nasif NOUN iajs-1880 236 5 , , PUNCT iajs-1880 236 6 and and CCONJ iajs-1880 236 7 a. a. NOUN iajs-1880 236 8 redhah redhah NOUN iajs-1880 236 9 , , PUNCT iajs-1880 236 10 assessment assessment NOUN iajs-1880 236 11 of of ADP iajs-1880 236 12 mcp-1 mcp-1 NOUN iajs-1880 236 13 and and CCONJ iajs-1880 236 14 vegf vegf NOUN iajs-1880 236 15 in in ADP iajs-1880 236 16 a a DET iajs-1880 236 17 study study NOUN iajs-1880 236 18 case case NOUN iajs-1880 236 19 . . PUNCT iajs-1880 237 1 endo endo NOUN iajs-1880 237 2 . . PUNCT iajs-1880 238 1 biol biol PROPN iajs-1880 238 2 . . PUNCT iajs-1880 239 1 j. j. PROPN iajs-1880 239 2 , , PUNCT iajs-1880 239 3 12 12 NUM iajs-1880 239 4 ( ( PUNCT iajs-1880 239 5 7 7 NUM iajs-1880 239 6 ): ): PUNCT iajs-1880 239 7 311 311 NUM iajs-1880 239 8 - - SYM iajs-1880 239 9 313 313 NUM iajs-1880 239 10 . . PUNCT iajs-1880 239 11 2014 2014 NUM iajs-1880 240 1 [ [ X iajs-1880 240 2 24 24 NUM iajs-1880 240 3 ] ] PUNCT iajs-1880 240 4 . . PUNCT iajs-1880 241 1 p.jun p.jun PROPN iajs-1880 241 2 , , PUNCT iajs-1880 241 3 monocyte monocyte NOUN iajs-1880 241 4 chemoattractant chemoattractant NOUN iajs-1880 241 5 protein protein NOUN iajs-1880 241 6 1 1 NUM iajs-1880 241 7 ( ( PUNCT iajs-1880 241 8 mcp-1 mcp-1 NOUN iajs-1880 241 9 ) ) PUNCT iajs-1880 241 10 in in ADP iajs-1880 241 11 obesity obesity NOUN iajs-1880 241 12 and and CCONJ iajs-1880 241 13 diabetes diabetes NOUN iajs-1880 241 14 . . PUNCT iajs-1880 242 1 cytokine cytokine NOUN iajs-1880 242 2 , , PUNCT iajs-1880 242 3 60 60 NUM iajs-1880 242 4 ( ( PUNCT iajs-1880 242 5 1 1 NUM iajs-1880 242 6 ): ): PUNCT iajs-1880 242 7 1 1 NUM iajs-1880 242 8 - - SYM iajs-1880 242 9 12 12 NUM iajs-1880 242 10 . . PUNCT iajs-1880 242 11 2012 2012 NUM iajs-1880 242 12 . . PUNCT iajs-1880 243 1 [ [ X iajs-1880 243 2 24 24 NUM iajs-1880 243 3 ] ] PUNCT iajs-1880 243 4 . . PUNCT iajs-1880 244 1 h.j.waheed h.j.waheed PROPN iajs-1880 244 2 ; ; PUNCT iajs-1880 244 3 m. m. PROPN iajs-1880 244 4 khalil khalil PROPN iajs-1880 244 5 and and CCONJ iajs-1880 244 6 s. s. PROPN iajs-1880 244 7 fawzi fawzi PROPN iajs-1880 244 8 , , PUNCT iajs-1880 244 9 evaluation evaluation NOUN iajs-1880 244 10 of of ADP iajs-1880 244 11 monocyte monocyte NOUN iajs-1880 244 12 chemoattractant chemoattractant NOUN iajs-1880 244 13 protein1 protein1 NOUN iajs-1880 244 14 ( ( PUNCT iajs-1880 244 15 mcp-1 mcp-1 NOUN iajs-1880 244 16 ) ) PUNCT iajs-1880 244 17 in in ADP iajs-1880 244 18 type type NOUN iajs-1880 244 19 2 2 NUM iajs-1880 244 20 diabetes diabetes NOUN iajs-1880 244 21 mellitus mellitus NOUN iajs-1880 244 22 . . PUNCT iajs-1880 245 1 int int NOUN iajs-1880 245 2 . . PUNCT iajs-1880 246 1 j. j. PROPN iajs-1880 246 2 sci sci PROPN iajs-1880 246 3 . . PUNCT iajs-1880 247 1 eng eng PROPN iajs-1880 247 2 . . PUNCT iajs-1880 248 1 res res PROPN iajs-1880 248 2 . . PROPN iajs-1880 248 3 , , PUNCT iajs-1880 248 4 6 6 NUM iajs-1880 248 5 ( ( PUNCT iajs-1880 248 6 5 5 NUM iajs-1880 248 7 ): ): PUNCT iajs-1880 248 8 791 791 NUM iajs-1880 248 9 - - SYM iajs-1880 248 10 797 797 NUM iajs-1880 248 11 . . X iajs-1880 248 12 2015 2015 NUM iajs-1880 249 1 [ [ X iajs-1880 249 2 25 25 NUM iajs-1880 249 3 ] ] PUNCT iajs-1880 249 4 . . PUNCT iajs-1880 250 1 m.karimi m.karimi NOUN iajs-1880 250 2 - - PUNCT iajs-1880 250 3 googheri googheri NOUN iajs-1880 250 4 ; ; PUNCT iajs-1880 250 5 h.daneshvar h.daneshvar NOUN iajs-1880 250 6 ; ; PUNCT iajs-1880 250 7 r. r. NOUN iajs-1880 250 8 nosratabadi nosratabadi NOUN iajs-1880 250 9 ; ; PUNCT iajs-1880 250 10 m. m. NOUN iajs-1880 250 11 zare zare PROPN iajs-1880 250 12 - - PUNCT iajs-1880 250 13 bidaki bidaki NOUN iajs-1880 250 14 ; ; PUNCT iajs-1880 250 15 g g PROPN iajs-1880 250 16 .hassanshahi .hassanshahi NOUN iajs-1880 250 17 . . PUNCT iajs-1880 250 18 ; ; PUNCT iajs-1880 250 19 m. m. PROPN iajs-1880 250 20 ebrahim ebrahim PROPN iajs-1880 250 21 ; ; PUNCT iajs-1880 250 22 m.k m.k PROPN iajs-1880 250 23 . . PROPN iajs-1880 250 24 arababadi arababadi PROPN iajs-1880 250 25 , , PUNCT iajs-1880 250 26 and and CCONJ iajs-1880 250 27 d. d. PROPN iajs-1880 250 28 kennedy kennedy PROPN iajs-1880 250 29 , , PUNCT iajs-1880 250 30 important important ADJ iajs-1880 250 31 roles role NOUN iajs-1880 250 32 played play VERB iajs-1880 250 33 by by ADP iajs-1880 250 34 tgf tgf PROPN iajs-1880 250 35 - - PUNCT iajs-1880 250 36 β β PROPN iajs-1880 250 37 in in ADP iajs-1880 250 38 hepatitis hepatitis PROPN iajs-1880 250 39 b b NOUN iajs-1880 250 40 infection infection NOUN iajs-1880 250 41 . . PUNCT iajs-1880 251 1 j. j. PROPN iajs-1880 251 2 med med PROPN iajs-1880 251 3 . . PUNCT iajs-1880 251 4 virol virol PROPN iajs-1880 251 5 . . PUNCT iajs-1880 252 1 , , PUNCT iajs-1880 252 2 86 86 NUM iajs-1880 252 3 ( ( PUNCT iajs-1880 252 4 1 1 NUM iajs-1880 252 5 ): ): PUNCT iajs-1880 252 6 102 102 NUM iajs-1880 252 7 - - SYM iajs-1880 252 8 108 108 NUM iajs-1880 252 9 . . PUNCT iajs-1880 253 1 2014 2014 NUM iajs-1880 253 2 . . PUNCT iajs-1880 254 1 [ [ X iajs-1880 254 2 26 26 NUM iajs-1880 254 3 ] ] PUNCT iajs-1880 254 4 . . PUNCT iajs-1880 255 1 a.strack a.strack PROPN iajs-1880 255 2 ; ; PUNCT iajs-1880 255 3 v.c v.c PROPN iajs-1880 255 4 . . PROPN iajs-1880 255 5 asensio asensio PROPN iajs-1880 255 6 ; ; PUNCT iajs-1880 255 7 i.l i.l PROPN iajs-1880 255 8 . . PROPN iajs-1880 255 9 campbell campbell PROPN iajs-1880 255 10 ; ; PUNCT iajs-1880 255 11 d. d. PROPN iajs-1880 255 12 schlüter schlüter PROPN iajs-1880 255 13 ; ; PUNCT iajs-1880 255 14 and and CCONJ iajs-1880 255 15 m. m. NOUN iajs-1880 255 16 deckert deckert PROPN iajs-1880 255 17 , , PUNCT iajs-1880 255 18 chemokines chemokine NOUN iajs-1880 255 19 are be AUX iajs-1880 255 20 differentially differentially ADV iajs-1880 255 21 expressed express VERB iajs-1880 255 22 by by ADP iajs-1880 255 23 astrocytes astrocyte NOUN iajs-1880 255 24 , , PUNCT iajs-1880 255 25 microglia microglia ADJ iajs-1880 255 26 and and CCONJ iajs-1880 255 27 inflammatory inflammatory ADJ iajs-1880 255 28 leukocytes leukocyte NOUN iajs-1880 255 29 in in ADP iajs-1880 255 30 toxoplasma toxoplasma NOUN iajs-1880 255 31 encephalitis encephalitis NOUN iajs-1880 255 32 and and CCONJ iajs-1880 255 33 critically critically ADV iajs-1880 255 34 regulated regulate VERB iajs-1880 255 35 by by ADP iajs-1880 255 36 interferon interferon ADJ iajs-1880 255 37 - - PUNCT iajs-1880 255 38 gamma gamma NOUN iajs-1880 255 39 . . PUNCT iajs-1880 256 1 acta acta PROPN iajs-1880 256 2 . . PUNCT iajs-1880 257 1 neuropathol neuropathol PROPN iajs-1880 257 2 . . PUNCT iajs-1880 257 3 , , PUNCT iajs-1880 257 4 103 103 NUM iajs-1880 257 5 ( ( PUNCT iajs-1880 257 6 5 5 NUM iajs-1880 257 7 ): ): PUNCT iajs-1880 257 8 458 458 NUM iajs-1880 257 9 - - SYM iajs-1880 257 10 468 468 NUM iajs-1880 257 11 . . PUNCT iajs-1880 257 12 2002 2002 NUM iajs-1880 257 13 . . PUNCT iajs-1880 258 1 [ [ X iajs-1880 258 2 27 27 NUM iajs-1880 258 3 ] ] PUNCT iajs-1880 258 4 . . PUNCT iajs-1880 259 1 m. m. NOUN iajs-1880 259 2 jagannathan jagannathan PROPN iajs-1880 259 3 ; ; PUNCT iajs-1880 259 4 m.e m.e PROPN iajs-1880 259 5 . . PROPN iajs-1880 259 6 mcdonnell mcdonnell PROPN iajs-1880 259 7 ; ; PUNCT iajs-1880 259 8 h.shin h.shin PROPN iajs-1880 259 9 , , PUNCT iajs-1880 259 10 ; ; PUNCT iajs-1880 259 11 q.rehman q.rehman ADJ iajs-1880 259 12 ; ; PUNCT iajs-1880 259 13 h. h. PROPN iajs-1880 259 14 hasturk hasturk PROPN iajs-1880 259 15 , , PUNCT iajs-1880 259 16 and and CCONJ iajs-1880 259 17 apovian apovian ADJ iajs-1880 259 18 , , PUNCT iajs-1880 259 19 c.m c.m PROPN iajs-1880 259 20 . . PROPN iajs-1880 259 21 elevated elevated ADJ iajs-1880 259 22 proinflammatory proinflammatory ADJ iajs-1880 259 23 cytokine cytokine NOUN iajs-1880 259 24 production production NOUN iajs-1880 259 25 by by ADP iajs-1880 259 26 a a DET iajs-1880 259 27 skewed skewed ADJ iajs-1880 259 28 t t NOUN iajs-1880 259 29 cell cell NOUN iajs-1880 259 30 compartment compartment NOUN iajs-1880 259 31 requires require VERB iajs-1880 259 32 monocytes monocyte NOUN iajs-1880 259 33 and and CCONJ iajs-1880 259 34 promotes promote VERB iajs-1880 259 35 inflammation inflammation NOUN iajs-1880 259 36 in in ADP iajs-1880 259 37 type type NOUN iajs-1880 259 38 2 2 NUM iajs-1880 259 39 diabetes diabetes NOUN iajs-1880 259 40 . . PUNCT iajs-1880 260 1 j. j. PROPN iajs-1880 260 2 immunol immunol PROPN iajs-1880 260 3 . . PROPN iajs-1880 260 4 , , PUNCT iajs-1880 260 5 186 186 NUM iajs-1880 260 6 ( ( PUNCT iajs-1880 260 7 2):1162–72 2):1162–72 NUM iajs-1880 260 8 . . NOUN iajs-1880 260 9 2011 2011 NUM iajs-1880 260 10 . . PUNCT iajs-1880 261 1 [ [ X iajs-1880 261 2 28 28 NUM iajs-1880 261 3 ] ] PUNCT iajs-1880 261 4 . . PUNCT iajs-1880 262 1 j.l.du j.l.du PROPN iajs-1880 262 2 ; ; PUNCT iajs-1880 262 3 c.k c.k PROPN iajs-1880 262 4 . . PROPN iajs-1880 262 5 sun sun PROPN iajs-1880 262 6 , , PUNCT iajs-1880 262 7 and and CCONJ iajs-1880 262 8 b.lü b.lü PROPN iajs-1880 262 9 , , PUNCT iajs-1880 262 10 association association NOUN iajs-1880 262 11 of of ADP iajs-1880 262 12 sels sel NOUN iajs-1880 262 13 mrna mrna PROPN iajs-1880 262 14 expression expression NOUN iajs-1880 262 15 in in ADP iajs-1880 262 16 omental omental ADJ iajs-1880 262 17 adipose adipose ADJ iajs-1880 262 18 tissue tissue NOUN iajs-1880 262 19 with with ADP iajs-1880 262 20 homa homa NOUN iajs-1880 262 21 - - PUNCT iajs-1880 262 22 ir ir PROPN iajs-1880 262 23 and and CCONJ iajs-1880 262 24 serum serum VERB iajs-1880 262 25 amyloid amyloid NOUN iajs-1880 262 26 a a PRON iajs-1880 262 27 in in ADP iajs-1880 262 28 patients patient NOUN iajs-1880 262 29 with with ADP iajs-1880 262 30 type type NOUN iajs-1880 262 31 2 2 NUM iajs-1880 262 32 diabetes diabetes NOUN iajs-1880 262 33 mellitus mellitus NOUN iajs-1880 262 34 . . PUNCT iajs-1880 263 1 chinese chinese PROPN iajs-1880 263 2 med med PROPN iajs-1880 263 3 . . PUNCT iajs-1880 264 1 j. j. PROPN iajs-1880 264 2 , , PUNCT iajs-1880 264 3 121 121 NUM iajs-1880 264 4 ( ( PUNCT iajs-1880 264 5 13 13 NUM iajs-1880 264 6 ): ): PUNCT iajs-1880 264 7 1165 1165 NUM iajs-1880 264 8 - - SYM iajs-1880 264 9 1168 1168 NUM iajs-1880 264 10 . . PUNCT iajs-1880 264 11 2008 2008 NUM iajs-1880 264 12 . . PUNCT iajs-1880 265 1 ihsciconf ihsciconf PROPN iajs-1880 265 2 2017 2017 NUM iajs-1880 265 3 special special ADJ iajs-1880 265 4 issue issue NOUN iajs-1880 265 5 ibn ibn PROPN iajs-1880 265 6 al al PROPN iajs-1880 265 7 - - PUNCT iajs-1880 265 8 haitham haitham PROPN iajs-1880 265 9 journal journal PROPN iajs-1880 265 10 for for ADP iajs-1880 265 11 pure pure ADJ iajs-1880 265 12 and and CCONJ iajs-1880 265 13 applied apply VERB iajs-1880 265 14 science science NOUN iajs-1880 265 15 https://doi.org/10.30526/2017.ihsciconf.1880 https://doi.org/10.30526/2017.ihsciconf.1880 PROPN iajs-1880 265 16 for for ADP iajs-1880 265 17 more more ADJ iajs-1880 265 18 information information NOUN iajs-1880 265 19 about about ADP iajs-1880 265 20 the the DET iajs-1880 265 21 conference conference NOUN iajs-1880 265 22 please please INTJ iajs-1880 265 23 visit visit VERB iajs-1880 265 24 the the DET iajs-1880 265 25 websites website NOUN iajs-1880 265 26 : : PUNCT iajs-1880 265 27 http://www.ihsciconf.org/conf/ http://www.ihsciconf.org/conf/ VERB iajs-1880 265 28           SPACE iajs-1880 265 29 www.ihsciconf.org www.ihsciconf.org ADJ iajs-1880 265 30     SPACE iajs-1880 265 31 biology|551 biology|551 PROPN iajs-1880 265 32         SPACE iajs-1880 266 1 [ [ X iajs-1880 266 2 29 29 NUM iajs-1880 266 3 ] ] PUNCT iajs-1880 266 4 . . PUNCT iajs-1880 267 1 r.e.lyons r.e.lyon NOUN iajs-1880 267 2 ; ; PUNCT iajs-1880 267 3 j.p.anthony j.p.anthony X iajs-1880 267 4 ; ; PUNCT iajs-1880 267 5 ferguson ferguson PROPN iajs-1880 267 6 d.j.p d.j.p PROPN iajs-1880 267 7 . . PUNCT iajs-1880 268 1 byrne byrne PROPN iajs-1880 268 2 , , PUNCT iajs-1880 268 3 n. n. NOUN iajs-1880 268 4 ; ; PUNCT iajs-1880 268 5 j.alexander j.alexander PROPN iajs-1880 268 6 ; ; PUNCT iajs-1880 268 7 f. f. PROPN iajs-1880 268 8 roberts roberts PROPN iajs-1880 268 9 , , PUNCT iajs-1880 268 10 and and CCONJ iajs-1880 268 11 c.w c.w PROPN iajs-1880 268 12 . . PROPN iajs-1880 268 13 roberts roberts PROPN iajs-1880 268 14 . . PUNCT iajs-1880 269 1 immunological immunological ADJ iajs-1880 269 2 studies study NOUN iajs-1880 269 3 of of ADP iajs-1880 269 4 chronic chronic ADJ iajs-1880 269 5 ocular ocular ADJ iajs-1880 269 6 transforming transform VERB iajs-1880 269 7 growth growth NOUN iajs-1880 269 8 factor factor NOUN iajs-1880 269 9 beta beta NOUN iajs-1880 269 10 and and CCONJ iajs-1880 269 11 a a DET iajs-1880 269 12 histocompatibility histocompatibility NOUN iajs-1880 269 13 complex complex ADJ iajs-1880 269 14 class class NOUN iajs-1880 269 15 i i PROPN iajs-1880 269 16 and and CCONJ iajs-1880 269 17 toxoplasmosis toxoplasmosis PROPN iajs-1880 269 18 : : PUNCT iajs-1880 269 19 up up ADP iajs-1880 269 20 - - PUNCT iajs-1880 269 21 regulation regulation NOUN iajs-1880 269 22 of of ADP iajs-1880 269 23 major major ADJ iajs-1880 269 24 protective protective ADJ iajs-1880 269 25 role role NOUN iajs-1880 269 26 for for ADP iajs-1880 269 27 interleukin-6 interleukin-6 PRON iajs-1880 269 28 . . PUNCT iajs-1880 270 1 infect infect VERB iajs-1880 270 2 . . PUNCT iajs-1880 271 1 immun immun PROPN iajs-1880 271 2 . . PROPN iajs-1880 271 3 , , PUNCT iajs-1880 271 4 69 69 NUM iajs-1880 271 5 ( ( PUNCT iajs-1880 271 6 4 4 NUM iajs-1880 271 7 ): ): PUNCT iajs-1880 271 8 2592 2592 NUM iajs-1880 271 9 - - SYM iajs-1880 271 10 2594 2594 NUM iajs-1880 271 11 . . PUNCT iajs-1880 272 1 2001 2001 NUM iajs-1880 273 1 [ [ X iajs-1880 273 2 30 30 NUM iajs-1880 273 3 ] ] PUNCT iajs-1880 273 4 . . PUNCT iajs-1880 274 1 c.r.mackenzie c.r.mackenzie NOUN iajs-1880 274 2 ; ; PUNCT iajs-1880 274 3 r.g.gonzalez r.g.gonzalez NOUN iajs-1880 274 4 ; ; PUNCT iajs-1880 274 5 e.kniep e.kniep PRON iajs-1880 274 6 ; ; PUNCT iajs-1880 274 7 s.roch s.roch ADJ iajs-1880 274 8 , , PUNCT iajs-1880 274 9 and and CCONJ iajs-1880 274 10 w. w. NOUN iajs-1880 274 11 daubener daubener NOUN iajs-1880 274 12 , , PUNCT iajs-1880 274 13 cytokine cytokine NOUN iajs-1880 274 14 mediated mediate VERB iajs-1880 274 15 regulation regulation NOUN iajs-1880 274 16 of of ADP iajs-1880 274 17 interferon interferon ADJ iajs-1880 274 18 - - PUNCT iajs-1880 274 19 gamma gamma NOUN iajs-1880 274 20 - - PUNCT iajs-1880 274 21 induced induce VERB iajs-1880 274 22 ido ido NOUN iajs-1880 274 23 activation activation NOUN iajs-1880 274 24 . . PUNCT iajs-1880 275 1 adv adv PROPN iajs-1880 275 2 . . PUNCT iajs-1880 276 1 exp exp PROPN iajs-1880 276 2 . . PROPN iajs-1880 276 3 med med PROPN iajs-1880 276 4 . . PUNCT iajs-1880 277 1 biol biol PROPN iajs-1880 277 2 . . PUNCT iajs-1880 277 3 , , PUNCT iajs-1880 277 4 467 467 NUM iajs-1880 277 5 : : SYM iajs-1880 277 6 533539 533539 NUM iajs-1880 277 7 . . PUNCT iajs-1880 278 1 1999 1999 NUM iajs-1880 279 1 [ [ X iajs-1880 279 2 31].l.e.bermudez 31].l.e.bermudez PROPN iajs-1880 279 3 ; ; PUNCT iajs-1880 279 4 g.covaro g.covaro NOUN iajs-1880 279 5 , , PUNCT iajs-1880 279 6 and and CCONJ iajs-1880 279 7 j.remington j.remington PROPN iajs-1880 279 8 , , PUNCT iajs-1880 279 9 infection infection NOUN iajs-1880 279 10 of of ADP iajs-1880 279 11 murine murine ADJ iajs-1880 279 12 macrophages macrophage NOUN iajs-1880 279 13 with with ADP iajs-1880 279 14 toxoplasma toxoplasma NOUN iajs-1880 279 15 gondii gondii NOUN iajs-1880 279 16 is be AUX iajs-1880 279 17 associated associate VERB iajs-1880 279 18 with with ADP iajs-1880 279 19 release release NOUN iajs-1880 279 20 of of ADP iajs-1880 279 21 transforming transform VERB iajs-1880 279 22 growth growth NOUN iajs-1880 279 23 factor factor NOUN iajs-1880 279 24 beta beta NOUN iajs-1880 279 25 and and CCONJ iajs-1880 279 26 down down ADP iajs-1880 279 27 regulation regulation NOUN iajs-1880 279 28 of of ADP iajs-1880 279 29 expression expression NOUN iajs-1880 279 30 of of ADP iajs-1880 279 31 tumor tumor NOUN iajs-1880 279 32 necrosis necrosis NOUN iajs-1880 279 33 factor factor NOUN iajs-1880 279 34 receptors receptor NOUN iajs-1880 279 35 . . PUNCT iajs-1880 280 1 infect infect VERB iajs-1880 280 2 immun immun PROPN iajs-1880 280 3 . . PROPN iajs-1880 281 1 , , PUNCT iajs-1880 281 2 61 61 NUM iajs-1880 281 3 ( ( PUNCT iajs-1880 281 4 10 10 NUM iajs-1880 281 5 ): ): SYM iajs-1880 281 6 41264130 41264130 NUM iajs-1880 281 7 . . PUNCT iajs-1880 282 1 1993 1993 NUM iajs-1880 283 1 [ [ X iajs-1880 283 2 32 32 NUM iajs-1880 283 3 ] ] PUNCT iajs-1880 283 4 . . PUNCT iajs-1880 284 1 c.n.nagineni c.n.nagineni NOUN iajs-1880 284 2 ; ; PUNCT iajs-1880 284 3 b.detrick b.detrick ADJ iajs-1880 284 4 , , PUNCT iajs-1880 284 5 and and CCONJ iajs-1880 284 6 j.j j.j PROPN iajs-1880 284 7 . . PROPN iajs-1880 284 8 hooks hook NOUN iajs-1880 284 9 , , PUNCT iajs-1880 284 10 transforming transform VERB iajs-1880 284 11 growth growth NOUN iajs-1880 284 12 factor factor NOUN iajs-1880 284 13 - - PUNCT iajs-1880 284 14 beta beta NOUN iajs-1880 284 15 expression expression NOUN iajs-1880 284 16 in in ADP iajs-1880 284 17 human human ADJ iajs-1880 284 18 retinal retinal ADJ iajs-1880 284 19 pigment pigment ADJ iajs-1880 284 20 epithelial epithelial ADJ iajs-1880 284 21 cells cell NOUN iajs-1880 284 22 is be AUX iajs-1880 284 23 enhanced enhance VERB iajs-1880 284 24 by by ADP iajs-1880 284 25 toxoplasma toxoplasma NOUN iajs-1880 284 26 gondii gondii NOUN iajs-1880 284 27 : : PUNCT iajs-1880 284 28 a a DET iajs-1880 284 29 possible possible ADJ iajs-1880 284 30 role role NOUN iajs-1880 284 31 in in ADP iajs-1880 284 32 the the DET iajs-1880 284 33 immunopathogenesis immunopathogenesis NOUN iajs-1880 284 34 of of ADP iajs-1880 284 35 retinochoroiditis retinochoroiditis NOUN iajs-1880 284 36 . . PUNCT iajs-1880 285 1 clin clin PROPN iajs-1880 285 2 . . PUNCT iajs-1880 286 1 exp exp PROPN iajs-1880 286 2 . . PUNCT iajs-1880 286 3 immunol immunol PROPN iajs-1880 286 4 . . PROPN iajs-1880 286 5 , , PUNCT iajs-1880 286 6 128 128 NUM iajs-1880 286 7 ( ( PUNCT iajs-1880 286 8 2 2 NUM iajs-1880 286 9 ): ): PUNCT iajs-1880 286 10 372 372 NUM iajs-1880 286 11 - - SYM iajs-1880 286 12 378 378 NUM iajs-1880 286 13 . . PUNCT iajs-1880 286 14 2002 2002 NUM